<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1 20151215//EN"  "JATS-archivearticle1.dtd"><article article-type="review-article" dtd-version="1.1" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn pub-type="epub" publication-format="electronic">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">65243</article-id><article-id pub-id-type="doi">10.7554/eLife.65243</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Review Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Evolutionary Biology</subject></subj-group></article-categories><title-group><article-title>Evolutionary conflicts and adverse effects of antiviral factors</article-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes" id="author-121281"><name><surname>Sauter</surname><given-names>Daniel</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0001-7665-0040</contrib-id><email>daniel.sauter@uni-ulm.de</email><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="other" rid="fund2"/><xref ref-type="other" rid="fund4"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-21373"><name><surname>Kirchhoff</surname><given-names>Frank</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-7052-2360</contrib-id><email>frank.kirchhoff@uni-ulm.de</email><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="fund1"/><xref ref-type="other" rid="fund2"/><xref ref-type="other" rid="fund3"/><xref ref-type="fn" rid="conf1"/></contrib><aff id="aff1"><label>1</label><institution>Institute of Molecular Virology, Ulm University Medical Center</institution><addr-line><named-content content-type="city">Ulm</named-content></addr-line><country>Germany</country></aff><aff id="aff2"><label>2</label><institution>Institute of Medical Virology and Epidemiology of Viral Diseases, University Hospital Tübingen</institution><addr-line><named-content content-type="city">Tübingen</named-content></addr-line><country>Germany</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor"><name><surname>Soldati-Favre</surname><given-names>Dominique</given-names></name><role>Reviewing Editor</role><aff><institution>University of Geneva</institution><country>Switzerland</country></aff></contrib><contrib contrib-type="senior_editor"><name><surname>Soldati-Favre</surname><given-names>Dominique</given-names></name><role>Senior Editor</role><aff><institution>University of Geneva</institution><country>Switzerland</country></aff></contrib></contrib-group><pub-date date-type="publication" publication-format="electronic"><day>15</day><month>01</month><year>2021</year></pub-date><pub-date pub-type="collection"><year>2021</year></pub-date><volume>10</volume><elocation-id>e65243</elocation-id><history><date date-type="received" iso-8601-date="2020-11-30"><day>30</day><month>11</month><year>2020</year></date><date date-type="accepted" iso-8601-date="2021-01-06"><day>06</day><month>01</month><year>2021</year></date></history><permissions><copyright-statement>© 2021, Sauter and Kirchhoff</copyright-statement><copyright-year>2021</copyright-year><copyright-holder>Sauter and Kirchhoff</copyright-holder><ali:free_to_read/><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><ali:license_ref>http://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-65243-v1.pdf"/><abstract><p>Human cells are equipped with a plethora of antiviral proteins protecting them against invading viral pathogens. In contrast to apoptotic or pyroptotic cell death, which serves as ultima ratio to combat viral infections, these cell-intrinsic restriction factors may prevent or at least slow down viral spread while allowing the host cell to survive. Nevertheless, their antiviral activity may also have detrimental effects on the host. While the molecular mechanisms underlying the antiviral activity of restriction factors are frequently well investigated, potential undesired effects of their antiviral functions on the host cell are hardly explored. With a focus on antiretroviral proteins, we summarize in this review how individual restriction factors may exert adverse effects as trade-off for efficient defense against attacking pathogens.</p></abstract><kwd-group kwd-group-type="author-keywords"><kwd>restriction factors</kwd><kwd>viral pathogens</kwd><kwd>adverse effects</kwd><kwd>innate immunitya</kwd></kwd-group><funding-group><award-group id="fund1"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100001659</institution-id><institution>Deutsche Forschungsgemeinschaft</institution></institution-wrap></funding-source><award-id>CRC1279</award-id><principal-award-recipient><name><surname>Kirchhoff</surname><given-names>Frank</given-names></name></principal-award-recipient></award-group><award-group id="fund2"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100001659</institution-id><institution>Deutsche Forschungsgemeinschaft</institution></institution-wrap></funding-source><award-id>SPP1923</award-id><principal-award-recipient><name><surname>Sauter</surname><given-names>Daniel</given-names></name><name><surname>Kirchhoff</surname><given-names>Frank</given-names></name></principal-award-recipient></award-group><award-group id="fund3"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100002347</institution-id><institution>Bundesministerium für Bildung und Forschung</institution></institution-wrap></funding-source><award-id>01KI20135</award-id><principal-award-recipient><name><surname>Kirchhoff</surname><given-names>Frank</given-names></name></principal-award-recipient></award-group><award-group id="fund4"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100001659</institution-id><institution>Deutsche Forschungsgemeinschaft</institution></institution-wrap></funding-source><award-id>SA 2676/3-1, Heisenberg-Programm</award-id><principal-award-recipient><name><surname>Sauter</surname><given-names>Daniel</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group><custom-meta-group><custom-meta specific-use="meta-only"><meta-name>Author impact statement</meta-name><meta-value>Innate antiviral factors do not always perfectly distinguish between self and foreign, and potential adverse effects of antiviral defense mechanisms for the host have been discussed.</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="s1" sec-type="intro"><title>Introduction</title><p>Restriction factors are structurally and functionally highly diverse cellular proteins that represent important effectors of the early immune response and may target viral pathogens by numerous mechanisms at essentially every step of their replication cycle (<xref ref-type="bibr" rid="bib61">Ghimire et al., 2018</xref>; <xref ref-type="bibr" rid="bib71">Harris et al., 2012</xref>; <xref ref-type="bibr" rid="bib97">Kluge et al., 2015</xref>; <xref ref-type="bibr" rid="bib119">Malim and Bieniasz, 2012</xref>). The term ‘restriction factor’ has already been established about 50 years ago following the discovery that the Friend virus susceptibility protein 1 (Fv1) protects mice against otherwise lethal Murine leukemia virus (MLV) infections (<xref ref-type="bibr" rid="bib113">Lilly, 1970</xref>). Since then, many cellular factors have been reported to exert antiviral activity. Among the first to be molecularly characterized was MxA, which protects cells against viruses replicating in the nucleus, such as influenza A virus (IAV) (<xref ref-type="bibr" rid="bib173">Staeheli et al., 1986</xref>). It is debated which of the many antiviral factors that have been reported deserve the designation restriction factor. Proteins that are not directly involved in antiviral immunity may still suppress viral replication if they modulate cellular pathways that are exploited by viruses. Thus, antiviral activity, particularly in overexpression settings, is insufficient for definitive assignment, and there is no unambiguous definition of restriction factors (<xref ref-type="bibr" rid="bib44">Doyle et al., 2015</xref>; <xref ref-type="bibr" rid="bib71">Harris et al., 2012</xref>; <xref ref-type="bibr" rid="bib97">Kluge et al., 2015</xref>). While exceptions do exist, most of these cellular antiviral factors share a few common characteristics. Although they are constitutively expressed in many cell types to provide immediate protection against viral pathogens, most of them are further upregulated by interferons (IFNs) upon sensing of viral invaders (<xref ref-type="bibr" rid="bib44">Doyle et al., 2015</xref>; <xref ref-type="bibr" rid="bib71">Harris et al., 2012</xref>; <xref ref-type="bibr" rid="bib97">Kluge et al., 2015</xref>). Innate antiviral factors have the task to protect us against a large variety of viruses. To fulfill this task, many restriction factors directly target evolutionarily conserved structural features (e.g. viral genomes) or events in the viral replication cycle (e.g. fusion, budding) and exert broad antiviral activity (<xref ref-type="table" rid="table1">Table 1</xref>, <xref ref-type="fig" rid="fig1">Figure 1</xref>; <xref ref-type="bibr" rid="bib97">Kluge et al., 2015</xref>). In contrast, some restriction factors inhibit viral pathogens more indirectly by limiting the availability of cellular resources such as nucleotides, transcription factors, or other virus-dependency factors (<xref ref-type="bibr" rid="bib18">Braun et al., 2019</xref>; <xref ref-type="bibr" rid="bib76">Hotter et al., 2019</xref>; <xref ref-type="bibr" rid="bib77">Hrecka et al., 2011</xref>; <xref ref-type="bibr" rid="bib100">Krapp et al., 2016</xref>; <xref ref-type="bibr" rid="bib102">Laguette et al., 2011</xref>; <xref ref-type="table" rid="table2">Table 2</xref>, <xref ref-type="fig" rid="fig2">Figure 2</xref>).</p><fig id="fig1" position="float"><label>Figure 1.</label><caption><title>Antiviral factors targeting components of the virus.</title><p>The retroviral replication is exemplarily shown to illustrate antiviral host factors (violet) that directly target viral proteins, nucleic acids, and membranes during essentially all steps of the viral life cycle. While some factors successfully distinguish between self (blue, right panel) and non-self (pink, left panel), others may have unintended side effects on the host as they also target cellular factors. CpG: cytosine guanine dinucleotides; dsRNA: double-stranded ribonucleic acid; CAP0: 5′ mRNA cap with unmethylated ribose hydroxy-groups; CAP1: 5′ mRNA cap with methylated ribose hydroxy-group; IRES: internal ribosome entry site; PPP: 5′-triphosphate group without cap; abbreviations of protein names are explained in the text.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-65243-fig1-v1.tif"/></fig><fig id="fig2" position="float"><label>Figure 2.</label><caption><title>Antiviral factors modulating virus-dependency factors.</title><p>Several antiviral host proteins (violet) suppress viral replication (left panel) by modulating the stability, localization, or activity of cellular factors (orange) involved in the viral replication cycle. Since these host factors also play important roles in the cell, their inhibition may be associated with detrimental side effects (right panel). dsRNA: double-stranded ribonucleic acid; tRNA: transfer ribonucleic acid; 25-HO-Chol.: 25-hydroxy-cholesterol; abbreviations of protein names are explained in the text.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-65243-fig2-v1.tif"/></fig><table-wrap id="table1" position="float"><label>Table 1.</label><caption><title>Selection of antiviral factors directly targeting viral replication (abbreviations are explained in the text).</title></caption><table frame="hsides" rules="groups"><thead><tr><th rowspan="2">Antiviral factor(s)</th><th rowspan="2">Target(s)</th><th rowspan="2">Discrimination between self and non-self</th><th rowspan="2">Effect on viral replication</th><th colspan="2">(Potential) Unwanted effects on host cell</th></tr><tr><th>Immediate</th><th>Long term</th></tr></thead><tbody><tr><td>IFITMs</td><td>Fusing membranes</td><td>Membrane curvature, lipid composition</td><td>Impaired fusion of viral and host membranes</td><td>Impaired fusion of cellular membranes</td><td>Constraints in membrane fusion (e.g. Syncytin-mediated trophoblast fusion)</td></tr><tr><td>SERINCs</td><td>Fusing membranes</td><td>Not known (viral glycoprotein dependency?)</td><td>Impaired fusion of viral and host membranes</td><td>None (?)</td><td/></tr><tr><td>TRIM5α, Fv1</td><td>Retroviral capsids</td><td>Specific protein-binding</td><td>Untimely uncoating</td><td>None (?)</td><td>Constraints in the co-option of endogenous retroviral capsid proteins</td></tr><tr><td>KAP1</td><td>Retroviral integrase</td><td>Specific protein-binding</td><td>Inhibition of integration</td><td>None</td><td/></tr><tr><td>ZAP/TRIM25/ KHNYN</td><td>RNA</td><td>CpG content</td><td>Degradation of viral RNA</td><td>Degradation of host RNA</td><td>CpG depletion (?)</td></tr><tr><td>RNAse L</td><td>RNA</td><td>dsRNA-dependent, OAS-mediated activation</td><td>Degradation of viral RNA</td><td>Degradation of host RNA</td><td>Avoidance of dsRNA</td></tr><tr><td>SAMHD1</td><td>RNA</td><td>Not known</td><td>Degradation of viral RNA</td><td>Degradation of host RNA (?)</td><td/></tr><tr><td>IFITs</td><td>RNA</td><td>IRES, modification of 5′ RNA ends (cap-1 vs. cap-0)</td><td>Inhibition of viral translation</td><td>Inhibition of cellular translation (?)</td><td>Depletion of IRES structures, constraints in mRNA capping</td></tr><tr><td>HERC5/ISG15</td><td>Numerous viral proteins (e.g. HIV-1 Gag, HPV capsid)</td><td>Preferred ISGylation of newly translated proteins</td><td>Inhibition of viral protein function</td><td>Inhibition of host protein function</td><td/></tr><tr><td>Tetherin</td><td>Budding membranes</td><td>Localization in lipid rafts</td><td>Inhibition of virion release</td><td>Inhibition of exosome release, inhibition of cell division (?)</td><td/></tr><tr><td>APOBECs</td><td>ssDNA, RNA</td><td>Partially sequence dependent</td><td>Introduction of lethal hypermutations in the viral genome</td><td>Emergence of detrimental mutations</td><td>Depletion of specific dinucleotides</td></tr></tbody></table></table-wrap><table-wrap id="table2" position="float"><label>Table 2.</label><caption><title>Selection of antiviral factors indirectly targeting viral replication (abbreviations are explained in the text).</title></caption><table frame="hsides" rules="groups"><thead><tr><th rowspan="2">Antiviral factor(s)</th><th rowspan="2">Target(s)</th><th rowspan="2">Discrimination between self and non-self</th><th rowspan="2">Effect on viral replication</th><th colspan="2">(Potential) Unwanted effects on host cell</th></tr><tr><th>Immediate</th><th>Long term</th></tr></thead><tbody><tr><td>IFITM3</td><td>VAPA, OSBP</td><td>Membrane curvature, lipid composition</td><td>Impaired fusion of viral and host membranes</td><td>Impaired fusion of cellular membranes</td><td>Constraints in membrane fusion (e.g. syncytin-mediated trophoblast fusion)</td></tr><tr><td>CH25H</td><td>Cholesterol</td><td>Not known</td><td>Impaired fusion of viral and host membranes, impaired membraneous web formation</td><td>Impaired fusion of host membranes (?)</td><td/></tr><tr><td>SAMHD1</td><td>dNTPs</td><td>Not known</td><td>Limits reverse transcription/viral DNA replication</td><td>Inhibition of host DNA replication</td><td>Regulation of SAMHD1 activity in dividing cells</td></tr><tr><td>MxB</td><td>Nucleoporins</td><td>Simultaneous interaction with viral (capsid) proteins</td><td>Reduced nuclear import of subviral complexes</td><td>Impaired nuclear pore transport</td><td>Evolution of diverse nuclear pore variants</td></tr><tr><td>KAP1</td><td>NuRD complex/HDACs, SETDB1, transcription factors</td><td>Not known</td><td>Suppression of viral gene transcription, latency</td><td>Suppression of host gene transcription</td><td/></tr><tr><td>TRIM22</td><td>Sp1</td><td>Not known</td><td>Reduced Sp1-driven expression of viral genes</td><td>Reduced Sp1-driven expression of host genes</td><td>Constraints in Sp1-driven gene expression</td></tr><tr><td>IFI16, MNDA, IFIX</td><td>Sp1</td><td>Chromatinization status of the DNA</td><td>Reduced Sp1-driven expression of viral genes</td><td>Reduced Sp1-driven expression of host genes</td><td>Constraints in Sp1-driven gene expression</td></tr><tr><td>PKR</td><td>eIF-2α</td><td>Activation by dsRNA</td><td>Reduced translation of viral mRNA</td><td>Reduced translation of host mRNA</td><td>Avoidance of dsRNA</td></tr><tr><td>IFITs</td><td>eIF3</td><td>IRES, modification of 5′ RNA ends</td><td>Inhibition of translation</td><td>Inhibition of translation (?)</td><td>Depletion of IRES structures, mRNA capping (methylated)</td></tr><tr><td>SLFN11</td><td>tRNA</td><td>preferred targeting of tRNAs exploited by viruses</td><td>Reduced translation of viral mRNA</td><td>Reduced translation of cellular mRNA</td><td>Specific codon usage pattern</td></tr><tr><td>PAR1, GBP2, GBP5</td><td>Furin</td><td>Not known</td><td>Impaired furin-mediated maturation of viral (glyco)proteins</td><td>Impaired proteolytic activation of host proteins</td><td>Constraints in furin-mediated protein cleavage</td></tr><tr><td>HERC5/ISG15</td><td>Numerous host proteins (e.g. IRF3, RIG-I, PKR)</td><td>Preferred ISGylation of newly translated proteins</td><td>Several proposed inhibitory mechanisms</td><td>Modulation of host protein stability and function</td><td/></tr><tr><td>Viperin</td><td>FPPS, <break/>CTP</td><td>Not known</td><td>Inhibition of viral budding, inhibition of viral RNA polymerization</td><td>Inhibition of cellular protein secretion and potentially cellular RNA synthesis</td><td/></tr></tbody></table></table-wrap><p>Due to their rapid replication rates, enormous number of progeny, and frequently high mutation rates, many viruses quickly adapt to their respective host environments. Altogether, viruses have evolved sophisticated strategies to evade or directly counteract many restriction factors. For example, they frequently mimic the properties of their host cells to avoid recognition by the cell. In addition, viral pathogens may capture cellular genes and transform them into effective tools against antiviral defense mechanisms (<xref ref-type="bibr" rid="bib45">Duggal and Emerman, 2012</xref>; <xref ref-type="bibr" rid="bib129">Nchioua et al., 2020b</xref>; <xref ref-type="bibr" rid="bib163">Sauter and Kirchhoff, 2018</xref>). This not only allows them to exploit host factors for their own purposes, but the cellular origin also makes it even more difficult for the host to discriminate between self and non-self. As a consequence of the need to maintain activity against evolving pathogens or to provide protection against newly emerging viruses, many restriction factors evolve particularly fast and show evolutionary signatures of adaptation (<xref ref-type="bibr" rid="bib24">Cagliani et al., 2014</xref>; <xref ref-type="bibr" rid="bib45">Duggal and Emerman, 2012</xref>; <xref ref-type="bibr" rid="bib148">Pyndiah et al., 2015</xref>). Particularly regions in antiviral proteins that directly interact with viral components either to inhibit or be targeted by them for counteraction show strong evidence for positive selection. One important consequence of this ever-ongoing virus–host arms race is that restriction factors are usually highly effective against poorly adapted viruses from other species thereby frequently representing potent barriers to successful cross-species transmissions. In contrast, they are often hardly effective against well-adapted viral pathogens in their natural hosts. Notably, their ability to interact with viral components allows some restriction factors to not only directly restrict viral pathogens but also act as pattern recognition receptors that induce and boost antiviral immune responses (<xref ref-type="bibr" rid="bib57">Galão et al., 2012</xref>; <xref ref-type="bibr" rid="bib75">Hotter et al., 2013</xref>; <xref ref-type="bibr" rid="bib82">Jakobsen et al., 2013</xref>; <xref ref-type="bibr" rid="bib86">Jønsson et al., 2017</xref>).</p><p>One formidable challenge for the host is the evolution of antiviral factors that effectively protect against foreign viral invaders without harming the cell. While it is advantageous for adaptive immune mechanisms to be specific for individual invading pathogens, innate immunity must provide broad-based protection against a huge variety of diverse potential viral invaders. This includes viruses that the individual or even the entire host species has never encountered before. Thus, it is obvious that innate immune factors need to strike a fine balance between protection against a broad range of viral pathogens and limiting the risk of unwanted off-target effects on the host organism. Effective antiviral defense mechanisms might cause undesired adverse effects by numerous mechanisms, for example because the antiviral factors do not perfectly distinguish between self and foreign, or because virus-dependency factors that are depleted are also important for cellular functions. In addition, immune activation alters the concentrations and activities of several cellular factors, many of which also fulfill important physiological functions. Finally, multiple cellular resources and machineries are redirected for defense or shutdown, so that they cannot perform their regular functions anymore. Altogether, it is evident that there are trade-offs between effective innate antiviral immune mechanisms and potential side effects on the host cell and consequently organism.</p><p>The molecular mechanisms of antiviral restriction factors and their viral antagonists have received substantial attention and have been the topic of several in-depth reviews (<xref ref-type="bibr" rid="bib71">Harris et al., 2012</xref>; <xref ref-type="bibr" rid="bib119">Malim and Bieniasz, 2012</xref>; <xref ref-type="bibr" rid="bib163">Sauter and Kirchhoff, 2018</xref>). In contrast, adverse effects of the antiviral activities of host restriction factors have received little attention, although they may play important roles in the clinical outcomes of viral infections. To close this gap, we here discuss some of the potential side effects associated with antiviral host proteins. We focus on three ways, by which antiviral proteins may result in detrimental effects. First, restriction factors may fail to discriminate between self and non-self. This is not surprising given that viruses exploit the cellular protein synthesis and trafficking machineries and all viral components are ultimately derived from the host cell. Second, some restriction factors not only suppress viral replication but also perform other functions in the cell. Consequently, their induction in response to infection or their counteraction by viral antagonists may perturb their physiological activity and thus, the state or function of the cell. Third, several antiviral factors do not target the pathogen directly but generate an antiviral environment by limiting the availability of so-called virus-dependency factors. These host factors are required for viral replication but generally also involved in cellular processes. A better understanding of trade-offs associated with the emergence of innate immunity factors is important because (1) side effects of antiviral proteins may contribute to the pathogenesis of infectious diseases, particularly in chronic viral infections, (2) aberrant expression and/or activity of antiviral proteins may result in disorders such as inflammatory auto-immune diseases, and (3) therapeutic approaches exploiting host restriction factors need to consider potential adverse effects. The detrimental effects of aberrant chronic immune activation in chronic viral infections, such as HIV/AIDS, are well documented (<xref ref-type="bibr" rid="bib16">Bloch et al., 2020</xref>; <xref ref-type="bibr" rid="bib37">Deeks, 2011</xref>). Accumulating evidence suggests that severe coronavirus disease 2019 (COVID-19) is also driven by excessive immune activation and expression of pro-inflammatory cytokines (the so-called ‘cytokine storm’) in response to SARS-CoV-2 infection (<xref ref-type="bibr" rid="bib105">Lariccia et al., 2020</xref>; <xref ref-type="bibr" rid="bib150">Quirch et al., 2020</xref>). The focus of the present review is on side effects of specific cell-intrinsic antiviral effectors. Our aim is not only to illustrate evolutionary conflicts associated with the acquisition of cellular antiviral proteins but also to provide insights into their physiological roles and potential adverse effects in virally infected cells and the host organism in general. Due to the constantly increasing number of newly discovered cellular proteins with antiviral activity, we had to limit our review to the description of a few exemplary factors. Since many of them are best characterized for their effects on HIV-1, we focus on antiretroviral proteins to illustrate different concepts of self versus non-self discrimination and mechanisms leading to unwanted side effects.</p><sec id="s1-1"><title>Suppression of viral entry</title><p>In order to replicate, viral pathogens must deliver their genetic material into the host cell. Preventing entry of enveloped viruses is advantageous for the host because it minimizes potentially harmful interactions with the pathogen and avoids manipulation of the host cell by intracellular viral factors. Individual cells may prevent entry of enveloped viruses by selfish or selfless mechanisms: Cells may exclusively protect themselves by downmodulating cellular receptors and cofactors required for infection or by expressing antiviral factors that inhibit fusion with viral particles. Alternatively, infected cells may prevent incorporation of functional viral envelope proteins in progeny virions or induce the incorporation of cellular factors that reduce viral infectiousness and, thus, protect bystander cells rather than themselves. All these modes of action are non-exclusive, and, as outlined below, some antiviral factors may act in both the viral target and producer cells.</p><p>Several cell-intrinsic entry inhibitors exert very broad antiviral activity. For example, members of the IFN-induced transmembrane (IFITM) family have been reported to protect cells against a large variety of viral pathogens (e.g. retro-, orthomyxo-, flavi-, rhabdo-, influenza A, and coronaviruses) (<xref ref-type="bibr" rid="bib10">Bailey et al., 2014</xref>; <xref ref-type="bibr" rid="bib41">Diamond and Farzan, 2013</xref>; <xref ref-type="bibr" rid="bib168">Shi et al., 2017</xref>; <xref ref-type="bibr" rid="bib169">Smith et al., 2014</xref>; <xref ref-type="fig" rid="fig1">Figure 1</xref>, left). At least three of the five human IFITM proteins (i.e. 1, 2, and 3) exert antiviral activity. IFITM3 has been suggested to exert its antiviral activity by interfering with the homeostasis of intracellular cholesterol levels. More specifically, IFITM3 induces the intracellular accumulation of cholesterol by interacting with the cholesterol regulatory factor oxysterol-binding protein (OSBP) and vesicle-membrane-protein-associated protein A (VAPA) (<xref ref-type="bibr" rid="bib5">Amini-Bavil-Olyaee et al., 2013</xref>; <xref ref-type="fig" rid="fig2">Figure 2</xref>). As a result, fusion of vesicular stomatitis virus (VSV) particles and potentially other viruses with the host cell membrane is inhibited. While the molecular mechanisms of IFITM1 and IFITM2 remain less clear, these two factors have also been suggested to restrict viral entry by modulating membrane fluidity and curvature (<xref ref-type="bibr" rid="bib109">Li et al., 2013</xref>). It is well known that the lipid composition of purified virions differs from that of typical mammalian cells (<xref ref-type="bibr" rid="bib81">Ivanova et al., 2015</xref>) and that the glycerophospholipid composition of membranes affects their curvature (<xref ref-type="bibr" rid="bib25">Casares et al., 2019</xref>). Since viral particles are usually much smaller than cells, they require stronger membrane curvature. In addition, fusion of viral membranes with cellular membranes may require strong negative bending, and the compositions of the viral and target cell membranes play key roles in the initiation and efficiency of fusion and thus viral entry (<xref ref-type="bibr" rid="bib175">Stiasny and Heinz, 2004</xref>, <xref ref-type="bibr" rid="bib3">Alexandrov et al., 2013</xref>). Nevertheless, virus–host and host–host membrane fusion events share several overlapping characteristics, and the broad antiviral activity of IFITMs may come at the cost of altered host membrane fusion. For example, increased IFITM levels have recently been shown to inhibit trophoblast fusion, a critical step in placenta formation (<xref ref-type="bibr" rid="bib21">Buchrieser et al., 2019</xref>; <xref ref-type="fig" rid="fig1">Figure 1</xref>, right). As a result, the syncytiotrophoblast does not form, and the fetus is restricted in growth. Like many other antiviral defense factors, IFITMs are strongly upregulated in the presence of IFNs. Thus, this undesired effect of IFITMs may explain why inflammation and IFNs are associated with premature termination of pregnancies and embryopathies (<xref ref-type="bibr" rid="bib195">Yockey and Iwasaki, 2018</xref>).</p><p>Another antiviral host protein modulating membranes is the IFN-inducible cholesterol-25-hydroxylase (CH25H). This factor inhibits not only fusion during entry of a variety of enveloped viruses (e.g. HCV, VSV, HSV, HIV, EBOV, RVFV, SARS-CoV-2, and Nipah virus) (<xref ref-type="bibr" rid="bib197">Zhao et al., 2020</xref>) but also HCV RNA replication by interfering with the formation of membranous webs that serve as HCV replication factories (<xref ref-type="bibr" rid="bib6">Anggakusuma et al., 2015</xref>; <xref ref-type="fig" rid="fig2">Figure 2</xref>). Both of these inhibitory effects require the enzymatic activity of CH25H and are mediated by its product 25-hydroxy-cholesterol (25HC). This also illustrates that membrane-modulating factors such as CH25H may interfere with viral pathogens at several steps of their replication cycle. Whether CH25H and 25HC also interfere with physiological membrane fusion within or between cells remains to be determined.</p><p>While IFITM proteins and CH25H seem to mainly (but not exclusively) exert their effects in viral target cells (<xref ref-type="bibr" rid="bib32">Compton et al., 2014</xref>), the antiviral factors SERINC3 and SERINC5 can be efficiently incorporated into virions and prevent subsequent rounds of infection, at least in the absence of an effective viral antagonist (<xref ref-type="bibr" rid="bib158">Rosa et al., 2015</xref>; <xref ref-type="bibr" rid="bib190">Usami et al., 2015</xref>). Although the exact inhibitory mechanism is unclear, it has been shown that SERINC5 prevents delivery of the viral core into target cells by impairing the fusion process (<xref ref-type="bibr" rid="bib22">Buffalo et al., 2019</xref>; <xref ref-type="bibr" rid="bib170">Sood et al., 2017</xref>; <xref ref-type="fig" rid="fig1">Figure 1</xref>, left). In the case of HIV-1, the effect of SERINCs also depends on the specific envelope glycoproteins and may involve changes in their clustering and/or conformation (<xref ref-type="bibr" rid="bib27">Chen et al., 2020</xref>; <xref ref-type="bibr" rid="bib50">Featherstone and Aiken, 2020</xref>). Thus, the presence of viral glycoproteins may help the cell to distinguish between cell–cell and virus–cell fusion events. The full antiviral spectrum of SERINC5 and its family members remains to be determined. Compared to IFITMs, it seems more confined to retroviruses (<xref ref-type="bibr" rid="bib73">Heigele et al., 2016</xref>), although it has recently been reported that SERINC5 also suppresses the production of hepatitis B virus particles (<xref ref-type="bibr" rid="bib115">Liu et al., 2020</xref>).</p><p>In contrast to IFITMs, CH25H and many other restriction factors, SERINC3 and 5 are not upregulated by IFN or other proinflammatory cytokines (<xref ref-type="bibr" rid="bib158">Rosa et al., 2015</xref>). The physiological role of SERINCs is under debate. These proteins were named SERINCs because it has initially been suggested that they mediate SERine INCorporation into lipid membranes (<xref ref-type="bibr" rid="bib80">Inuzuka et al., 2005</xref>). However, more recent data did not confirm effects of SERINC5 on the lipid composition of cells or viral particles (<xref ref-type="bibr" rid="bib187">Trautz et al., 2017</xref>). Furthermore, SERINC5<sup>−/−</sup> mice show no obvious phenotypic defects (<xref ref-type="bibr" rid="bib185">Timilsina et al., 2020</xref>). Altogether, it has been established that SERINC expression levels do not change under inflammatory conditions, and recent data suggest that SERINC5 might not exert important functions beyond antiviral immune defense. Thus, SERINC5 may impair the infectivity of retroviral particles without causing detrimental side effects.</p></sec><sec id="s1-2"><title>Inhibition of viral reverse transcription and uncoating</title><p>Virion fusion with the cell membrane allows viral genomes to enter the cell. In the case of retroviruses, the viral RNA genome is reverse transcribed into linear double-stranded DNA and transported into the nucleus for integration into the host cell genome. Initially, it was thought that retroviral capsids rapidly disassemble upon cytosolic entry. However, recent data suggest that the HIV-1 capsid probably remains intact, or nearly so, until after nuclear import (<xref ref-type="bibr" rid="bib134">Novikova et al., 2019</xref>). The integrity of the capsid structure is thought to be important for intracellular trafficking, suppression of innate immune sensing, reverse transcription, and nuclear import of the viral genome (<xref ref-type="bibr" rid="bib83">James and Jacques, 2018</xref>; <xref ref-type="bibr" rid="bib106">Le Sage et al., 2014</xref>). Thus, reverse transcription and uncoating are tightly linked and have to proceed in a well-coordinated manner for successful infection. One antiviral factor that perturbs this process is tripartite motif-containing protein 5α (TRIM5α). This protein belongs to a large family of ~100 TRIMs (<xref ref-type="bibr" rid="bib70">Han et al., 2011</xref>), many of which are involved in the innate response to viral infection (<xref ref-type="bibr" rid="bib99">Koepke et al., 2021</xref>). TRIM5α directly interacts with retroviral capsids and results in accelerated uncoating and consequently inhibition of reverse transcription (<xref ref-type="bibr" rid="bib58">Ganser-Pornillos et al., 2011</xref>; <xref ref-type="bibr" rid="bib177">Stremlau et al., 2004</xref>; <xref ref-type="fig" rid="fig1">Figure 1</xref>, left). The high specificity of TRIM5α–capsid interactions and the absence of capsid-like structures from most host cells minimizes the risk of unintended off-target effects but at the same time enables retroviral pathogens to develop resistance. In fact, the evolution of the interaction interface between TRIM5α and retroviral capsids provides a prime example for the arms race between innate defense factors and viral evasion mechanisms. TRIM5α shows strong signatures of positive selection (<xref ref-type="bibr" rid="bib88">Kaiser et al., 2007</xref>; <xref ref-type="bibr" rid="bib164">Sawyer et al., 2005</xref>), particularly in the interaction interface with retroviral capsids (<xref ref-type="bibr" rid="bib121">McCarthy et al., 2015</xref>). Consequently, TRIM5α acts in a species-specific manner. For example, the HIV-1 capsid efficiently interacts and is restricted by TRIM5α from rhesus macaques but is largely resistant to human TRIM5α (<xref ref-type="bibr" rid="bib177">Stremlau et al., 2004</xref>), possibly due to protective shielding by cyclophilin A (<xref ref-type="bibr" rid="bib96">Kim et al., 2019</xref>). Because of this high specificity, it was thought that TRIM5α only restricts retroviruses. Recent findings, however, suggest that TRIM5α is also active against some flaviviruses (<xref ref-type="bibr" rid="bib28">Chiramel et al., 2019</xref>). Whether or not TRIM5α exerts a relevant physiological function and whether its induction by IFNs may be associated with detrimental effects is largely unknown. It has been reported, however, that TRIM5α overexpression induces morphological changes in HEK293T cells that are suppressed by interaction with the heat shock protein 70 (Hsp70) (<xref ref-type="bibr" rid="bib79">Hwang et al., 2010</xref>).</p><p>Another factor, SAM domain and HD domain-containing protein 1 (SAMHD1) suppresses reverse transcription of various retroviruses by creating a cellular environment that is not permissive for viral replication (<xref ref-type="bibr" rid="bib77">Hrecka et al., 2011</xref>; <xref ref-type="bibr" rid="bib102">Laguette et al., 2011</xref>). Specifically, SAMHD1 is an enzyme that removes the triphosphate from dNTPs, thereby depleting cells of the pool of dNTPs required for reverse transcription (<xref ref-type="bibr" rid="bib65">Goldstone et al., 2011</xref>; <xref ref-type="bibr" rid="bib103">Lahouassa et al., 2012</xref>; <xref ref-type="bibr" rid="bib147">Powell et al., 2011</xref>; <xref ref-type="fig" rid="fig2">Figure 2</xref>, left). The levels of dNTPs as well as the activity of SAMHD1 vary substantially between various cell types, and SAMHD1 mainly restricts retroviral replication in cells that have relatively low levels of dNTPs to start with, that is non-dividing macrophages and resting T cells (<xref ref-type="bibr" rid="bib11">Baldauf et al., 2012</xref>; <xref ref-type="bibr" rid="bib39">Descours et al., 2012</xref>; <xref ref-type="bibr" rid="bib77">Hrecka et al., 2011</xref>; <xref ref-type="bibr" rid="bib102">Laguette et al., 2011</xref>). In contrast to other antiviral factors, the expression levels of SAMHD1 are not altered by immune activation. Instead, the enzymatic and antiviral activities of SAMHD1 are regulated by post-translational modifications, that is phosphorylation and acetylation (<xref ref-type="bibr" rid="bib34">Cribier et al., 2013</xref>). Since dNTPs are critical for host DNA replication, their depletion by SAMHD1 will keep cells in a non-dividing state (<xref ref-type="fig" rid="fig2">Figure 2</xref>, right). However, cell division is a key mechanism for successful immune responses. Thus, efficient reduction of the dNTP pool by activated SAMHD1 is obviously only an option for antiviral defense in specific cell types because it would otherwise exert detrimental immune suppressive effects. In addition, it is known that mutations in SAMHD1 are associated with the Aicardi–Goutières syndrome, and recent studies suggest roles of SAMHD1 in double-stranded break repair, genomic stability, and potentially some types of cancer (<xref ref-type="bibr" rid="bib30">Coggins et al., 2020</xref>). Altogether, accumulating evidence suggests that altered SAMHD1 activity due to activation by the innate immune response or inhibition by lentiviral antagonists, that is Vpx and Vpr (<xref ref-type="bibr" rid="bib55">Fregoso et al., 2013</xref>; <xref ref-type="bibr" rid="bib77">Hrecka et al., 2011</xref>; <xref ref-type="bibr" rid="bib102">Laguette et al., 2011</xref>), may have significant adverse effects on the cell.</p></sec><sec id="s1-3"><title>Nuclear import</title><p>Before retroviral DNA can be integrated into host chromosomes, subviral complexes need to enter the nucleus via nuclear pore complexes. This step is inhibited by the IFN-inducible protein MxB (<xref ref-type="bibr" rid="bib67">Goujon et al., 2013</xref>; <xref ref-type="bibr" rid="bib89">Kane et al., 2013</xref>; <xref ref-type="bibr" rid="bib114">Liu et al., 2013</xref>), which directly interacts with the retroviral capsid (<xref ref-type="bibr" rid="bib56">Fricke et al., 2014</xref>) and several nucleoporins and nucleoporin-like proteins (<xref ref-type="bibr" rid="bib42">Dicks et al., 2018</xref>; <xref ref-type="fig" rid="fig2">Figure 2</xref>, <xref ref-type="table" rid="table2">Table 2</xref>). The positioning of MxB at the nuclear pore complex (NPC) is mediated by a nuclear localization signal-like sequence in its N-terminus. This sequence stretch is absent from its paralog MxA, which inhibits diverse viral pathogens, but not retroviruses (<xref ref-type="bibr" rid="bib69">Haller et al., 2015</xref>). Notably, the composition of NPCs varies considerably within and between different cells, and not all of them may be efficiently targeted by MxB (<xref ref-type="bibr" rid="bib42">Dicks et al., 2018</xref>; <xref ref-type="bibr" rid="bib90">Kane et al., 2018</xref>). Thus, MxB-mediated inhibition of the retroviral pre-integration complex depends on the cell type and the import pathway that is used by the virus. While there is emerging evidence for a dysregulation of nuclear pore transport by MxB, this restriction factor may achieve some specificity by simultaneously interacting with components of the retroviral core.</p></sec><sec id="s1-4"><title>Proviral integration and transcription</title><p>Integration of the linear retroviral dsDNA into the host genome is essential for efficient viral transcription and productive infection. This step is inhibited by KRAB-associated protein-1 (KAP1), also known as TRIM28, another member of the TRIM family (<xref ref-type="bibr" rid="bib4">Allouch et al., 2011</xref>). KAP1 inhibits proviral integration by inducing deacetylation of the retroviral integrase via recruitment of a protein complex including histone deacetylases (HDACs) (<xref ref-type="fig" rid="fig1">Figures 1</xref> and <xref ref-type="fig" rid="fig2">2</xref>, left). More importantly, the recruitment of HDACs and the histone methylase SETDB1 by KAP1 also results in epigenetic changes that induce heterochromatinization, repress transcription, and may therefore also promote viral latency (<xref ref-type="fig" rid="fig2">Figure 2</xref>, left). For example, latency of the Kaposi's sarcoma-associated herpesvirus has been shown to be regulated by KAP1 (<xref ref-type="bibr" rid="bib26">Chang et al., 2009</xref>). Furthermore, KAP1 also plays a key role in silencing transposable elements, including endogenous retroviruses (<xref ref-type="bibr" rid="bib184">Tie et al., 2018</xref>). Recent evidence suggests that KAP interacts with a variety of cellular factors involved in DNA interaction and is recruited to actively transcribed polymerase II promoters (<xref ref-type="bibr" rid="bib92">Kauzlaric et al., 2020</xref>). Thus, the repressive activity of KAP1 is not specifically directed against viral genes. In line with this, it has been reported that KAP1 also governs the expression of tumor-suppressor genes (<xref ref-type="bibr" rid="bib166">Serra et al., 2014</xref>). In contrast to many other antiviral factors, KAP1 is not further inducible by IFNs, possibly because changes in its expression or activity upon viral infection may result in unwanted effects on the host cell (<xref ref-type="fig" rid="fig2">Figure 2</xref>, right).</p><p>Viral pathogens must exploit cellular machineries for efficient transcription of their own genes, and recent studies suggest that some IFN-inducible antiviral factors limit the availability of cellular transcription factors to inhibit viral pathogens. Initially, it has been reported that TRIM22 suppresses basal HIV-1 transcription as it inhibits binding of the transcription factor Sp1 to the HIV-1 LTR promoter via a poorly described mechanism (<xref ref-type="bibr" rid="bib189">Turrini et al., 2019</xref>; <xref ref-type="bibr" rid="bib188">Turrini et al., 2015</xref>; <xref ref-type="fig" rid="fig2">Figure 2</xref>, left). More recently, it has been shown that nuclear members of the human PYHIN family (i.e. IFIX/PYHIN1, IFI16, and MNDA) directly interact with Sp1 via their pyrin domains, thereby limiting the availability of Sp1 for HIV-1 transcription (<xref ref-type="bibr" rid="bib17">Bosso et al., 2020</xref>; <xref ref-type="bibr" rid="bib76">Hotter et al., 2019</xref>; <xref ref-type="fig" rid="fig2">Figure 2</xref>, left). Sp1 is critical for efficient expression of multiple pathogens, and it has been reported that IFI16 restricts retro-, herpes-, and papillomaviruses, possibly by several non-exclusive mechanisms (<xref ref-type="bibr" rid="bib59">Gariano et al., 2012</xref>; <xref ref-type="bibr" rid="bib85">Johnson et al., 2014</xref>; <xref ref-type="bibr" rid="bib116">Lo Cigno et al., 2015</xref>). It has been suggested that IFI16 may cooperatively bind dsDNA in a length-dependent manner and cluster into protein filaments (<xref ref-type="bibr" rid="bib126">Morrone et al., 2014</xref>). Assembly into filaments is mediated by conserved residues in the pyrin domain and required for high-affinity binding of DNA via the HIN domains. Nuclear PYHIN proteins, including IFI16, were proposed to distinguish self from foreign (<xref ref-type="bibr" rid="bib126">Morrone et al., 2014</xref>; <xref ref-type="bibr" rid="bib176">Stratmann et al., 2015</xref>) by associating only with under-chromatinized foreign DNAs. However, the HIN domains of human PYHIN proteins known to be required for DNA interaction were dispensable for their antiretroviral activity (<xref ref-type="bibr" rid="bib17">Bosso et al., 2020</xref>; <xref ref-type="bibr" rid="bib76">Hotter et al., 2019</xref>). Instead, the pyrin domain of human PYHIN proteins competed with Sp1 binding sites in DNAs for Sp1 interaction. Sp1 is also involved in the expression of numerous cellular proteins that play roles in cancer and inflammatory diseases (<xref ref-type="bibr" rid="bib112">Li and Davie, 2010</xref>; <xref ref-type="bibr" rid="bib135">O'Connor et al., 2016</xref>; <xref ref-type="bibr" rid="bib161">Safe et al., 2014</xref>). Thus, attenuation of Sp1 function by TRIM22 or PYHIN proteins will most likely also significantly reduce Sp1-driven expression of cellular genes and presumably affect multiple physiological and pathological processes (<xref ref-type="fig" rid="fig2">Figure 2</xref>, right).</p></sec><sec id="s1-5"><title>mRNA degradation and inhibition of viral mRNA translation</title><p>Although viral pathogens exploit the cellular protein synthesis machinery, a few characteristics (e.g. codon usage, CpG dinucleotide content, 5′ cap, formation of double strands, and/or specific secondary structures) may distinguish cellular from viral mRNAs. These characteristics are exploited by antiviral host factors such as ZAP, SLFN11, PKR, or IFITs to preferentially target viral transcripts (<xref ref-type="bibr" rid="bib128">Nchioua et al., 2020a</xref>). However, many viruses mimic the mRNA structure and composition of their respective host species to evade restriction. For example, mammalian genomes show marked suppression of CpG dinucleotides, and it is long known that many RNA viruses mimic this feature of their vertebrate hosts (<xref ref-type="bibr" rid="bib33">Cooper and Gerber-Huber, 1985</xref>; <xref ref-type="bibr" rid="bib91">Karlin et al., 1994</xref>; <xref ref-type="bibr" rid="bib193">Woo et al., 2007</xref>). Only recently, however, the zinc-finger antiviral protein (ZAP, also known as ARTD13, PARP13, and ZC3HAV1) has been identified as one of the possible driving forces behind the suppression of CpG dinucleotides in vertebrate RNA viruses (<xref ref-type="bibr" rid="bib180">Takata et al., 2017</xref>). It has been shown that ZAP binds to regions in HIV-1 mRNAs with high CpG content to target them for degradation, thereby reducing viral protein expression and replication (<xref ref-type="fig" rid="fig1">Figure 1</xref>, left) (<xref ref-type="bibr" rid="bib98">Kmiec et al., 2020</xref>; <xref ref-type="bibr" rid="bib123">Meagher et al., 2019</xref>; <xref ref-type="bibr" rid="bib180">Takata et al., 2017</xref>). Notably, TRIM25 and KHNYN have been reported as important cofactors since ZAP itself does not degrade viral RNA (<xref ref-type="bibr" rid="bib51">Ficarelli et al., 2019</xref>; <xref ref-type="bibr" rid="bib111">Li et al., 2017</xref>; <xref ref-type="bibr" rid="bib198">Zheng et al., 2017</xref>). KHNYN contains an RNase NYN domain and seems critical for RNA degradation, while the role of TRIM25 in ZAP-mediated restriction is currently less clear. It has been shown that artificial increases in CpG numbers significantly increase the susceptibility of HIV-1 and echoviruses to ZAP inhibition (<xref ref-type="bibr" rid="bib52">Ficarelli et al., 2020</xref>; <xref ref-type="bibr" rid="bib136">Odon et al., 2019</xref>; <xref ref-type="bibr" rid="bib180">Takata et al., 2017</xref>). ZAP shows activity against retro-, alpha-, filo-, hepadna-, picorna-, toga-, herpes-, corona-, and flaviviruses as well as retroelements (<xref ref-type="bibr" rid="bib66">Goodier et al., 2015</xref>; <xref ref-type="bibr" rid="bib129">Nchioua et al., 2020b</xref>) and thus, may drive CpG suppression in many viral pathogens. Notably, CpG frequency is not the only determinant of ZAP sensitivity. For example, the number of CpGs at the 5′ end of the <italic>env</italic> gene rather than overall CpG frequency determines ZAP sensitivity of primary HIV-1 strains (<xref ref-type="bibr" rid="bib98">Kmiec et al., 2020</xref>). The CpG content in mammalian mRNAs varies substantially, and high ZAP levels may even restrict viral RNAs showing degrees of CpG suppression that are similar to those of the human genome (<xref ref-type="bibr" rid="bib129">Nchioua et al., 2020b</xref>). Most importantly, ZAP also regulates the amounts of hundreds of cellular transcripts. For example, ZAP strongly decreases <italic>TRAILR4</italic> mRNA levels by binding to a region in its 3′ untranslated region (<xref ref-type="bibr" rid="bib186">Todorova et al., 2014</xref>; <xref ref-type="fig" rid="fig1">Figure 1</xref>, right).</p><p>In addition to KHNYN, several other host RNases have been shown to degrade viral RNAs. One well-characterized example is RNase L. This nuclease is activated by 2′,5′-oligoadenylates synthesized by oligoadenylate synthetases (OAS) that are induced by IFN and activated by dsRNA (<xref ref-type="bibr" rid="bib110">Li et al., 2016</xref>; <xref ref-type="fig" rid="fig1">Figure 1</xref>, left). Thus, the OAS–RNase L innate immune pathway is specifically induced in the presence of dsRNA and restricts replication of diverse viral pathogens. While dsRNAs are more frequently found in viral RNAs, they also exist in some cellular RNAs, and it has been reported that RNase L degrades both viral and cellular RNAs (<xref ref-type="bibr" rid="bib20">Brennan-Laun et al., 2014</xref>; <xref ref-type="fig" rid="fig1">Figure 1</xref>, right). Intriguingly, knockout of <italic>OAS3</italic> has recently also been shown to rescue replication of viruses with elevated CpG dinucleotide numbers, similar to a knockout of ZAP (<xref ref-type="bibr" rid="bib136">Odon et al., 2019</xref>). Thus, both factors may target overlapping RNAs. Degradation of retroviral RNAs has also been reported for SAMHD1 (<xref ref-type="bibr" rid="bib159">Ryoo et al., 2014</xref>; <xref ref-type="fig" rid="fig1">Figure 1</xref>), but subsequent findings suggested that this activity is marginal and does not contribute to the antiviral activity of this factor (<xref ref-type="bibr" rid="bib7">Antonucci et al., 2016</xref>). Notably, antiviral RNases such as RNase L or KHNYN provide an interesting example of antiviral pathways in which target specificity is not determined by the effector itself but by cellular cofactors such as ZAP and OAS that recognize characteristics of viral RNAs. Nevertheless, a sharp distinction of self from non-self RNA is not always possible, and many RNases also cleave various cellular RNAs. It will clearly be of interest to determine which cellular RNAs are affected and to which extent.</p><p>At first glance, targeting of self by antiviral factors seems to represent an unintended off-target effect. However, this view may be too simplistic: The regulation of cellular mRNAs by several antivirally active proteins, for example, may actually also be beneficial to the host. This includes ZAP, which may promote apoptosis of cancer cells by depleting <italic>TRAILR4</italic> transcripts (<xref ref-type="bibr" rid="bib186">Todorova et al., 2014</xref>). Sensing of self RNAs may even boost the potency of anti-cancer drugs. For example, the OAS-RNase L pathway has been shown to enhance the anti-cancer activity of 5-azacytidine since this drug induced the production of cellular dsRNAs (<xref ref-type="bibr" rid="bib12">Banerjee et al., 2019</xref>).</p><p>Antiviral defense factors may not only degrade viral RNAs but also suppress translation of viral proteins without affecting RNA levels. For example, the serine/threonine-protein kinase PKR phosphorylates the eukaryotic translation initiation factor eIF2-α, thereby converting it into a global protein synthesis inhibitor (<xref ref-type="bibr" rid="bib40">Dever et al., 1992</xref>; <xref ref-type="fig" rid="fig2">Figure 2</xref>). Similar to the OAS–RNase L pathway, some specificity is acquired via a dsRNA-dependent activation of PKR. Furthermore, eIF2-α phosphorylation does not necessarily result in a complete shutdown of protein synthesis but allows the translation of specific integrated stress response mRNAs and thus, potentially allows the cell to survive (<xref ref-type="bibr" rid="bib139">Pakos-Zebrucka et al., 2016</xref>). Notably, however, survival of a cell upon induction of a PKR-mediated stress response requires the simultaneous activation of pro-survival pathways (<xref ref-type="bibr" rid="bib149">Qiao et al., 2020</xref>).</p><p>A more specific discrimination between self and non-self is achieved by IFN-induced proteins with tetratricopeptide repeats (IFITs) (<xref ref-type="bibr" rid="bib1">Abbas et al., 2013</xref>; <xref ref-type="bibr" rid="bib144">Pichlmair et al., 2011</xref>). IFIT1 preferentially interacts with tri-phosphorylated RNA (PPP-RNA) that is usually absent in cells from higher eukaryotes but frequently generated during viral replication cycles (<xref ref-type="bibr" rid="bib101">Kumar et al., 2014</xref>; <xref ref-type="fig" rid="fig1">Figure 1</xref>). In contrast to IFIT1, IFIT2 and IFIT3 seem not to interact with viral RNAs but bind to IFIT1 to form the active antiviral complex (<xref ref-type="bibr" rid="bib53">Fleith et al., 2018</xref>). Altogether, IFITs seem to preferentially target viral as well as misfolded or not properly modified cellular RNAs in the cytoplasm (<xref ref-type="bibr" rid="bib60">Gebhardt et al., 2017</xref>). IFITs have been shown to suppress translation of viral proteins by interfering with the recruitment of the initiation factor 3 (eIF3) translation complex (<xref ref-type="bibr" rid="bib68">Guo et al., 2000</xref>; <xref ref-type="bibr" rid="bib78">Hui et al., 2003</xref>; <xref ref-type="fig" rid="fig2">Figure 2</xref>). This suppressive effect may also have detrimental effects on cellular mRNA translation. Many viruses use internal ribosome entry sites (IRES) for cap-independent translation of viral proteins (<xref ref-type="bibr" rid="bib120">Martinez-Salas et al., 2017</xref>; <xref ref-type="bibr" rid="bib156">Roberts and Wieden, 2018</xref>), and it has been reported that IFIT1 suppresses IRES-dependent mRNA translation of HCV (<xref ref-type="bibr" rid="bib152">Raychoudhuri et al., 2011</xref>). While IRES elements are found in many viral genomes, they have also been detected in several cellular RNAs (<xref ref-type="bibr" rid="bib64">Godet et al., 2019</xref>). Thus, induction of aberrant IFIT expression by IFNs may not only affect the translation of viral proteins but also inhibit the synthesis of specific cellular factors (<xref ref-type="fig" rid="fig1">Figure 1</xref>, right). It is well established that all eukaryotic mRNAs contain a 5′ m7G cap (also called cap-0), that is, an N7-methylated guanosine linked to the first nucleotide of the RNA that is critical for proper processing, nuclear export, and cap-dependent protein synthesis (<xref ref-type="bibr" rid="bib36">Decroly et al., 2012</xref>). Additional methylation at the 2′O position of the initiating nucleotide generates a so-called cap-1. This 2′O methylation allows IFIT proteins as well as the immune sensors RIG-I and MDA5 to discriminate cellular RNAs from others (<xref ref-type="bibr" rid="bib151">Ramanathan et al., 2016</xref>). IFITs efficiently suppress viral RNAs lacking 2′O methylation in both cell culture and mouse models in an IFN-dependent manner (<xref ref-type="bibr" rid="bib1">Abbas et al., 2013</xref>; <xref ref-type="bibr" rid="bib35">Daffis et al., 2010</xref>; <xref ref-type="bibr" rid="bib101">Kumar et al., 2014</xref>; <xref ref-type="bibr" rid="bib144">Pichlmair et al., 2011</xref>). Altogether, it is emerging that RNA capping processes are more complex than anticipated, and it will be of interest to further clarify their role in innate antiviral immunity and inflammation.</p><p>In comparison to IFITs, another innate immune factor, Schlafen family member 11 (SLFN11), inhibits HIV protein translation in a codon-dependent fashion (<xref ref-type="bibr" rid="bib108">Li et al., 2012</xref>). Specifically, it has been suggested that SLFN11 exploits the viral codon preference for adenine-rich sequences and sequesters or modifies specific tRNAs to attenuate viral protein synthesis (<xref ref-type="fig" rid="fig2">Figure 2</xref>). Notably, epigenetic silencing of SLFN11 expression seems to be associated with resistance to specific cancer drugs (<xref ref-type="bibr" rid="bib133">Nogales et al., 2016</xref>). The underlying mechanisms remain to be determined, but it has been suggested that epigenetic silencing of SLFN11 might have an impact on the DNA damage response system. Whether or not increased immune activated SLFN11 expression would actually enhance the efficacy of anti-cancer drugs is not known.</p></sec><sec id="s1-6"><title>Post-translational modifications of viral proteins</title><p>Upon translation, viral proteins depend on a variety of host enzymes that mediate post-translational modifications. These include phosphorylation, N- and O-linked glycosylation, acetylation, the attachment of hydrophobic groups for membrane localization (e.g. myristoylation, GPI anchor addition), and many other processes that determine protein stability, localization, and activity. Consequently, modulation of these modifications may represent an efficient means of the host to interfere with viral replication. One post-translational modification that is targeted by host factors to suppress viral protein maturation is proteolytic cleavage. While many viral pathogens encode proteases to mediate proteolytic processing of their own (poly)proteins, most of them also exploit cellular proteases. One prominent example is the ubiquitously expressed host protease furin/PCSK3 that activates a variety of viral envelope glycoproteins by cleaving a poly-basic consensus motif (R-X-K/R-R↓). Among others, this comprises the envelope (Env) proteins of retroviruses such as HIV-1 (<xref ref-type="bibr" rid="bib122">McCune et al., 1988</xref>), the hemagglutinin (HA) proteins of highly pathogenic avian influenza A viruses (<xref ref-type="bibr" rid="bib93">Kawaoka et al., 1987</xref>), the fusion (F) protein of monogenavirales such as human metapneumo- or measles viruses (<xref ref-type="bibr" rid="bib154">Richardson et al., 1986</xref>), and prM proteins of different flaviviruses (<xref ref-type="bibr" rid="bib153">Rice et al., 1985</xref>; <xref ref-type="bibr" rid="bib172">Stadler et al., 1997</xref>). Without proteolytic activation, these viral glycoproteins are not able to mediate fusion of the virion membrane with the target cell. In 2013, Aerts and colleagues identified protease-activated receptor 1 (PAR1) as an endogenous inhibitor of furin (<xref ref-type="fig" rid="fig2">Figure 2</xref>) that interferes with the proteolytic activation of the human metapneumovirus F protein (<xref ref-type="bibr" rid="bib2">Aerts et al., 2013</xref>). In line with the exploitation of furin by many viral pathogens, PAR1 also reduces the processing of the HIV-1 Env precursor gp160 into its mature subunits gp120 and gp41 (<xref ref-type="bibr" rid="bib160">Sachan et al., 2019</xref>). More recently, guanylate-binding proteins 2 and 5 (GBP2 and GBP5) were also shown to inhibit the enzymatic activity of furin (<xref ref-type="fig" rid="fig2">Figure 2</xref>), thereby inhibiting replication of HIV-1, measles virus, Zika virus, and most likely additional furin-dependent viruses (<xref ref-type="bibr" rid="bib18">Braun et al., 2019</xref>; <xref ref-type="bibr" rid="bib100">Krapp et al., 2016</xref>). Thus, inhibition of the broadly used virus-dependency factor furin allows the host to restrict replication of diverse viral pathogens. Notably, however, furin also cleaves and activates more than 100 cellular factors, including hormones, growth factors, cytokines, adhesion molecules, and receptors (<xref ref-type="bibr" rid="bib19">Braun and Sauter, 2019</xref>; <xref ref-type="bibr" rid="bib183">Tian et al., 2011</xref>). As a result, the expression of PAR1, GBP2, and GBP5 may come at the cost of disturbed host protein maturation. Indeed, increased levels of GBP2 and GBP5 were associated with reduced furin-mediated cleavage of matrix metalloproteinase-14 and glypican-3 (<xref ref-type="bibr" rid="bib18">Braun et al., 2019</xref>). Although GBP2 and GBP5 are constitutively expressed in many cell types, they belong to the most strongly IFN-γ-inducible proteins. This IFN responsiveness may help to reduce unintended off-target effects and limit expression to cells that are already infected or at risk of infection.</p><p>In addition to inhibiting normal post-translation modifications of viral proteins, infected cells may also ‘mark’ viral proteins to prevent them from exerting their functions. For example, ISGylation has been shown to negatively interfere with the stability, activity, and/or assembly of viral proteins (<xref ref-type="fig" rid="fig1">Figure 1</xref>, left). This post-translational modification involves the addition of the small ubiquitin-like molecule ISG15 by the HECT and RLD domain containing E3 ubiquitin protein ligase 5 (HERC5). One well-characterized target of HERC5/ISG15 is the non-structural protein 1 (NS1) of IAV. Here, ISGylation abrogates the ability of NS1 to counteract PKR-mediated antiviral effects (<xref ref-type="bibr" rid="bib181">Tang et al., 2010</xref>). Similarly, ISGylated pUL26 of the human cytomegalovirus loses its ability to suppress NF-κB-mediated immune responses (<xref ref-type="bibr" rid="bib95">Kim et al., 2016</xref>). The number of viral ISGylation targets is constantly increasing, and accumulating evidence suggests that HERC5/ISG15 do not specifically target individual viral proteins but generally modify newly synthesized proteins (<xref ref-type="bibr" rid="bib47">Durfee et al., 2010</xref>). In line with this, HERC5/ISG15 is associated with polyribosomes and mediates ISGylation of viral, mammalian, and bacterial substrates in a sequence-independent manner (<xref ref-type="bibr" rid="bib47">Durfee et al., 2010</xref>). Thus, ISGylation may represent a rather unspecific IFN-induced immune response that does not distinguish between self and non-self (<xref ref-type="fig" rid="fig1">Figure 1</xref>). Nevertheless, viruses may be particularly affected due to dominant-negative sterical interference of ISGylated viral proteins with virion assembly. In the case of the L1 capsid protein of human papillomavirus (HPV) and the nucleoprotein (NP) of Influenza B virus, for example, ISGylation inhibits viral particle formation by preventing viral protein assembly (<xref ref-type="bibr" rid="bib47">Durfee et al., 2010</xref>; <xref ref-type="bibr" rid="bib196">Zhao et al., 2016</xref>). A similar mechanism has been proposed for HIV-1 Gag (<xref ref-type="bibr" rid="bib194">Woods et al., 2011</xref>). Negative side effects of ISGylation on the host cell seem highly likely, particularly since attachment of ISG15 also interferes with protein ubiquitination and natural protein turnover (<xref ref-type="bibr" rid="bib38">Desai et al., 2006</xref>). Nevertheless, these adverse effects may be limited, since only a minor fraction of the total target protein is ISGylated during viral infection (<xref ref-type="bibr" rid="bib141">Perng and Lenschow, 2018</xref>; <xref ref-type="bibr" rid="bib196">Zhao et al., 2016</xref>). While this percentage may be sufficient to interfere with virion assembly in a dominant-negative manner, it is tempting to speculate that the function of most cellular proteins may remain largely unaffected. In some cases, ISGylation is also exploited by the host to regulate the activity of cellular factors involved in antiviral immunity. For example, ISG15 enhances antiviral immune responses by stabilizing the transcription factors STAT1 and IRF3 (<xref ref-type="bibr" rid="bib118">Malakhova et al., 2003</xref>; <xref ref-type="bibr" rid="bib167">Shi et al., 2010</xref>) and activating PKR (<xref ref-type="bibr" rid="bib137">Okumura et al., 2013</xref>) but suppresses sensing of viral RNA via ISGylation of RIG-I (<xref ref-type="bibr" rid="bib94">Kim et al., 2008</xref>; <xref ref-type="fig" rid="fig2">Figure 2</xref>).</p><p>In summary, these examples illustrate that post-translational modifications represent an effective mechanism of the host to interfere with replication of diverse viral pathogens. However, protein-modifying enzymes frequently affect both viral and cellular proteins, since features generally distinguishing self from non-self proteins are missing. The induction of factors regulating post-translational modifications (e.g. ISG15, GBP2, GBP5) upon viral infection may represent one means to limit potential harmful side effects on the host.</p></sec><sec id="s1-7"><title>Discrimination between host and virus membranes during budding</title><p>Upon assembly of viral proteins and nucleic acids, enveloped progeny virions bud from cellular membranes. Depending on the virus species, budding takes place in cellular compartments (e.g. ER, Golgi, plasma membrane) or specific virus-induced organelles. Not surprisingly, host factors interfering with membrane composition, transport, or curvature may affect virus budding. For example, the IFN-inducible protein viperin/RSAD2 exerts antiviral activity by interfering with cholesterol metabolism and, thus, lipid composition of membranes. Viperin has been shown to interact with farnesyl diphosphate synthase (FPPS), an enzyme essential for isoprenoid biosynthesis (<xref ref-type="fig" rid="fig2">Figure 2</xref>). While one study reported a decrease in the enzymatic activity of FPPS (<xref ref-type="bibr" rid="bib192">Wang et al., 2007</xref>), a more recent publication demonstrated that viperin decreases total cellular levels of FPPS rather than inhibiting its activity (<xref ref-type="bibr" rid="bib117">Makins et al., 2016</xref>). As a result of reduced FPPS levels, detergent-resistant membrane microdomains (i.e. lipid rafts) that serve as budding sites for many enveloped viruses do not form properly. A direct link of FPPS depletion and reduced virus release has been demonstrated for IAV (<xref ref-type="bibr" rid="bib192">Wang et al., 2007</xref>). Whether viperin-mediated restriction of other viral pathogens (e.g. measles virus, CHIKV, HCV, DENV, WNV, HIV) also involves FPPS remains to be determined (<xref ref-type="bibr" rid="bib62">Ghosh and Marsh, 2020</xref>). Since lipid rafts also serve as platforms for entry of enveloped and non-enveloped viruses, it is tempting to speculate that viperin may additionally interfere with this early step of the viral replication cycle. Intriguingly, viperin also inhibits viral RNA synthesis by converting cytidine triphosphate (CTP) into the chain terminator 3′-deoxy-3′,4′-didehydro-CTP (ddhCTP) (<xref ref-type="bibr" rid="bib63">Gizzi et al., 2018</xref>). ddhCTP levels are elevated in IFN-α-stimulated cells and inhibit in vivo replication of Zikavirus and potentially other RNA viruses. As a consequence of these independent antiviral activities, viperin may affect the host cell metabolism in several ways: While the production of ddhCTP may suppress cellular transcription, the modulation of FPPS may also come at a cost since lipid rafts play key roles in cellular membrane protein trafficking, signal transduction and receptor trafficking. In line with this, viperin has been shown to reduce cellular protein release (<xref ref-type="bibr" rid="bib74">Hinson and Cresswell, 2009</xref>; <xref ref-type="fig" rid="fig2">Figure 2</xref>).</p><p>Another well-characterized and broadly active antiviral factor that targets membranes to inhibit virus release is tetherin/BST-2 (<xref ref-type="fig" rid="fig1">Figure 1</xref>; <xref ref-type="bibr" rid="bib130">Neil et al., 2008</xref>; <xref ref-type="bibr" rid="bib191">Van Damme et al., 2008</xref>). Instead of altering membrane composition, tetherin acts as a physical leash that prevents the release of newly formed virions from infected cells. This inhibitory activity depends on the unusual topology of tetherin, in which an N-terminal transmembrane domain and a C-terminal GPI anchor are linked by an extracellular coiled-coil domain (<xref ref-type="bibr" rid="bib140">Perez-Caballero et al., 2009</xref>). The GPI anchor localizes to lipid rafts and is incorporated into the membrane of many enveloped viruses during budding, whereas the transmembrane domain remains attached to the virus-producing cell. This simple, yet effective mechanism allows tetherin to restrict a broad variety of envelope viruses including retro-, filo-, and herpesviruses (<xref ref-type="bibr" rid="bib131">Neil, 2013</xref>). Furthermore, the localization around lipid rafts, the preferred budding site of many enveloped viruses (<xref ref-type="bibr" rid="bib179">Suzuki and Suzuki, 2006</xref>), as well as its IFN inducibility may help to limit unwanted side effects on cellular budding events. Nevertheless, it has been shown that tetherin fails to distinguish between budding virions and cellular exosomes as release of the latter is also inhibited (<xref ref-type="bibr" rid="bib49">Edgar et al., 2016</xref>).</p><p>Overall, the current literature suggests that membrane-targeting antiviral factors have the potential to target several steps of the viral replication cycle including fusion, formation of membranous replication complexes, and budding. A clear discrimination between self and non-self membranes can hardly be achieved since viral membranes are always derived from host cell membranes. Nevertheless, some specificity may be conferred by targeting detergent-rich membrane microdomains that serve as entry and budding sites for several viruses or by detecting specific membrane curvatures.</p></sec><sec id="s1-8"><title>APOBEC3-induced mutations</title><p>Some antiviral factors may exert their inhibitory activity even after successful budding and release of newly formed virions. As discussed above, this includes cellular proteins such as SERINC5 or IFITMs that are incorporated into progeny virions and impair their infectivity. Other cellular factors that are well known to impair virion infectivity, albeit at an even later stage, are members of the APOBEC3 (apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3) family. APOBEC3 proteins are cytidine deaminases that interact with viral RNAs and are encapsidated into newly formed virions. They are best established as restriction factors of retroviruses and retrotransposons (<xref ref-type="bibr" rid="bib87">Jónsson and Andrésdóttir, 2013</xref>). However, they have also been reported to be involved in the control of other RNA viruses (<xref ref-type="bibr" rid="bib125">Milewska et al., 2018</xref>) as well as some DNA viruses such as herpes-, parvo-, and hepadnaviruses (<xref ref-type="bibr" rid="bib84">Janahi and McGarvey, 2013</xref>; <xref ref-type="bibr" rid="bib127">Nakaya et al., 2016</xref>). Their importance is evident from the fact that several virus families evolved APOBEC3 antagonists such as the Vif protein of lentiviruses, the nucleocapsid of HTLV-1, the glyco-Gag of MLV, and the Bet protein of foamy viruses (<xref ref-type="bibr" rid="bib72">Harris and Dudley, 2015</xref>). In the case of retroviruses, virion incorporation results in deamination of cytosine residues during the reverse transcription process and consequently degradation of reversed transcribed DNA prior to integration as well as lethal G to A coding strand mutations in the integrated provirus. Humans possess seven A3 proteins (A, B, C, D, F, G, and H) resulting from gene duplications on chromosome 22 (<xref ref-type="bibr" rid="bib162">Salter et al., 2016</xref>). The best characterized antiretroviral factor APOBEC3G preferentially targets CC residues and frequently converts the tryptophan codon TGG to a TAG stop codon (<xref ref-type="bibr" rid="bib174">Stavrou and Ross, 2015</xref>). Other ABOPEC3 proteins most often target CT motifs and, thus, usually cause GAA or GA to AAA and AA missense mutations, respectively.</p><p>However, APOBEC proteins introduce mutations not only in viral nucleic acids but also in cellular nucleic acids. In fact, the first example of mRNA editing observed in vertebrates was the C to U editing of apolipoprotein B (ApoB) mRNA by APOBEC1 (<xref ref-type="bibr" rid="bib146">Powell et al., 1987</xref>; <xref ref-type="bibr" rid="bib182">Teng et al., 1993</xref>). This editing step allows the synthesis of two protein isoforms (ApoB48 and ApoB100) from the same precursor mRNA and coined the term ‘APOBEC’. Activation-induced cytidine deaminase (AID), another member of the APOBEC protein family, induces mutations in single-stranded DNA and plays a key role in immunoglobulin diversification (<xref ref-type="bibr" rid="bib142">Petersen-Mahrt et al., 2002</xref>). While these examples illustrate that editing of viral and cellular nucleic acids may be beneficial to the host, the mutagenic activity of APOBEC proteins may also come at a cost. For example, AID-induced mutations not only increase the antibody repertoire of B cells, but also contribute to the development of B-cell lymphomas (<xref ref-type="bibr" rid="bib107">Lenz and Staudt, 2010</xref>). Similarly, APOBEC3 proteins, especially APOBEC3B, are emerging as major factors causing mutations in human cancers (<xref ref-type="bibr" rid="bib138">Olson et al., 2018</xref>; <xref ref-type="bibr" rid="bib165">Seplyarskiy et al., 2016</xref>; <xref ref-type="bibr" rid="bib199">Zou et al., 2017</xref>). They may induce C to U deamination of single-stranded cellular DNA that is produced during the repair of double-stranded DNA or becomes accessible on the lagging strand during DNA replication (<xref ref-type="bibr" rid="bib143">Petljak et al., 2019</xref>; <xref ref-type="bibr" rid="bib165">Seplyarskiy et al., 2016</xref>). Comprehensive sequence analyses revealed that APOBEC-specific mutation signatures are found in more than half of all human cancer types, albeit with variable impact within each tumor (<xref ref-type="bibr" rid="bib3">Alexandrov et al., 2013</xref>; <xref ref-type="bibr" rid="bib23">Burns et al., 2013</xref>; <xref ref-type="bibr" rid="bib155">Roberts et al., 2013</xref>). Furthermore, increased levels of APOBEC expression due to the presence of high-risk genetic variants or increased IFN-γ signaling are associated with particularly high levels of APOBEC3-mediated mutagenesis in human cancers (<xref ref-type="bibr" rid="bib157">Roper et al., 2019</xref>). This suggests that chronic inflammation associated with increased IFN levels and expression of APOBEC proteins favors the accumulation of mutations associated with tumor development and metastasis. Altogether, it is becoming evident that APOBEC3 proteins not only protect us against viral pathogens, but also cause somatic mutations driving tumor evolution, metastasis, and/or therapy resistance (<xref ref-type="bibr" rid="bib138">Olson et al., 2018</xref>). Notably, individual APOBEC3 family members differ in their efficacy against specific RNA and DNA viruses, as well as their contribution to cancer development. Thus, it will be interesting to clarify whether it might be possible to specifically target selected APOBEC3 proteins causing detrimental effects in therapeutic interventions.</p></sec><sec id="s1-9"><title>Discrimination between exogenous and endogenous retroviruses</title><p>One particular challenge in the discrimination of self from non-self is the recognition of endogenous retroviruses (ERVs) by sensors and effectors of the innate immune response. ERVs are fossils of once infectious retroviruses that make up about 5–8% of the human DNA. Their ancestors infected germ cells and integrated their proviral DNA into the host genome. While many integrated proviruses were lost during evolution, others got fixed in the population and are now inherited in a Mendelian manner. In many cases, these endogenous retroviral sequences are silenced by genetic and epigenetic mechanisms as well as antiviral factors to prevent detrimental effects of their activation and spread. Some ERVs, however, have been co-opted by the host and fulfill important physiological functions in vivo. Consequently, restriction factors targeting retroviral components need to discriminate between beneficial endogenous retroviruses and their harmful counterparts to limit detrimental side effects.</p><p>One important physiological role of several endogenous retroviruses is their ability to regulate cellular gene expression. ERVs harbor numerous transcription factor binding sites, and many of them act as enhancer or promoter elements for host genes (<xref ref-type="bibr" rid="bib31">Cohen et al., 2009</xref>; <xref ref-type="fig" rid="fig3">Figure 3</xref>, top). For example, expression of the tumor-suppressor GTAp63 is driven by an endogenous retroviral promoter of the LTR12 family (<xref ref-type="bibr" rid="bib14">Beyer et al., 2011</xref>). Accumulating evidence suggests that <italic>cis</italic>-regulatory ERVs also help to mount an efficient immune response upon infection. Expression of the inflammasome component AIM2, for example, is enhanced by an ERV of the MER41 family (<xref ref-type="bibr" rid="bib29">Chuong et al., 2016</xref>). Similarly, transcription of <italic>GBP2</italic> and <italic>GBP5</italic> is regulated by endogenous retroviral LTR12C elements (<xref ref-type="bibr" rid="bib171">Srinivasachar Badarinarayan et al., 2020</xref>). However, aberrant hyperactivation of endogenous retroviral promoters can also enhance the expression of oncogenes such as <italic>CSF1R</italic> (<xref ref-type="bibr" rid="bib104">Lamprecht et al., 2010</xref>) and contribute to disease progression. Thus, the integration of transposable elements may result in a significant evolutionary conflict. On the one hand, detrimental ERV-derived regulatory elements need to be inactivated by antiviral factors such as KAP1 that epigenetically silences transposable elements (<xref ref-type="bibr" rid="bib48">Ecco et al., 2017</xref>). On the other hand, ERV promoters and enhancers that provide a selection advantage need to be excluded from these silencing mechanisms. Aberrant ERV-driven expression of oncogenes such as <italic>CSF1R</italic> or <italic>IRF5</italic> in cancer cells illustrates that this discrimination is not always successful and may lead to severe disease (<xref ref-type="bibr" rid="bib9">Babaian and Mager, 2016</xref>).</p><fig id="fig3" position="float"><label>Figure 3.</label><caption><title>Dual role of endogenous retroviruses (ERVs).</title><p>ERV-derived regulatory elements (promoters, enhancers, repressors, insulators) and proteins (syncytin-1, syncytin-2, suppressyn, etc.) may have beneficial (left) or detrimental (right) effects on the host. Abbreviations are explained in the text.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-65243-fig3-v1.tif"/></fig><p>The evolutionary conflict associated with the fixation and co-option of ERVs is further illustrated by the exaptation of ERV-derived Env proteins such as syncytin-1 or syncytin-2 (<xref ref-type="fig" rid="fig3">Figure 3</xref>, bottom). These two envelope proteins have retained their activity upon fixation in humans where they mediate the fusion of trophoblast cells into the syncytiotrophoblast, an essential step during placenta formation (<xref ref-type="bibr" rid="bib15">Blaise et al., 2003</xref>; <xref ref-type="bibr" rid="bib124">Mi et al., 2000</xref>). This fusion step closely resembles the fusion of viral and cellular membranes mediated by the envelope proteins of pathogenic exogenous retroviruses. Not surprisingly, antiviral host proteins targeting retroviral fusion events fail to distinguish between beneficial and detrimental retroviral Env proteins. As already noted above, this includes IFITM1-3 that have been shown to suppress syncytin-mediated trophoblast fusion if expressed in the placenta (<xref ref-type="bibr" rid="bib21">Buchrieser et al., 2019</xref>). Most likely, other factors targeting retroviral membrane fusion (e.g. SERINCs, CH25H) or Env maturation (e.g. PAR1, GBP2, GBP5) may result in similar unwanted side effects if expressed in the placenta. Another retroviral Env protein that has been co-opted during primate evolution is suppressyn that fails to mediate fusion as it lacks parts of its C-terminal domain (<xref ref-type="bibr" rid="bib178">Sugimoto et al., 2013</xref>). Nevertheless, it may act as important regulator of placenta formation since it shares its receptor ASCT2 with syncytin-1 (<xref ref-type="bibr" rid="bib178">Sugimoto et al., 2013</xref>). Furthermore, blockage of ASCT2 by suppressyn has recently been suggested to protect primates from infection with RD114/simian type D retroviruses that use the same receptor for entry (<xref ref-type="bibr" rid="bib54">Frank et al., 2020</xref>). Whether or how suppressyn activity is affected by antiretroviral host proteins remains unclear. Finally, some of the co-opted ERV-derived envelope proteins may contribute to pathogenesis of neurological disorders (<xref ref-type="bibr" rid="bib43">Dolei et al., 2015</xref>). This includes the induction of neuroinflammation and oligodendrocyte death by syncytin-mediated release of cytotoxins by astrocytes (<xref ref-type="bibr" rid="bib8">Antony et al., 2007</xref>). Thus, ERV-derived proteins cannot be simply categorized into good and evil, and antiviral host proteins targeting ERVs may have beneficial or detrimental effects depending on their level, timing, and site of expression.</p></sec><sec id="s1-10"><title>Long-term effects of antiviral factors on host evolution</title><p>Importantly, the ever-ongoing battle with viral pathogens has not only consequences for the individuum but also created and still shapes most parts of the human genome. This is most obvious from the fact that more than half of the human genome is composed of transposable elements (e.g. LINEs, SINEs, HERV), while only 1–2% encode for proteins (<xref ref-type="bibr" rid="bib46">Dunham et al., 2012</xref>). Furthermore, human evolution is under numerous constraints in order to maintain effective innate antiviral defense mechanisms while avoiding severe adverse effects (<xref ref-type="fig" rid="fig4">Figure 4</xref>). For example, the human genome must maintain low levels of CpG dinucleotides and has to avoid utilization of specific codons to prevent cellular mRNA degradation or suppression of translation by ZAP and SLFN11, respectively. While APOBEC3 proteins preferentially target single-stranded viral RNAs and DNAs, they also introduce mutations in the human genome (<xref ref-type="bibr" rid="bib145">Pinto et al., 2016</xref>) and play a key role in cancer development (<xref ref-type="bibr" rid="bib165">Seplyarskiy et al., 2016</xref>). Thus, the human genome is under selection pressure for suppression of APOBEC3 recognition motifs and may accumulate APOBEC3-induced mutations over time. Similarly, mRNA secondary structures such as IRES elements or mRNAs without 5′ cap are under negative selection as they may be targeted by different sensors and effectors of antiviral immunity. Accumulation evidence shows that several IFN-inducible factors restrict viral gene expression by limiting the availability of the transcription factor Sp1. This factor is also involved in many cellular processes such as differentiation, growth, apoptosis, immune, and DNA responses as well as chromatin remodeling. It is conceivable, however, that a transcription factor that becomes limiting under conditions of infection and/or inflammation should not become too important to ensure proper functioning of the cell and the organisms under these conditions. Finally, the co-option of endogenous retroviral Gag or Env proteins by the host cell is complicated by the presence of antiviral factors targeting exactly these structures. The exploitation of Env-derived syncytins provides a prime example as they are essential for placenta development in humans but may be inhibited by IFITMs.</p><fig id="fig4" position="float"><label>Figure 4.</label><caption><title>Long-term effects of antiviral proteins on host evolution.</title><p>Antiviral proteins (violet) exert selection pressure on host factors to limit similarities with viral factors. As a result, the emergence of antiviral cellular factors may be associated with constraints in host evolution.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-65243-fig4-v1.tif"/></fig></sec><sec id="s1-11"><title>Conclusion and perspectives</title><p>It is tempting to speculate how the human genome might have evolved in the absence of antiviral factors. Most likely, humans would have benefitted from a larger flexibility in the primary sequence, secondary structure, and modification of mRNAs due to the lack of RNA-binding antiviral proteins. In this case, the lack of constraints may have facilitated the evolution of novel mechanisms regulating gene expression and translation as well as a faster adaptation of host genes to novel selection pressures. Moreover, the absence of antiviral factors targeting epigenetic modifications, transcription or translation may have allowed a larger flexibility in the tissue- and cell type-specific expression of cellular genes and facilitated the evolution of new transcript variants and protein isoforms. Apart from gene expression and protein synthesis, membrane budding and fusion events within and between cells may have evolved in a different manner since any similarities with viral entry or budding events would not be problematic. On the other hand, however, the absence of viruses and antiviral factors would have precluded the integration and exploitation of (retro)viral sequences. This includes the co-option of virus-derived <italic>cis</italic>-regulatory elements (e.g. promoters, enhancers, insulators) as well as viral proteins (e.g. Env). Notably, the presence of repetitive viral elements also facilitates gene loss and duplication events and, thus, faster adaptation of the human organism to an ever-changing environment. Similarly, the mutagenic activity of antiviral factor such as APOBEC3 proteins may not always have detrimental effects but also facilitate adaptation of the host to environmental changes. Thus, targeting of cellular nucleic acids or proteins by antiviral factors may not necessarily be detrimental, but also help the host to regulate cellular processes, particularly in response to stress stimuli that induce the expression of antiviral proteins. Consequently, both the absence and presence of antiviral factors as well as endogenous viral elements may provide selection advantages to the host. At the end of the day, host organisms may have found a balance that allows them to efficiently fight off most of the viral pathogens they encounter, while tolerating a few drawbacks that may be associated with the activity of antiviral proteins. One interesting question is whether special features may allow some species to minimize adverse effects of innate immune mechanisms. For example, it has been suggested that the high body temperatures and metabolic rates achieved during flight promoted the evolution of reduced reaction to foreign and self-DNAs in bats (<xref ref-type="bibr" rid="bib13">Banerjee et al., 2020</xref>). Without this adaptation, the DNA damage that is associated with high metabolic activity would most likely result in detrimentally increased sensing of self-DNA. Since other vertebrate species also differ in their body temperatures and metabolic activities, it will be interesting whether such protective mechanisms are confirmed, for example, in birds. Metabolic activities may even exert protective effects in human individuals since anti-inflammatory effects of physical exercise are well documented although the underlying mechanisms remain poorly understood (<xref ref-type="bibr" rid="bib132">Nieman and Wentz, 2019</xref>).</p><p>While we can only speculate about how humans may have evolved in a world without viruses, there is one thing we can say for certain: the human organism has been shaped to a large extent by viruses. This is not only due to the presence of hundreds of thousands of endogenous retroviral sequences in our genome but also due to the consequence of the evolution of antiviral factors that have driven the evolution of the entire human genome.</p></sec></sec></body><back><ack id="ack"><title>Acknowledgements</title><p>We thank Dorota Kmiec, Elisabeth Braun, and Konstantin Sparrer for critical reading of the article and helpful comments and discussions. We apologize to all the authors whose favorite antiviral factors were not included in this article. This work was supported by the Deutsche Forschungsgemeinschaft (CRC 1279, SPP 1923, and SA2676/3-1) and the BMBF (01KI20135).</p></ack><sec id="s2" sec-type="additional-information"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interests</title><fn fn-type="COI-statement" id="conf1"><p>No competing interests declared</p></fn></fn-group></sec><ref-list><title>References</title><ref id="bib1"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Abbas</surname> <given-names>YM</given-names></name><name><surname>Pichlmair</surname> <given-names>A</given-names></name><name><surname>Górna</surname> <given-names>MW</given-names></name><name><surname>Superti-Furga</surname> <given-names>G</given-names></name><name><surname>Nagar</surname> <given-names>B</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Structural basis for viral 5'-PPP-RNA recognition by human IFIT proteins</article-title><source>Nature</source><volume>494</volume><fpage>60</fpage><lpage>64</lpage><pub-id pub-id-type="doi">10.1038/nature11783</pub-id><pub-id pub-id-type="pmid">23334420</pub-id></element-citation></ref><ref id="bib2"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Aerts</surname> <given-names>L</given-names></name><name><surname>Hamelin</surname> <given-names>MÈ</given-names></name><name><surname>Rhéaume</surname> <given-names>C</given-names></name><name><surname>Lavigne</surname> <given-names>S</given-names></name><name><surname>Couture</surname> <given-names>C</given-names></name><name><surname>Kim</surname> <given-names>W</given-names></name><name><surname>Susan-Resiga</surname> <given-names>D</given-names></name><name><surname>Prat</surname> <given-names>A</given-names></name><name><surname>Seidah</surname> <given-names>NG</given-names></name><name><surname>Vergnolle</surname> <given-names>N</given-names></name><name><surname>Riteau</surname> <given-names>B</given-names></name><name><surname>Boivin</surname> <given-names>G</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Modulation of protease activated receptor 1 influences human Metapneumovirus disease severity in a mouse model</article-title><source>PLOS ONE</source><volume>8</volume><elocation-id>e72529</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0072529</pub-id><pub-id pub-id-type="pmid">24015257</pub-id></element-citation></ref><ref id="bib3"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Alexandrov</surname> <given-names>LB</given-names></name><name><surname>Nik-Zainal</surname> <given-names>S</given-names></name><name><surname>Wedge</surname> <given-names>DC</given-names></name><name><surname>Aparicio</surname> <given-names>SA</given-names></name><name><surname>Behjati</surname> <given-names>S</given-names></name><name><surname>Biankin</surname> <given-names>AV</given-names></name><name><surname>Bignell</surname> <given-names>GR</given-names></name><name><surname>Bolli</surname> <given-names>N</given-names></name><name><surname>Borg</surname> <given-names>A</given-names></name><name><surname>Børresen-Dale</surname> <given-names>AL</given-names></name><name><surname>Boyault</surname> <given-names>S</given-names></name><name><surname>Burkhardt</surname> <given-names>B</given-names></name><name><surname>Butler</surname> <given-names>AP</given-names></name><name><surname>Caldas</surname> <given-names>C</given-names></name><name><surname>Davies</surname> <given-names>HR</given-names></name><name><surname>Desmedt</surname> <given-names>C</given-names></name><name><surname>Eils</surname> <given-names>R</given-names></name><name><surname>Eyfjörd</surname> <given-names>JE</given-names></name><name><surname>Foekens</surname> <given-names>JA</given-names></name><name><surname>Greaves</surname> <given-names>M</given-names></name><name><surname>Hosoda</surname> <given-names>F</given-names></name><name><surname>Hutter</surname> <given-names>B</given-names></name><name><surname>Ilicic</surname> <given-names>T</given-names></name><name><surname>Imbeaud</surname> <given-names>S</given-names></name><name><surname>Imielinski</surname> <given-names>M</given-names></name><name><surname>Imielinsk</surname> <given-names>M</given-names></name><name><surname>Jäger</surname> <given-names>N</given-names></name><name><surname>Jones</surname> <given-names>DT</given-names></name><name><surname>Jones</surname> <given-names>D</given-names></name><name><surname>Knappskog</surname> <given-names>S</given-names></name><name><surname>Kool</surname> <given-names>M</given-names></name><name><surname>Lakhani</surname> <given-names>SR</given-names></name><name><surname>López-Otín</surname> <given-names>C</given-names></name><name><surname>Martin</surname> <given-names>S</given-names></name><name><surname>Munshi</surname> <given-names>NC</given-names></name><name><surname>Nakamura</surname> <given-names>H</given-names></name><name><surname>Northcott</surname> <given-names>PA</given-names></name><name><surname>Pajic</surname> <given-names>M</given-names></name><name><surname>Papaemmanuil</surname> <given-names>E</given-names></name><name><surname>Paradiso</surname> <given-names>A</given-names></name><name><surname>Pearson</surname> <given-names>JV</given-names></name><name><surname>Puente</surname> <given-names>XS</given-names></name><name><surname>Raine</surname> <given-names>K</given-names></name><name><surname>Ramakrishna</surname> <given-names>M</given-names></name><name><surname>Richardson</surname> <given-names>AL</given-names></name><name><surname>Richter</surname> <given-names>J</given-names></name><name><surname>Rosenstiel</surname> <given-names>P</given-names></name><name><surname>Schlesner</surname> <given-names>M</given-names></name><name><surname>Schumacher</surname> <given-names>TN</given-names></name><name><surname>Span</surname> <given-names>PN</given-names></name><name><surname>Teague</surname> <given-names>JW</given-names></name><name><surname>Totoki</surname> <given-names>Y</given-names></name><name><surname>Tutt</surname> <given-names>AN</given-names></name><name><surname>Valdés-Mas</surname> <given-names>R</given-names></name><name><surname>van Buuren</surname> <given-names>MM</given-names></name><name><surname>van 't Veer</surname> <given-names>L</given-names></name><name><surname>Vincent-Salomon</surname> <given-names>A</given-names></name><name><surname>Waddell</surname> <given-names>N</given-names></name><name><surname>Yates</surname> <given-names>LR</given-names></name><collab>Australian Pancreatic Cancer Genome Initiative</collab><collab>ICGC Breast Cancer Consortium</collab><collab>ICGC MMML-Seq Consortium</collab><collab>ICGC PedBrain</collab><name><surname>Zucman-Rossi</surname> <given-names>J</given-names></name><name><surname>Futreal</surname> <given-names>PA</given-names></name><name><surname>McDermott</surname> <given-names>U</given-names></name><name><surname>Lichter</surname> <given-names>P</given-names></name><name><surname>Meyerson</surname> <given-names>M</given-names></name><name><surname>Grimmond</surname> <given-names>SM</given-names></name><name><surname>Siebert</surname> <given-names>R</given-names></name><name><surname>Campo</surname> <given-names>E</given-names></name><name><surname>Shibata</surname> <given-names>T</given-names></name><name><surname>Pfister</surname> <given-names>SM</given-names></name><name><surname>Campbell</surname> <given-names>PJ</given-names></name><name><surname>Stratton</surname> <given-names>MR</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Signatures of mutational processes in human Cancer</article-title><source>Nature</source><volume>500</volume><fpage>415</fpage><lpage>421</lpage><pub-id pub-id-type="doi">10.1038/nature12477</pub-id><pub-id pub-id-type="pmid">23945592</pub-id></element-citation></ref><ref id="bib4"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Allouch</surname> <given-names>A</given-names></name><name><surname>Di Primio</surname> <given-names>C</given-names></name><name><surname>Alpi</surname> <given-names>E</given-names></name><name><surname>Lusic</surname> <given-names>M</given-names></name><name><surname>Arosio</surname> <given-names>D</given-names></name><name><surname>Giacca</surname> <given-names>M</given-names></name><name><surname>Cereseto</surname> <given-names>A</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>The TRIM family protein KAP1 inhibits HIV-1 integration</article-title><source>Cell Host &amp; Microbe</source><volume>9</volume><fpage>484</fpage><lpage>495</lpage><pub-id pub-id-type="doi">10.1016/j.chom.2011.05.004</pub-id><pub-id pub-id-type="pmid">21669397</pub-id></element-citation></ref><ref id="bib5"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Amini-Bavil-Olyaee</surname> <given-names>S</given-names></name><name><surname>Choi</surname> <given-names>YJ</given-names></name><name><surname>Lee</surname> <given-names>JH</given-names></name><name><surname>Shi</surname> <given-names>M</given-names></name><name><surname>Huang</surname> <given-names>IC</given-names></name><name><surname>Farzan</surname> <given-names>M</given-names></name><name><surname>Jung</surname> <given-names>JU</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>The antiviral effector IFITM3 disrupts intracellular cholesterol homeostasis to block viral entry</article-title><source>Cell Host &amp; Microbe</source><volume>13</volume><fpage>452</fpage><lpage>464</lpage><pub-id pub-id-type="doi">10.1016/j.chom.2013.03.006</pub-id><pub-id pub-id-type="pmid">23601107</pub-id></element-citation></ref><ref id="bib6"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Anggakusuma</surname></name> <name><surname>Romero-Brey</surname> <given-names>I</given-names></name><name><surname>Berger</surname> <given-names>C</given-names></name><name><surname>Colpitts</surname> <given-names>CC</given-names></name><name><surname>Boldanova</surname> <given-names>T</given-names></name><name><surname>Engelmann</surname> <given-names>M</given-names></name><name><surname>Todt</surname> <given-names>D</given-names></name><name><surname>Perin</surname> <given-names>PM</given-names></name><name><surname>Behrendt</surname> <given-names>P</given-names></name><name><surname>Vondran</surname> <given-names>FW</given-names></name><name><surname>Xu</surname> <given-names>S</given-names></name><name><surname>Goffinet</surname> <given-names>C</given-names></name><name><surname>Schang</surname> <given-names>LM</given-names></name><name><surname>Heim</surname> <given-names>MH</given-names></name><name><surname>Bartenschlager</surname> <given-names>R</given-names></name><name><surname>Pietschmann</surname> <given-names>T</given-names></name><name><surname>Steinmann</surname> <given-names>E</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Interferon-inducible cholesterol-25-hydroxylase restricts hepatitis C virus replication through blockage of membranous web formation</article-title><source>Hepatology</source><volume>62</volume><fpage>702</fpage><lpage>714</lpage><pub-id pub-id-type="doi">10.1002/hep.27913</pub-id><pub-id pub-id-type="pmid">25999047</pub-id></element-citation></ref><ref id="bib7"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Antonucci</surname> <given-names>JM</given-names></name><name><surname>St Gelais</surname> <given-names>C</given-names></name><name><surname>de Silva</surname> <given-names>S</given-names></name><name><surname>Yount</surname> <given-names>JS</given-names></name><name><surname>Tang</surname> <given-names>C</given-names></name><name><surname>Ji</surname> <given-names>X</given-names></name><name><surname>Shepard</surname> <given-names>C</given-names></name><name><surname>Xiong</surname> <given-names>Y</given-names></name><name><surname>Kim</surname> <given-names>B</given-names></name><name><surname>Wu</surname> <given-names>L</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>SAMHD1-mediated HIV-1 restriction in cells does not involve ribonuclease activity</article-title><source>Nature Medicine</source><volume>22</volume><fpage>1072</fpage><lpage>1074</lpage><pub-id pub-id-type="doi">10.1038/nm.4163</pub-id><pub-id pub-id-type="pmid">27711056</pub-id></element-citation></ref><ref id="bib8"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Antony</surname> <given-names>JM</given-names></name><name><surname>Ellestad</surname> <given-names>KK</given-names></name><name><surname>Hammond</surname> <given-names>R</given-names></name><name><surname>Imaizumi</surname> <given-names>K</given-names></name><name><surname>Mallet</surname> <given-names>F</given-names></name><name><surname>Warren</surname> <given-names>KG</given-names></name><name><surname>Power</surname> <given-names>C</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>The human endogenous retrovirus envelope glycoprotein, syncytin-1, regulates neuroinflammation and its receptor expression in multiple sclerosis: a role for endoplasmic reticulum chaperones in astrocytes</article-title><source>The Journal of Immunology</source><volume>179</volume><fpage>1210</fpage><lpage>1224</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.179.2.1210</pub-id><pub-id pub-id-type="pmid">17617614</pub-id></element-citation></ref><ref id="bib9"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Babaian</surname> <given-names>A</given-names></name><name><surname>Mager</surname> <given-names>DL</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Endogenous retroviral promoter Exaptation in human Cancer</article-title><source>Mobile DNA</source><volume>7</volume><elocation-id>24</elocation-id><pub-id pub-id-type="doi">10.1186/s13100-016-0080-x</pub-id><pub-id pub-id-type="pmid">27980689</pub-id></element-citation></ref><ref id="bib10"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bailey</surname> <given-names>CC</given-names></name><name><surname>Zhong</surname> <given-names>G</given-names></name><name><surname>Huang</surname> <given-names>IC</given-names></name><name><surname>Farzan</surname> <given-names>M</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>IFITM-Family proteins: the cell's First Line of Antiviral Defense</article-title><source>Annual Review of Virology</source><volume>1</volume><fpage>261</fpage><lpage>283</lpage><pub-id pub-id-type="doi">10.1146/annurev-virology-031413-085537</pub-id><pub-id pub-id-type="pmid">25599080</pub-id></element-citation></ref><ref id="bib11"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Baldauf</surname> <given-names>HM</given-names></name><name><surname>Pan</surname> <given-names>X</given-names></name><name><surname>Erikson</surname> <given-names>E</given-names></name><name><surname>Schmidt</surname> <given-names>S</given-names></name><name><surname>Daddacha</surname> <given-names>W</given-names></name><name><surname>Burggraf</surname> <given-names>M</given-names></name><name><surname>Schenkova</surname> <given-names>K</given-names></name><name><surname>Ambiel</surname> <given-names>I</given-names></name><name><surname>Wabnitz</surname> <given-names>G</given-names></name><name><surname>Gramberg</surname> <given-names>T</given-names></name><name><surname>Panitz</surname> <given-names>S</given-names></name><name><surname>Flory</surname> <given-names>E</given-names></name><name><surname>Landau</surname> <given-names>NR</given-names></name><name><surname>Sertel</surname> <given-names>S</given-names></name><name><surname>Rutsch</surname> <given-names>F</given-names></name><name><surname>Lasitschka</surname> <given-names>F</given-names></name><name><surname>Kim</surname> <given-names>B</given-names></name><name><surname>König</surname> <given-names>R</given-names></name><name><surname>Fackler</surname> <given-names>OT</given-names></name><name><surname>Keppler</surname> <given-names>OT</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>SAMHD1 restricts HIV-1 infection in resting CD4(+) T cells</article-title><source>Nature Medicine</source><volume>18</volume><fpage>1682</fpage><lpage>1688</lpage><pub-id pub-id-type="doi">10.1038/nm.2964</pub-id><pub-id pub-id-type="pmid">22972397</pub-id></element-citation></ref><ref id="bib12"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Banerjee</surname> <given-names>S</given-names></name><name><surname>Gusho</surname> <given-names>E</given-names></name><name><surname>Gaughan</surname> <given-names>C</given-names></name><name><surname>Dong</surname> <given-names>B</given-names></name><name><surname>Gu</surname> <given-names>X</given-names></name><name><surname>Holvey-Bates</surname> <given-names>E</given-names></name><name><surname>Talukdar</surname> <given-names>M</given-names></name><name><surname>Li</surname> <given-names>Y</given-names></name><name><surname>Weiss</surname> <given-names>SR</given-names></name><name><surname>Sicheri</surname> <given-names>F</given-names></name><name><surname>Saunthararajah</surname> <given-names>Y</given-names></name><name><surname>Stark</surname> <given-names>GR</given-names></name><name><surname>Silverman</surname> <given-names>RH</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>OAS-RNase L innate immune pathway mediates the cytotoxicity of a DNA-demethylating drug</article-title><source>PNAS</source><volume>116</volume><fpage>5071</fpage><lpage>5076</lpage><pub-id pub-id-type="doi">10.1073/pnas.1815071116</pub-id><pub-id pub-id-type="pmid">30814222</pub-id></element-citation></ref><ref id="bib13"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Banerjee</surname> <given-names>A</given-names></name><name><surname>Baker</surname> <given-names>ML</given-names></name><name><surname>Kulcsar</surname> <given-names>K</given-names></name><name><surname>Misra</surname> <given-names>V</given-names></name><name><surname>Plowright</surname> <given-names>R</given-names></name><name><surname>Mossman</surname> <given-names>K</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Novel insights into immune systems of bats</article-title><source>Frontiers in Immunology</source><volume>11</volume><elocation-id>26</elocation-id><pub-id pub-id-type="doi">10.3389/fimmu.2020.00026</pub-id><pub-id pub-id-type="pmid">32117225</pub-id></element-citation></ref><ref id="bib14"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Beyer</surname> <given-names>U</given-names></name><name><surname>Moll-Rocek</surname> <given-names>J</given-names></name><name><surname>Moll</surname> <given-names>UM</given-names></name><name><surname>Dobbelstein</surname> <given-names>M</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Endogenous retrovirus drives hitherto unknown proapoptotic p63 isoforms in the male germ line of humans and great apes</article-title><source>PNAS</source><volume>108</volume><fpage>3624</fpage><lpage>3629</lpage><pub-id pub-id-type="doi">10.1073/pnas.1016201108</pub-id><pub-id pub-id-type="pmid">21300884</pub-id></element-citation></ref><ref id="bib15"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Blaise</surname> <given-names>S</given-names></name><name><surname>de Parseval</surname> <given-names>N</given-names></name><name><surname>Bénit</surname> <given-names>L</given-names></name><name><surname>Heidmann</surname> <given-names>T</given-names></name></person-group><year iso-8601-date="2003">2003</year><article-title>Genomewide screening for fusogenic human endogenous retrovirus envelopes identifies syncytin 2, a gene conserved on primate evolution</article-title><source>PNAS</source><volume>100</volume><fpage>13013</fpage><lpage>13018</lpage><pub-id pub-id-type="doi">10.1073/pnas.2132646100</pub-id><pub-id pub-id-type="pmid">14557543</pub-id></element-citation></ref><ref id="bib16"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bloch</surname> <given-names>M</given-names></name><name><surname>John</surname> <given-names>M</given-names></name><name><surname>Smith</surname> <given-names>D</given-names></name><name><surname>Rasmussen</surname> <given-names>TA</given-names></name><name><surname>Wright</surname> <given-names>E</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Managing HIV-associated inflammation and ageing in the era of modern ART</article-title><source>HIV Medicine</source><volume>21 Suppl 3</volume><fpage>2</fpage><lpage>16</lpage><pub-id pub-id-type="doi">10.1111/hiv.12952</pub-id><pub-id pub-id-type="pmid">33022087</pub-id></element-citation></ref><ref id="bib17"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bosso</surname> <given-names>M</given-names></name><name><surname>Prelli Bozzo</surname> <given-names>C</given-names></name><name><surname>Hotter</surname> <given-names>D</given-names></name><name><surname>Volcic</surname> <given-names>M</given-names></name><name><surname>Stürzel</surname> <given-names>CM</given-names></name><name><surname>Rammelt</surname> <given-names>A</given-names></name><name><surname>Ni</surname> <given-names>Y</given-names></name><name><surname>Urban</surname> <given-names>S</given-names></name><name><surname>Becker</surname> <given-names>M</given-names></name><name><surname>Schelhaas</surname> <given-names>M</given-names></name><name><surname>Wittmann</surname> <given-names>S</given-names></name><name><surname>Christensen</surname> <given-names>MH</given-names></name><name><surname>Schmidt</surname> <given-names>FI</given-names></name><name><surname>Gramberg</surname> <given-names>T</given-names></name><name><surname>Sparrer</surname> <given-names>KMJ</given-names></name><name><surname>Sauter</surname> <given-names>D</given-names></name><name><surname>Kirchhoff</surname> <given-names>F</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Nuclear PYHIN proteins target the host transcription factor Sp1 thereby restricting HIV-1 in human macrophages and CD4+ T cells</article-title><source>PLOS Pathogens</source><volume>16</volume><elocation-id>e1008752</elocation-id><pub-id pub-id-type="doi">10.1371/journal.ppat.1008752</pub-id><pub-id pub-id-type="pmid">32760121</pub-id></element-citation></ref><ref id="bib18"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Braun</surname> <given-names>E</given-names></name><name><surname>Hotter</surname> <given-names>D</given-names></name><name><surname>Koepke</surname> <given-names>L</given-names></name><name><surname>Zech</surname> <given-names>F</given-names></name><name><surname>Groß</surname> <given-names>R</given-names></name><name><surname>Sparrer</surname> <given-names>KMJ</given-names></name><name><surname>Müller</surname> <given-names>JA</given-names></name><name><surname>Pfaller</surname> <given-names>CK</given-names></name><name><surname>Heusinger</surname> <given-names>E</given-names></name><name><surname>Wombacher</surname> <given-names>R</given-names></name><name><surname>Sutter</surname> <given-names>K</given-names></name><name><surname>Dittmer</surname> <given-names>U</given-names></name><name><surname>Winkler</surname> <given-names>M</given-names></name><name><surname>Simmons</surname> <given-names>G</given-names></name><name><surname>Jakobsen</surname> <given-names>MR</given-names></name><name><surname>Conzelmann</surname> <given-names>KK</given-names></name><name><surname>Pöhlmann</surname> <given-names>S</given-names></name><name><surname>Münch</surname> <given-names>J</given-names></name><name><surname>Fackler</surname> <given-names>OT</given-names></name><name><surname>Kirchhoff</surname> <given-names>F</given-names></name><name><surname>Sauter</surname> <given-names>D</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Guanylate-Binding proteins 2 and 5 exert broad antiviral activity by inhibiting Furin-Mediated processing of viral envelope proteins</article-title><source>Cell Reports</source><volume>27</volume><fpage>2092</fpage><lpage>2104</lpage><pub-id pub-id-type="doi">10.1016/j.celrep.2019.04.063</pub-id><pub-id pub-id-type="pmid">31091448</pub-id></element-citation></ref><ref id="bib19"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Braun</surname> <given-names>E</given-names></name><name><surname>Sauter</surname> <given-names>D</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Furin-mediated protein processing in infectious diseases and Cancer</article-title><source>Clinical &amp; Translational Immunology</source><volume>8</volume><elocation-id>e1073</elocation-id><pub-id pub-id-type="doi">10.1002/cti2.1073</pub-id><pub-id pub-id-type="pmid">31406574</pub-id></element-citation></ref><ref id="bib20"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brennan-Laun</surname> <given-names>SE</given-names></name><name><surname>Ezelle</surname> <given-names>HJ</given-names></name><name><surname>Li</surname> <given-names>XL</given-names></name><name><surname>Hassel</surname> <given-names>BA</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>RNase-L control of cellular mRNAs: roles in biologic functions and mechanisms of substrate targeting</article-title><source>Journal of Interferon &amp; Cytokine Research</source><volume>34</volume><fpage>275</fpage><lpage>288</lpage><pub-id pub-id-type="doi">10.1089/jir.2013.0147</pub-id><pub-id pub-id-type="pmid">24697205</pub-id></element-citation></ref><ref id="bib21"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Buchrieser</surname> <given-names>J</given-names></name><name><surname>Degrelle</surname> <given-names>SA</given-names></name><name><surname>Couderc</surname> <given-names>T</given-names></name><name><surname>Nevers</surname> <given-names>Q</given-names></name><name><surname>Disson</surname> <given-names>O</given-names></name><name><surname>Manet</surname> <given-names>C</given-names></name><name><surname>Donahue</surname> <given-names>DA</given-names></name><name><surname>Porrot</surname> <given-names>F</given-names></name><name><surname>Hillion</surname> <given-names>KH</given-names></name><name><surname>Perthame</surname> <given-names>E</given-names></name><name><surname>Arroyo</surname> <given-names>MV</given-names></name><name><surname>Souquere</surname> <given-names>S</given-names></name><name><surname>Ruigrok</surname> <given-names>K</given-names></name><name><surname>Dupressoir</surname> <given-names>A</given-names></name><name><surname>Heidmann</surname> <given-names>T</given-names></name><name><surname>Montagutelli</surname> <given-names>X</given-names></name><name><surname>Fournier</surname> <given-names>T</given-names></name><name><surname>Lecuit</surname> <given-names>M</given-names></name><name><surname>Schwartz</surname> <given-names>O</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>IFITM proteins inhibit placental syncytiotrophoblast formation and promote fetal demise</article-title><source>Science</source><volume>365</volume><fpage>176</fpage><lpage>180</lpage><pub-id pub-id-type="doi">10.1126/science.aaw7733</pub-id><pub-id pub-id-type="pmid">31296770</pub-id></element-citation></ref><ref id="bib22"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Buffalo</surname> <given-names>CZ</given-names></name><name><surname>Stürzel</surname> <given-names>CM</given-names></name><name><surname>Heusinger</surname> <given-names>E</given-names></name><name><surname>Kmiec</surname> <given-names>D</given-names></name><name><surname>Kirchhoff</surname> <given-names>F</given-names></name><name><surname>Hurley</surname> <given-names>JH</given-names></name><name><surname>Ren</surname> <given-names>X</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Structural basis for tetherin antagonism as a barrier to zoonotic lentiviral transmission</article-title><source>Cell Host &amp; Microbe</source><volume>26</volume><fpage>359</fpage><lpage>368</lpage><pub-id pub-id-type="doi">10.1016/j.chom.2019.08.002</pub-id><pub-id pub-id-type="pmid">31447307</pub-id></element-citation></ref><ref id="bib23"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Burns</surname> <given-names>MB</given-names></name><name><surname>Temiz</surname> <given-names>NA</given-names></name><name><surname>Harris</surname> <given-names>RS</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Evidence for APOBEC3B mutagenesis in multiple human cancers</article-title><source>Nature Genetics</source><volume>45</volume><fpage>977</fpage><lpage>983</lpage><pub-id pub-id-type="doi">10.1038/ng.2701</pub-id></element-citation></ref><ref id="bib24"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cagliani</surname> <given-names>R</given-names></name><name><surname>Forni</surname> <given-names>D</given-names></name><name><surname>Biasin</surname> <given-names>M</given-names></name><name><surname>Comabella</surname> <given-names>M</given-names></name><name><surname>Guerini</surname> <given-names>FR</given-names></name><name><surname>Riva</surname> <given-names>S</given-names></name><name><surname>Pozzoli</surname> <given-names>U</given-names></name><name><surname>Agliardi</surname> <given-names>C</given-names></name><name><surname>Caputo</surname> <given-names>D</given-names></name><name><surname>Malhotra</surname> <given-names>S</given-names></name><name><surname>Montalban</surname> <given-names>X</given-names></name><name><surname>Bresolin</surname> <given-names>N</given-names></name><name><surname>Clerici</surname> <given-names>M</given-names></name><name><surname>Sironi</surname> <given-names>M</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Ancient and recent selective pressures shaped genetic diversity at AIM2-like nucleic acid sensors</article-title><source>Genome Biology and Evolution</source><volume>6</volume><fpage>830</fpage><lpage>845</lpage><pub-id pub-id-type="doi">10.1093/gbe/evu066</pub-id><pub-id pub-id-type="pmid">24682156</pub-id></element-citation></ref><ref id="bib25"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Casares</surname> <given-names>D</given-names></name><name><surname>Escribá</surname> <given-names>PV</given-names></name><name><surname>Rosselló</surname> <given-names>CA</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Membrane lipid composition: effect on membrane and organelle structure, function and compartmentalization and therapeutic avenues</article-title><source>International Journal of Molecular Sciences</source><volume>20</volume><elocation-id>2167</elocation-id><pub-id pub-id-type="doi">10.3390/ijms20092167</pub-id></element-citation></ref><ref id="bib26"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chang</surname> <given-names>PC</given-names></name><name><surname>Fitzgerald</surname> <given-names>LD</given-names></name><name><surname>Van Geelen</surname> <given-names>A</given-names></name><name><surname>Izumiya</surname> <given-names>Y</given-names></name><name><surname>Ellison</surname> <given-names>TJ</given-names></name><name><surname>Wang</surname> <given-names>DH</given-names></name><name><surname>Ann</surname> <given-names>DK</given-names></name><name><surname>Luciw</surname> <given-names>PA</given-names></name><name><surname>Kung</surname> <given-names>HJ</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Kruppel-associated box domain-associated protein-1 as a latency regulator for kaposi's sarcoma-associated herpesvirus and its modulation by the viral protein kinase</article-title><source>Cancer Research</source><volume>69</volume><fpage>5681</fpage><lpage>5689</lpage><pub-id pub-id-type="doi">10.1158/0008-5472.CAN-08-4570</pub-id><pub-id pub-id-type="pmid">19584288</pub-id></element-citation></ref><ref id="bib27"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname> <given-names>YC</given-names></name><name><surname>Sood</surname> <given-names>C</given-names></name><name><surname>Marin</surname> <given-names>M</given-names></name><name><surname>Aaron</surname> <given-names>J</given-names></name><name><surname>Gratton</surname> <given-names>E</given-names></name><name><surname>Salaita</surname> <given-names>K</given-names></name><name><surname>Melikyan</surname> <given-names>GB</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Super-Resolution fluorescence imaging reveals that serine incorporator protein 5 inhibits human immunodeficiency virus fusion by disrupting envelope glycoprotein clusters</article-title><source>ACS Nano</source><volume>14</volume><fpage>10929</fpage><lpage>10943</lpage><pub-id pub-id-type="doi">10.1021/acsnano.0c02699</pub-id><pub-id pub-id-type="pmid">32441921</pub-id></element-citation></ref><ref id="bib28"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chiramel</surname> <given-names>AI</given-names></name><name><surname>Meyerson</surname> <given-names>NR</given-names></name><name><surname>McNally</surname> <given-names>KL</given-names></name><name><surname>Broeckel</surname> <given-names>RM</given-names></name><name><surname>Montoya</surname> <given-names>VR</given-names></name><name><surname>Méndez-Solís</surname> <given-names>O</given-names></name><name><surname>Robertson</surname> <given-names>SJ</given-names></name><name><surname>Sturdevant</surname> <given-names>GL</given-names></name><name><surname>Lubick</surname> <given-names>KJ</given-names></name><name><surname>Nair</surname> <given-names>V</given-names></name><name><surname>Youseff</surname> <given-names>BH</given-names></name><name><surname>Ireland</surname> <given-names>RM</given-names></name><name><surname>Bosio</surname> <given-names>CM</given-names></name><name><surname>Kim</surname> <given-names>K</given-names></name><name><surname>Luban</surname> <given-names>J</given-names></name><name><surname>Hirsch</surname> <given-names>VM</given-names></name><name><surname>Taylor</surname> <given-names>RT</given-names></name><name><surname>Bouamr</surname> <given-names>F</given-names></name><name><surname>Sawyer</surname> <given-names>SL</given-names></name><name><surname>Best</surname> <given-names>SM</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>TRIM5α restricts Flavivirus replication by targeting the viral protease for proteasomal degradation</article-title><source>Cell Reports</source><volume>27</volume><fpage>3269</fpage><lpage>3283</lpage><pub-id pub-id-type="doi">10.1016/j.celrep.2019.05.040</pub-id><pub-id pub-id-type="pmid">31189110</pub-id></element-citation></ref><ref id="bib29"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chuong</surname> <given-names>EB</given-names></name><name><surname>Elde</surname> <given-names>NC</given-names></name><name><surname>Feschotte</surname> <given-names>C</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Regulatory evolution of innate immunity through co-option of endogenous retroviruses</article-title><source>Science</source><volume>351</volume><fpage>1083</fpage><lpage>1087</lpage><pub-id pub-id-type="doi">10.1126/science.aad5497</pub-id><pub-id pub-id-type="pmid">26941318</pub-id></element-citation></ref><ref id="bib30"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Coggins</surname> <given-names>S</given-names></name><name><surname>Mahboubi</surname> <given-names>B</given-names></name><name><surname>Schinazi</surname> <given-names>RF</given-names></name><name><surname>Kim</surname> <given-names>B</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>SAMHD1 functions and human diseases</article-title><source>Viruses</source><volume>12</volume><elocation-id>382</elocation-id><pub-id pub-id-type="doi">10.3390/v12040382</pub-id></element-citation></ref><ref id="bib31"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cohen</surname> <given-names>CJ</given-names></name><name><surname>Lock</surname> <given-names>WM</given-names></name><name><surname>Mager</surname> <given-names>DL</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Endogenous retroviral LTRs as promoters for human genes: A critical assessment</article-title><source>Gene</source><volume>448</volume><fpage>105</fpage><lpage>114</lpage><pub-id pub-id-type="doi">10.1016/j.gene.2009.06.020</pub-id></element-citation></ref><ref id="bib32"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Compton</surname> <given-names>AA</given-names></name><name><surname>Bruel</surname> <given-names>T</given-names></name><name><surname>Porrot</surname> <given-names>F</given-names></name><name><surname>Mallet</surname> <given-names>A</given-names></name><name><surname>Sachse</surname> <given-names>M</given-names></name><name><surname>Euvrard</surname> <given-names>M</given-names></name><name><surname>Liang</surname> <given-names>C</given-names></name><name><surname>Casartelli</surname> <given-names>N</given-names></name><name><surname>Schwartz</surname> <given-names>O</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>IFITM proteins incorporated into HIV-1 virions impair viral fusion and spread</article-title><source>Cell Host &amp; Microbe</source><volume>16</volume><fpage>736</fpage><lpage>747</lpage><pub-id pub-id-type="doi">10.1016/j.chom.2014.11.001</pub-id><pub-id pub-id-type="pmid">25464829</pub-id></element-citation></ref><ref id="bib33"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cooper</surname> <given-names>DN</given-names></name><name><surname>Gerber-Huber</surname> <given-names>S</given-names></name></person-group><year iso-8601-date="1985">1985</year><article-title>DNA methylation and CpG suppression</article-title><source>Cell Differentiation</source><volume>17</volume><fpage>199</fpage><lpage>205</lpage><pub-id pub-id-type="doi">10.1016/0045-6039(85)90488-9</pub-id></element-citation></ref><ref id="bib34"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cribier</surname> <given-names>A</given-names></name><name><surname>Descours</surname> <given-names>B</given-names></name><name><surname>Valadão</surname> <given-names>ALC</given-names></name><name><surname>Laguette</surname> <given-names>N</given-names></name><name><surname>Benkirane</surname> <given-names>M</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Phosphorylation of SAMHD1 by Cyclin A2/CDK1 Regulates Its Restriction Activity toward HIV-1</article-title><source>Cell Reports</source><volume>3</volume><fpage>1036</fpage><lpage>1043</lpage><pub-id pub-id-type="doi">10.1016/j.celrep.2013.03.017</pub-id></element-citation></ref><ref id="bib35"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Daffis</surname> <given-names>S</given-names></name><name><surname>Szretter</surname> <given-names>KJ</given-names></name><name><surname>Schriewer</surname> <given-names>J</given-names></name><name><surname>Li</surname> <given-names>J</given-names></name><name><surname>Youn</surname> <given-names>S</given-names></name><name><surname>Errett</surname> <given-names>J</given-names></name><name><surname>Lin</surname> <given-names>T-Y</given-names></name><name><surname>Schneller</surname> <given-names>S</given-names></name><name><surname>Zust</surname> <given-names>R</given-names></name><name><surname>Dong</surname> <given-names>H</given-names></name><name><surname>Thiel</surname> <given-names>V</given-names></name><name><surname>Sen</surname> <given-names>GC</given-names></name><name><surname>Fensterl</surname> <given-names>V</given-names></name><name><surname>Klimstra</surname> <given-names>WB</given-names></name><name><surname>Pierson</surname> <given-names>TC</given-names></name><name><surname>Buller</surname> <given-names>RM</given-names></name><name><surname>Gale Jr</surname> <given-names>M</given-names></name><name><surname>Shi</surname> <given-names>P-Y</given-names></name><name><surname>Diamond</surname> <given-names>MS</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>2′-O methylation of the viral mRNA cap evades host restriction by IFIT family members</article-title><source>Nature</source><volume>468</volume><fpage>452</fpage><lpage>456</lpage><pub-id pub-id-type="doi">10.1038/nature09489</pub-id></element-citation></ref><ref id="bib36"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Decroly</surname> <given-names>E</given-names></name><name><surname>Ferron</surname> <given-names>F</given-names></name><name><surname>Lescar</surname> <given-names>J</given-names></name><name><surname>Canard</surname> <given-names>B</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Conventional and unconventional mechanisms for capping viral mRNA</article-title><source>Nature Reviews Microbiology</source><volume>10</volume><fpage>51</fpage><lpage>65</lpage><pub-id pub-id-type="doi">10.1038/nrmicro2675</pub-id></element-citation></ref><ref id="bib37"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Deeks</surname> <given-names>SG</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>HIV infection, inflammation, Immunosenescence, and aging</article-title><source>Annual Review of Medicine</source><volume>62</volume><fpage>141</fpage><lpage>155</lpage><pub-id pub-id-type="doi">10.1146/annurev-med-042909-093756</pub-id><pub-id pub-id-type="pmid">21090961</pub-id></element-citation></ref><ref id="bib38"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Desai</surname> <given-names>SD</given-names></name><name><surname>Haas</surname> <given-names>AL</given-names></name><name><surname>Wood</surname> <given-names>LM</given-names></name><name><surname>Tsai</surname> <given-names>YC</given-names></name><name><surname>Pestka</surname> <given-names>S</given-names></name><name><surname>Rubin</surname> <given-names>EH</given-names></name><name><surname>Saleem</surname> <given-names>A</given-names></name><name><surname>Nur-E-Kamal</surname> <given-names>A</given-names></name><name><surname>Liu</surname> <given-names>LF</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>Elevated expression of ISG15 in tumor cells interferes with the ubiquitin/26S proteasome pathway</article-title><source>Cancer Research</source><volume>66</volume><fpage>921</fpage><lpage>928</lpage><pub-id pub-id-type="doi">10.1158/0008-5472.CAN-05-1123</pub-id><pub-id pub-id-type="pmid">16424026</pub-id></element-citation></ref><ref id="bib39"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Descours</surname> <given-names>B</given-names></name><name><surname>Cribier</surname> <given-names>A</given-names></name><name><surname>Chable-Bessia</surname> <given-names>C</given-names></name><name><surname>Ayinde</surname> <given-names>D</given-names></name><name><surname>Rice</surname> <given-names>G</given-names></name><name><surname>Crow</surname> <given-names>Y</given-names></name><name><surname>Yatim</surname> <given-names>A</given-names></name><name><surname>Schwartz</surname> <given-names>O</given-names></name><name><surname>Laguette</surname> <given-names>N</given-names></name><name><surname>Benkirane</surname> <given-names>M</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>SAMHD1 restricts HIV-1 reverse transcription in quiescent CD4(+) T-cells</article-title><source>Retrovirology</source><volume>9</volume><elocation-id>87</elocation-id><pub-id pub-id-type="doi">10.1186/1742-4690-9-87</pub-id><pub-id pub-id-type="pmid">23092122</pub-id></element-citation></ref><ref id="bib40"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dever</surname> <given-names>TE</given-names></name><name><surname>Feng</surname> <given-names>L</given-names></name><name><surname>Wek</surname> <given-names>RC</given-names></name><name><surname>Cigan</surname> <given-names>AM</given-names></name><name><surname>Donahue</surname> <given-names>TF</given-names></name><name><surname>Hinnebusch</surname> <given-names>AG</given-names></name></person-group><year iso-8601-date="1992">1992</year><article-title>Phosphorylation of initiation factor 2 alpha by protein kinase GCN2 mediates gene-specific translational control of GCN4 in yeast</article-title><source>Cell</source><volume>68</volume><fpage>585</fpage><lpage>596</lpage><pub-id pub-id-type="doi">10.1016/0092-8674(92)90193-G</pub-id><pub-id pub-id-type="pmid">1739968</pub-id></element-citation></ref><ref id="bib41"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Diamond</surname> <given-names>MS</given-names></name><name><surname>Farzan</surname> <given-names>M</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>The broad-spectrum antiviral functions of IFIT and IFITM proteins</article-title><source>Nature Reviews Immunology</source><volume>13</volume><fpage>46</fpage><lpage>57</lpage><pub-id pub-id-type="doi">10.1038/nri3344</pub-id><pub-id pub-id-type="pmid">23237964</pub-id></element-citation></ref><ref id="bib42"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dicks</surname> <given-names>MDJ</given-names></name><name><surname>Betancor</surname> <given-names>G</given-names></name><name><surname>Jimenez-Guardeño</surname> <given-names>JM</given-names></name><name><surname>Pessel-Vivares</surname> <given-names>L</given-names></name><name><surname>Apolonia</surname> <given-names>L</given-names></name><name><surname>Goujon</surname> <given-names>C</given-names></name><name><surname>Malim</surname> <given-names>MH</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Multiple components of the nuclear pore complex interact with the amino-terminus of MX2 to facilitate HIV-1 restriction</article-title><source>PLOS Pathogens</source><volume>14</volume><elocation-id>e1007408</elocation-id><pub-id pub-id-type="doi">10.1371/journal.ppat.1007408</pub-id><pub-id pub-id-type="pmid">30496303</pub-id></element-citation></ref><ref id="bib43"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dolei</surname> <given-names>A</given-names></name><name><surname>Uleri</surname> <given-names>E</given-names></name><name><surname>Ibba</surname> <given-names>G</given-names></name><name><surname>Caocci</surname> <given-names>M</given-names></name><name><surname>Piu</surname> <given-names>C</given-names></name><name><surname>Serra</surname> <given-names>C</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>The aliens inside human DNA: herv-w/MSRV/syncytin-1 endogenous retroviruses and neurodegeneration</article-title><source>The Journal of Infection in Developing Countries</source><volume>9</volume><fpage>577</fpage><lpage>587</lpage><pub-id pub-id-type="doi">10.3855/jidc.6916</pub-id><pub-id pub-id-type="pmid">26142666</pub-id></element-citation></ref><ref id="bib44"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Doyle</surname> <given-names>T</given-names></name><name><surname>Goujon</surname> <given-names>C</given-names></name><name><surname>Malim</surname> <given-names>MH</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>HIV-1 and interferons: who's interfering with whom?</article-title><source>Nature Reviews Microbiology</source><volume>13</volume><fpage>403</fpage><lpage>413</lpage><pub-id pub-id-type="doi">10.1038/nrmicro3449</pub-id><pub-id pub-id-type="pmid">25915633</pub-id></element-citation></ref><ref id="bib45"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Duggal</surname> <given-names>NK</given-names></name><name><surname>Emerman</surname> <given-names>M</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Evolutionary conflicts between viruses and restriction factors shape immunity</article-title><source>Nature Reviews Immunology</source><volume>12</volume><fpage>687</fpage><lpage>695</lpage><pub-id pub-id-type="doi">10.1038/nri3295</pub-id><pub-id pub-id-type="pmid">22976433</pub-id></element-citation></ref><ref id="bib46"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dunham</surname> <given-names>I</given-names></name><name><surname>Kundaje</surname> <given-names>A</given-names></name><name><surname>Aldred</surname> <given-names>SF</given-names></name><name><surname>Collins</surname> <given-names>PJ</given-names></name><name><surname>Davis</surname> <given-names>CA</given-names></name><name><surname>Doyle</surname> <given-names>F</given-names></name><name><surname>Epstein</surname> <given-names>CB</given-names></name><name><surname>Frietze</surname> <given-names>S</given-names></name><name><surname>Harrow</surname> <given-names>J</given-names></name><name><surname>Kaul</surname> <given-names>R</given-names></name><name><surname>Khatun</surname> <given-names>J</given-names></name><name><surname>Lajoie</surname> <given-names>BR</given-names></name><name><surname>Landt</surname> <given-names>SG</given-names></name><name><surname>Lee</surname> <given-names>BK</given-names></name><name><surname>Pauli</surname> <given-names>F</given-names></name><name><surname>Rosenbloom</surname> <given-names>KR</given-names></name><name><surname>Sabo</surname> <given-names>P</given-names></name><name><surname>Safi</surname> <given-names>A</given-names></name><name><surname>Sanyal</surname> <given-names>A</given-names></name><name><surname>Shoresh</surname> <given-names>N</given-names></name><name><surname>Simon</surname> <given-names>JM</given-names></name><name><surname>Song</surname> <given-names>L</given-names></name><name><surname>Trinklein</surname> <given-names>ND</given-names></name><name><surname>Altshuler</surname> <given-names>RC</given-names></name><name><surname>Birney</surname> <given-names>E</given-names></name><name><surname>Brown</surname> <given-names>JB</given-names></name><name><surname>Cheng</surname> <given-names>C</given-names></name><name><surname>Djebali</surname> <given-names>S</given-names></name><name><surname>Dong</surname> <given-names>X</given-names></name><name><surname>Ernst</surname> <given-names>J</given-names></name><name><surname>Furey</surname> <given-names>TS</given-names></name><name><surname>Gerstein</surname> <given-names>M</given-names></name><name><surname>Giardine</surname> <given-names>B</given-names></name><name><surname>Greven</surname> <given-names>M</given-names></name><name><surname>Hardison</surname> <given-names>RC</given-names></name><name><surname>Harris</surname> <given-names>RS</given-names></name><name><surname>Herrero</surname> <given-names>J</given-names></name><name><surname>Hoffman</surname> <given-names>MM</given-names></name><name><surname>Iyer</surname> <given-names>S</given-names></name><name><surname>Kellis</surname> <given-names>M</given-names></name><name><surname>Kheradpour</surname> <given-names>P</given-names></name><name><surname>Lassmann</surname> <given-names>T</given-names></name><name><surname>Li</surname> <given-names>Q</given-names></name><name><surname>Lin</surname> <given-names>X</given-names></name><name><surname>Marinov</surname> <given-names>GK</given-names></name><name><surname>Merkel</surname> <given-names>A</given-names></name><name><surname>Mortazavi</surname> <given-names>A</given-names></name><name><surname>Parker</surname> <given-names>SCJ</given-names></name><name><surname>Reddy</surname> <given-names>TE</given-names></name><name><surname>Rozowsky</surname> <given-names>J</given-names></name><name><surname>Schlesinger</surname> <given-names>F</given-names></name><name><surname>Thurman</surname> <given-names>RE</given-names></name><name><surname>Wang</surname> <given-names>J</given-names></name><name><surname>Ward</surname> <given-names>LD</given-names></name><name><surname>Whitfield</surname> <given-names>TW</given-names></name><name><surname>Wilder</surname> <given-names>SP</given-names></name><name><surname>Wu</surname> <given-names>W</given-names></name><name><surname>Hs</surname> <given-names>X</given-names></name><name><surname>Yip</surname> <given-names>KY</given-names></name><name><surname>Zhuang</surname> <given-names>J</given-names></name><name><surname>Bernstein</surname> <given-names>BE</given-names></name><name><surname>Green</surname> <given-names>ED</given-names></name><name><surname>Gunter</surname> <given-names>C</given-names></name><name><surname>Snyder</surname> <given-names>M</given-names></name><name><surname>Pazin</surname> <given-names>MJ</given-names></name><name><surname>Lowdon</surname> <given-names>RF</given-names></name><name><surname>Dillon</surname> <given-names>LAL</given-names></name><name><surname>Adams</surname> <given-names>LB</given-names></name><name><surname>Kelly</surname> <given-names>CJ</given-names></name><name><surname>Zhang</surname> <given-names>J</given-names></name><name><surname>Wexler</surname> <given-names>JR</given-names></name><name><surname>Good</surname> <given-names>PJ</given-names></name><name><surname>Feingold</surname> <given-names>EA</given-names></name><name><surname>Crawford</surname> <given-names>GE</given-names></name><name><surname>Dekker</surname> <given-names>J</given-names></name><name><surname>Elnitski</surname> <given-names>L</given-names></name><name><surname>Farnham</surname> <given-names>PJ</given-names></name><name><surname>Giddings</surname> <given-names>MC</given-names></name><name><surname>Gingeras</surname> <given-names>TR</given-names></name><name><surname>Guigó</surname> <given-names>R</given-names></name><name><surname>Hubbard</surname> <given-names>TJ</given-names></name><name><surname>Kent</surname> <given-names>WJ</given-names></name><name><surname>Lieb</surname> <given-names>JD</given-names></name><name><surname>Margulies</surname> <given-names>EH</given-names></name><name><surname>Myers</surname> <given-names>RM</given-names></name><name><surname>Stamatoyannopoulos</surname> <given-names>JA</given-names></name><name><surname>Tenenbaum</surname> <given-names>SA</given-names></name><name><surname>Weng</surname> <given-names>Z</given-names></name><name><surname>White</surname> <given-names>KP</given-names></name><name><surname>Wold</surname> <given-names>B</given-names></name><name><surname>Yu</surname> <given-names>Y</given-names></name><name><surname>Wrobel</surname> <given-names>J</given-names></name><name><surname>Risk</surname> <given-names>BA</given-names></name><name><surname>Gunawardena</surname> <given-names>HP</given-names></name><name><surname>Kuiper</surname> <given-names>HC</given-names></name><name><surname>Maier</surname> <given-names>CW</given-names></name><name><surname>Xie</surname> <given-names>L</given-names></name><name><surname>Chen</surname> <given-names>X</given-names></name><name><surname>Mikkelsen</surname> <given-names>TS</given-names></name><name><surname>Gillespie</surname> <given-names>S</given-names></name><name><surname>Goren</surname> <given-names>A</given-names></name><name><surname>Ram</surname> <given-names>O</given-names></name><name><surname>Zhang</surname> <given-names>X</given-names></name><name><surname>Wang</surname> <given-names>L</given-names></name><name><surname>Issner</surname> <given-names>R</given-names></name><name><surname>Coyne</surname> <given-names>MJ</given-names></name><name><surname>Durham</surname> <given-names>T</given-names></name><name><surname>Ku</surname> <given-names>M</given-names></name><name><surname>Truong</surname> <given-names>T</given-names></name><name><surname>Eaton</surname> <given-names>ML</given-names></name><name><surname>Dobin</surname> <given-names>A</given-names></name><name><surname>Tanzer</surname> <given-names>A</given-names></name><name><surname>Lagarde</surname> <given-names>J</given-names></name><name><surname>Lin</surname> <given-names>W</given-names></name><name><surname>Xue</surname> <given-names>C</given-names></name><name><surname>Williams</surname> <given-names>BA</given-names></name><name><surname>Zaleski</surname> <given-names>C</given-names></name><name><surname>Röder M</surname> <given-names>KF</given-names></name><name><surname>Abdelhamid</surname> <given-names>RF</given-names></name><name><surname>Alioto</surname> <given-names>T</given-names></name><name><surname>Antoshechkin</surname> <given-names>I</given-names></name><name><surname>Baer</surname> <given-names>MT</given-names></name><name><surname>Batut</surname> <given-names>P</given-names></name><name><surname>Bell</surname> <given-names>I</given-names></name><name><surname>Bell</surname> <given-names>K</given-names></name><name><surname>Chakrabortty</surname> <given-names>S</given-names></name><name><surname>Chrast</surname> <given-names>J</given-names></name><name><surname>Curado</surname> <given-names>J</given-names></name><name><surname>Derrien</surname> <given-names>T</given-names></name><name><surname>Drenkow</surname> <given-names>J</given-names></name><name><surname>Dumais</surname> <given-names>E</given-names></name><name><surname>Dumais</surname> <given-names>J</given-names></name><name><surname>Duttagupta</surname> <given-names>R</given-names></name><name><surname>Fastuca</surname> <given-names>M</given-names></name><name><surname>Fejes-Toth</surname> <given-names>K</given-names></name><name><surname>Ferreira</surname> <given-names>P</given-names></name><name><surname>Foissac</surname> <given-names>S</given-names></name><name><surname>Fullwood</surname> <given-names>MJ</given-names></name><name><surname>Gao</surname> <given-names>H</given-names></name><name><surname>Gonzalez</surname> <given-names>D</given-names></name><name><surname>Gordon</surname> <given-names>A</given-names></name><name><surname>Howald</surname> <given-names>C</given-names></name><name><surname>Jha</surname> <given-names>S</given-names></name><name><surname>Johnson</surname> <given-names>R</given-names></name><name><surname>Kapranov</surname> <given-names>P</given-names></name><name><surname>King</surname> <given-names>B</given-names></name><name><surname>Kingswood</surname> <given-names>C</given-names></name><name><surname>Li</surname> <given-names>G</given-names></name><name><surname>Luo</surname> <given-names>OJ</given-names></name><name><surname>Park</surname> <given-names>E</given-names></name><name><surname>Preall</surname> <given-names>JB</given-names></name><name><surname>Presaud</surname> <given-names>K</given-names></name><name><surname>Ribeca</surname> <given-names>P</given-names></name><name><surname>Robyr</surname> <given-names>D</given-names></name><name><surname>Ruan</surname> <given-names>X</given-names></name><name><surname>Sammeth</surname> <given-names>M</given-names></name><name><surname>Sandhu</surname> <given-names>KS</given-names></name><name><surname>Schaeffer</surname> <given-names>L</given-names></name><name><surname>See</surname> <given-names>LH</given-names></name><name><surname>Shahab</surname> <given-names>A</given-names></name><name><surname>Skancke</surname> <given-names>J</given-names></name><name><surname>Suzuki</surname> <given-names>AM</given-names></name><name><surname>Takahashi</surname> <given-names>H</given-names></name><name><surname>Tilgner</surname> <given-names>H</given-names></name><name><surname>Trout</surname> <given-names>D</given-names></name><name><surname>Walters</surname> <given-names>N</given-names></name><name><surname>Huaien</surname> <given-names>W</given-names></name><name><surname>Hayashizaki</surname> <given-names>Y</given-names></name><name><surname>Reymond</surname> <given-names>A</given-names></name><name><surname>Antonarakis</surname> <given-names>SE</given-names></name><name><surname>Hannon</surname> <given-names>GJ</given-names></name><name><surname>Ruan</surname> <given-names>Y</given-names></name><name><surname>Carninci</surname> <given-names>P</given-names></name><name><surname>Sloan</surname> <given-names>CA</given-names></name><name><surname>Learned</surname> <given-names>K</given-names></name><name><surname>Malladi</surname> <given-names>VS</given-names></name><name><surname>Wong</surname> <given-names>MC</given-names></name><name><surname>Barber</surname> <given-names>GP</given-names></name><name><surname>Cline</surname> <given-names>MS</given-names></name><name><surname>Dreszer</surname> <given-names>TR</given-names></name><name><surname>Heitner</surname> <given-names>SG</given-names></name><name><surname>Karolchik</surname> <given-names>D</given-names></name><name><surname>Kirkup</surname> <given-names>VM</given-names></name><name><surname>Meyer</surname> <given-names>LR</given-names></name><name><surname>Long</surname> <given-names>JC</given-names></name><name><surname>Maddren</surname> <given-names>M</given-names></name><name><surname>Raney</surname> <given-names>BJ</given-names></name><name><surname>Grasfeder</surname> <given-names>LL</given-names></name><name><surname>Giresi</surname> <given-names>PG</given-names></name><name><surname>Battenhouse</surname> <given-names>A</given-names></name><name><surname>Sheffield</surname> <given-names>NC</given-names></name><name><surname>Showers</surname> <given-names>KA</given-names></name><name><surname>London</surname> <given-names>D</given-names></name><name><surname>Bhinge</surname> <given-names>AA</given-names></name><name><surname>Shestak</surname> <given-names>C</given-names></name><name><surname>Schaner</surname> <given-names>MR</given-names></name><name><surname>Kim</surname> <given-names>SK</given-names></name><name><surname>Zhang</surname> <given-names>ZZ</given-names></name><name><surname>Mieczkowski</surname> <given-names>PA</given-names></name><name><surname>Mieczkowska</surname> <given-names>JO</given-names></name><name><surname>Liu</surname> <given-names>Z</given-names></name><name><surname>McDaniell</surname> <given-names>RM</given-names></name><name><surname>Ni</surname> <given-names>Y</given-names></name><name><surname>Rashid</surname> <given-names>NU</given-names></name><name><surname>Kim</surname> <given-names>MJ</given-names></name><name><surname>Adar</surname> <given-names>S</given-names></name><name><surname>Zhancheng</surname> <given-names>Z</given-names></name><name><surname>Wang</surname> <given-names>T</given-names></name><name><surname>Winter</surname> <given-names>D</given-names></name><name><surname>Keefe</surname> <given-names>D</given-names></name><name><surname>Iyer</surname> <given-names>VR</given-names></name><name><surname>Zheng</surname> <given-names>M</given-names></name><name><surname>Wang</surname> <given-names>P</given-names></name><name><surname>Gertz</surname> <given-names>J</given-names></name><name><surname>Vielmetter</surname> <given-names>J</given-names></name><name><surname>Partridge</surname> <given-names>EC</given-names></name><name><surname>Varley</surname> <given-names>KE</given-names></name><name><surname>Gasper</surname> <given-names>C</given-names></name><name><surname>Bansal</surname> <given-names>A</given-names></name><name><surname>Pepke</surname> <given-names>S</given-names></name><name><surname>Jain</surname> <given-names>P</given-names></name><name><surname>Amrhein</surname> <given-names>H</given-names></name><name><surname>Bowling</surname> <given-names>KM</given-names></name><name><surname>Anaya</surname> <given-names>M</given-names></name><name><surname>Cross</surname> <given-names>MK</given-names></name><name><surname>Muratet</surname> <given-names>MA</given-names></name><name><surname>Newberry</surname> <given-names>KM</given-names></name><name><surname>McCue</surname> <given-names>K</given-names></name><name><surname>Nesmith</surname> <given-names>AS</given-names></name><name><surname>Fisher-Aylor</surname> <given-names>KI</given-names></name><name><surname>Pusey</surname> <given-names>B</given-names></name><name><surname>DeSalvo</surname> <given-names>G</given-names></name><name><surname>Parker</surname> <given-names>SL</given-names></name><name><surname>Sreeram</surname> <given-names>B</given-names></name><name><surname>Davis</surname> <given-names>NS</given-names></name><name><surname>Meadows</surname> <given-names>SK</given-names></name><name><surname>Eggleston</surname> <given-names>T</given-names></name><name><surname>Newberry</surname> <given-names>JS</given-names></name><name><surname>Levy</surname> <given-names>SE</given-names></name><name><surname>Absher</surname> <given-names>DM</given-names></name><name><surname>Wong</surname> <given-names>WH</given-names></name><name><surname>Blow</surname> <given-names>MJ</given-names></name><name><surname>Visel</surname> <given-names>A</given-names></name><name><surname>Pennachio</surname> <given-names>LA</given-names></name><name><surname>Petrykowska</surname> <given-names>HM</given-names></name><name><surname>Abyzov</surname> <given-names>A</given-names></name><name><surname>Aken</surname> <given-names>B</given-names></name><name><surname>Barrell</surname> <given-names>D</given-names></name><name><surname>Barson</surname> <given-names>G</given-names></name><name><surname>Berry</surname> <given-names>A</given-names></name><name><surname>Bignell</surname> <given-names>A</given-names></name><name><surname>Boychenko</surname> <given-names>V</given-names></name><name><surname>Bussotti</surname> <given-names>G</given-names></name><name><surname>Davidson</surname> <given-names>C</given-names></name><name><surname>Despacio-Reyes</surname> <given-names>G</given-names></name><name><surname>Diekhans</surname> <given-names>M</given-names></name><name><surname>Ezkurdia</surname> <given-names>I</given-names></name><name><surname>Frankish</surname> <given-names>A</given-names></name><name><surname>Gilbert</surname> <given-names>J</given-names></name><name><surname>Gonzalez</surname> <given-names>JM</given-names></name><name><surname>Griffiths</surname> <given-names>E</given-names></name><name><surname>Harte</surname> <given-names>R</given-names></name><name><surname>Hendrix</surname> <given-names>DA</given-names></name><name><surname>Hunt</surname> <given-names>T</given-names></name><name><surname>Jungreis</surname> <given-names>I</given-names></name><name><surname>Kay</surname> <given-names>M</given-names></name><name><surname>Khurana</surname> <given-names>E</given-names></name><name><surname>Leng</surname> <given-names>J</given-names></name><name><surname>Lin</surname> <given-names>MF</given-names></name><name><surname>Loveland</surname> <given-names>J</given-names></name><name><surname>Lu</surname> <given-names>Z</given-names></name><name><surname>Manthravadi</surname> <given-names>D</given-names></name><name><surname>Mariotti</surname> <given-names>M</given-names></name><name><surname>Mudge</surname> <given-names>J</given-names></name><name><surname>Mukherjee</surname> <given-names>G</given-names></name><name><surname>Notredame</surname> <given-names>C</given-names></name><name><surname>Pei</surname> <given-names>B</given-names></name><name><surname>Rodriguez</surname> <given-names>JM</given-names></name><name><surname>Saunders</surname> <given-names>G</given-names></name><name><surname>Sboner</surname> <given-names>A</given-names></name><name><surname>Searle</surname> <given-names>S</given-names></name><name><surname>Sisu</surname> <given-names>C</given-names></name><name><surname>Snow</surname> <given-names>C</given-names></name><name><surname>Steward</surname> <given-names>C</given-names></name><name><surname>Tapanari</surname> <given-names>E</given-names></name><name><surname>Tress</surname> <given-names>ML</given-names></name><name><surname>Van Baren</surname> <given-names>MJ</given-names></name><name><surname>Washietl</surname> <given-names>S</given-names></name><name><surname>Wilming</surname> <given-names>L</given-names></name><name><surname>Zadissa</surname> <given-names>A</given-names></name><name><surname>Zhengdong</surname> <given-names>Z</given-names></name><name><surname>Brent</surname> <given-names>M</given-names></name><name><surname>Haussler</surname> <given-names>D</given-names></name><name><surname>Valencia</surname> <given-names>A</given-names></name><name><surname>Addleman</surname> <given-names>N</given-names></name><name><surname>Alexander</surname> <given-names>RP</given-names></name><name><surname>Auerbach</surname> <given-names>RK</given-names></name><name><surname>Suganthi</surname> <given-names>B</given-names></name><name><surname>Bettinger</surname> <given-names>K</given-names></name><name><surname>Bhardwaj</surname> <given-names>N</given-names></name><name><surname>Boyle</surname> <given-names>AP</given-names></name><name><surname>Cao</surname> <given-names>AR</given-names></name><name><surname>Cayting</surname> <given-names>P</given-names></name><name><surname>Charos</surname> <given-names>A</given-names></name><name><surname>Cheng</surname> <given-names>Y</given-names></name><name><surname>Eastman</surname> <given-names>C</given-names></name><name><surname>Euskirchen</surname> <given-names>G</given-names></name><name><surname>Fleming</surname> <given-names>JD</given-names></name><name><surname>Grubert</surname> <given-names>F</given-names></name><name><surname>Habegger</surname> <given-names>L</given-names></name><name><surname>Hariharan</surname> <given-names>M</given-names></name><name><surname>Harmanci</surname> <given-names>A</given-names></name><name><surname>Iyengar</surname> <given-names>S</given-names></name><name><surname>Jin</surname> <given-names>VX</given-names></name><name><surname>Karczewski</surname> <given-names>KJ</given-names></name><name><surname>Kasowski</surname> <given-names>M</given-names></name><name><surname>Lacroute</surname> <given-names>P</given-names></name><name><surname>Lam</surname> <given-names>H</given-names></name><name><surname>Lamarre-Vincent</surname> <given-names>N</given-names></name><name><surname>Lian</surname> <given-names>J</given-names></name><name><surname>Lindahl-Allen</surname> <given-names>M</given-names></name><name><surname>Min</surname> <given-names>R</given-names></name><name><surname>Miotto</surname> <given-names>B</given-names></name><name><surname>Monahan</surname> <given-names>H</given-names></name><name><surname>Moqtaderi</surname> <given-names>Z</given-names></name><name><surname>Xj</surname> <given-names>M</given-names></name><name><surname>O’Geen</surname> <given-names>H</given-names></name><name><surname>Ouyang</surname> <given-names>Z</given-names></name><name><surname>Patacsil</surname> <given-names>D</given-names></name><name><surname>Raha</surname> <given-names>D</given-names></name><name><surname>Ramirez</surname> <given-names>L</given-names></name><name><surname>Reed</surname> <given-names>B</given-names></name><name><surname>Shi</surname> <given-names>M</given-names></name><name><surname>Slifer</surname> <given-names>T</given-names></name><name><surname>Witt</surname> <given-names>H</given-names></name><name><surname>Wu</surname> <given-names>L</given-names></name><name><surname>Xu</surname> <given-names>X</given-names></name><name><surname>Yan</surname> <given-names>KK</given-names></name><name><surname>Yang</surname> <given-names>X</given-names></name><name><surname>Struhl</surname> <given-names>K</given-names></name><name><surname>Weissman</surname> <given-names>SM</given-names></name><name><surname>Penalva</surname> <given-names>LO</given-names></name><name><surname>Karmakar</surname> <given-names>S</given-names></name><name><surname>Bhanvadia</surname> <given-names>RR</given-names></name><name><surname>Choudhury</surname> <given-names>A</given-names></name><name><surname>Domanus</surname> <given-names>M</given-names></name><name><surname>Ma</surname> <given-names>L</given-names></name><name><surname>Moran</surname> <given-names>J</given-names></name><name><surname>Victorsen</surname> <given-names>A</given-names></name><name><surname>Auer</surname> <given-names>T</given-names></name><name><surname>Centanin</surname> <given-names>L</given-names></name><name><surname>Eichenlaub</surname> <given-names>M</given-names></name><name><surname>Gruhl</surname> <given-names>F</given-names></name><name><surname>Heermann</surname> <given-names>S</given-names></name><name><surname>Hoeckendorf</surname> <given-names>B</given-names></name><name><surname>Inoue</surname> <given-names>D</given-names></name><name><surname>Kellner</surname> <given-names>T</given-names></name><name><surname>Kirchmaier</surname> <given-names>S</given-names></name><name><surname>Mueller</surname> <given-names>C</given-names></name><name><surname>Reinhardt</surname> <given-names>R</given-names></name><name><surname>Schertel</surname> <given-names>L</given-names></name><name><surname>Schneider</surname> <given-names>S</given-names></name><name><surname>Sinn</surname> <given-names>R</given-names></name><name><surname>Wittbrodt</surname> <given-names>B</given-names></name><name><surname>Wittbrodt</surname> <given-names>J</given-names></name><name><surname>Jain</surname> <given-names>G</given-names></name><name><surname>Balasundaram</surname> <given-names>G</given-names></name><name><surname>Bates</surname> <given-names>DL</given-names></name><name><surname>Byron</surname> <given-names>R</given-names></name><name><surname>Canfield</surname> <given-names>TK</given-names></name><name><surname>Diegel</surname> <given-names>MJ</given-names></name><name><surname>Dunn</surname> <given-names>D</given-names></name><name><surname>Ebersol</surname> <given-names>AK</given-names></name><name><surname>Frum</surname> <given-names>T</given-names></name><name><surname>Garg</surname> <given-names>K</given-names></name><name><surname>Gist</surname> <given-names>E</given-names></name><name><surname>Hansen</surname> <given-names>RS</given-names></name><name><surname>Boatman</surname> <given-names>L</given-names></name><name><surname>Haugen</surname> <given-names>E</given-names></name><name><surname>Humbert</surname> <given-names>R</given-names></name><name><surname>Johnson</surname> <given-names>AK</given-names></name><name><surname>Johnson</surname> <given-names>EM</given-names></name><name><surname>Kutyavin</surname> <given-names>T</given-names></name> <name><surname>Lee</surname> <given-names>K</given-names></name><name><surname>Lotakis</surname> <given-names>D</given-names></name><name><surname>Maurano</surname> <given-names>MT</given-names></name><name><surname>Neph</surname> <given-names>SJ</given-names></name><name><surname>Neri</surname> <given-names>F</given-names></name> <name><surname>Nguyen</surname> <given-names>ED</given-names></name><name><surname>Qu</surname> <given-names>H</given-names></name><name><surname>Reynolds</surname> <given-names>AP</given-names></name><name><surname>Roach</surname> <given-names>V</given-names></name><name><surname>Rynes</surname> <given-names>E</given-names></name><name><surname>Sanchez</surname> <given-names>ME</given-names></name><name><surname>Sandstrom</surname> <given-names>RS</given-names></name><name><surname>Shafer</surname> <given-names>AO</given-names></name><name><surname>Stergachis</surname> <given-names>AB</given-names></name><name><surname>Thomas</surname> <given-names>S</given-names></name><name><surname>Vernot</surname> <given-names>B</given-names></name><name><surname>Vierstra</surname> <given-names>J</given-names></name><name><surname>Vong</surname> <given-names>S</given-names></name><name><surname>Hao</surname> <given-names>W</given-names></name><name><surname>Weaver</surname> <given-names>MA</given-names></name><name><surname>Yan</surname> <given-names>Y</given-names></name><name><surname>Zhang</surname> <given-names>M</given-names></name><name><surname>Akey</surname> <given-names>JM</given-names></name><name><surname>Bender</surname> <given-names>M</given-names></name><name><surname>Dorschner</surname> <given-names>MO</given-names></name><name><surname>Groudine</surname> <given-names>M</given-names></name><name><surname>MacCoss</surname> <given-names>MJ</given-names></name><name><surname>Navas</surname> <given-names>P</given-names></name><name><surname>Stamatoyannopoulos</surname> <given-names>G</given-names></name><name><surname>Beal</surname> <given-names>K</given-names></name><name><surname>Brazma</surname> <given-names>A</given-names></name><name><surname>Flicek</surname> <given-names>P</given-names></name><name><surname>Johnson</surname> <given-names>N</given-names></name><name><surname>Lukk</surname> <given-names>M</given-names></name><name><surname>Luscombe</surname> <given-names>NM</given-names></name><name><surname>Sobral</surname> <given-names>D</given-names></name><name><surname>Vaquerizas</surname> <given-names>JM</given-names></name><name><surname>Batzoglou</surname> <given-names>S</given-names></name><name><surname>Sidow</surname> <given-names>A</given-names></name><name><surname>Hussami</surname> <given-names>N</given-names></name><name><surname>Kyriazopoulou-Panagiotopoulou</surname> <given-names>S</given-names></name><name><surname>Libbrecht</surname> <given-names>MW</given-names></name><name><surname>Schaub</surname> <given-names>MA</given-names></name><name><surname>Miller</surname> <given-names>W</given-names></name><name><surname>Bickel</surname> <given-names>PJ</given-names></name><name><surname>Banfai</surname> <given-names>B</given-names></name><name><surname>Boley</surname> <given-names>NP</given-names></name><name><surname>Huang</surname> <given-names>H</given-names></name><name><surname>Jj</surname> <given-names>L</given-names></name><name><surname>Noble</surname> <given-names>WS</given-names></name><name><surname>Bilmes</surname> <given-names>JA</given-names></name><name><surname>Buske</surname> <given-names>OJ</given-names></name><name><surname>Sahu</surname> <given-names>AD</given-names></name><name><surname>Kharchenko</surname> <given-names>P</given-names></name> <name><surname>Park</surname> <given-names>PJ</given-names></name><name><surname>Baker</surname> <given-names>D</given-names></name><name><surname>Taylor</surname> <given-names>J</given-names></name><name><surname>Lochovsky</surname> <given-names>L</given-names></name><collab>ENCODE Project Consortium</collab></person-group><year iso-8601-date="2012">2012</year><article-title>An integrated encyclopedia of DNA elements in the human genome</article-title><source>Nature</source><volume>489</volume><fpage>57</fpage><lpage>74</lpage><pub-id pub-id-type="doi">10.1038/nature11247</pub-id><pub-id pub-id-type="pmid">22955616</pub-id></element-citation></ref><ref id="bib47"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Durfee</surname> <given-names>LA</given-names></name><name><surname>Lyon</surname> <given-names>N</given-names></name><name><surname>Seo</surname> <given-names>K</given-names></name><name><surname>Huibregtse</surname> <given-names>JM</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>The ISG15 conjugation system broadly targets newly synthesized proteins: implications for the antiviral function of ISG15</article-title><source>Molecular Cell</source><volume>38</volume><fpage>722</fpage><lpage>732</lpage><pub-id pub-id-type="doi">10.1016/j.molcel.2010.05.002</pub-id><pub-id pub-id-type="pmid">20542004</pub-id></element-citation></ref><ref id="bib48"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ecco</surname> <given-names>G</given-names></name><name><surname>Imbeault</surname> <given-names>M</given-names></name><name><surname>Trono</surname> <given-names>D</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>KRAB zinc finger proteins</article-title><source>Development</source><volume>144</volume><fpage>2719</fpage><lpage>2729</lpage><pub-id pub-id-type="doi">10.1242/dev.132605</pub-id><pub-id pub-id-type="pmid">28765213</pub-id></element-citation></ref><ref id="bib49"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Edgar</surname> <given-names>JR</given-names></name><name><surname>Manna</surname> <given-names>PT</given-names></name><name><surname>Nishimura</surname> <given-names>S</given-names></name><name><surname>Banting</surname> <given-names>G</given-names></name><name><surname>Robinson</surname> <given-names>MS</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Tetherin is an exosomal tether</article-title><source>eLife</source><volume>5</volume><elocation-id>e17180</elocation-id><pub-id pub-id-type="doi">10.7554/eLife.17180</pub-id><pub-id pub-id-type="pmid">27657169</pub-id></element-citation></ref><ref id="bib50"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Featherstone</surname> <given-names>A</given-names></name><name><surname>Aiken</surname> <given-names>C</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>SERINC5 inhibits HIV-1 infectivity by altering the conformation of gp120 on HIV-1 particles</article-title><source>Journal of Virology</source><volume>94</volume><elocation-id>e00594</elocation-id><pub-id pub-id-type="doi">10.1128/JVI.00594-20</pub-id><pub-id pub-id-type="pmid">32796070</pub-id></element-citation></ref><ref id="bib51"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ficarelli</surname> <given-names>M</given-names></name><name><surname>Wilson</surname> <given-names>H</given-names></name><name><surname>Pedro Galão</surname> <given-names>R</given-names></name><name><surname>Mazzon</surname> <given-names>M</given-names></name><name><surname>Antzin-Anduetza</surname> <given-names>I</given-names></name><name><surname>Marsh</surname> <given-names>M</given-names></name><name><surname>Neil</surname> <given-names>SJ</given-names></name><name><surname>Swanson</surname> <given-names>CM</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>KHNYN is essential for the zinc finger antiviral protein (ZAP) to restrict HIV-1 containing clustered CpG dinucleotides</article-title><source>eLife</source><volume>8</volume><elocation-id>e46767</elocation-id><pub-id pub-id-type="doi">10.7554/eLife.46767</pub-id><pub-id pub-id-type="pmid">31284899</pub-id></element-citation></ref><ref id="bib52"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ficarelli</surname> <given-names>M</given-names></name><name><surname>Antzin-Anduetza</surname> <given-names>I</given-names></name><name><surname>Hugh-White</surname> <given-names>R</given-names></name><name><surname>Firth</surname> <given-names>AE</given-names></name><name><surname>Sertkaya</surname> <given-names>H</given-names></name><name><surname>Wilson</surname> <given-names>H</given-names></name><name><surname>Neil</surname> <given-names>SJD</given-names></name><name><surname>Schulz</surname> <given-names>R</given-names></name><name><surname>Swanson</surname> <given-names>CM</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>CpG dinucleotides inhibit HIV-1 replication through zinc finger antiviral protein (ZAP)-Dependent and -Independent mechanisms</article-title><source>Journal of Virology</source><volume>94</volume><elocation-id>JVI.01337-19</elocation-id><pub-id pub-id-type="doi">10.1128/JVI.01337-19</pub-id></element-citation></ref><ref id="bib53"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fleith</surname> <given-names>RC</given-names></name><name><surname>Mears</surname> <given-names>HV</given-names></name><name><surname>Leong</surname> <given-names>XY</given-names></name><name><surname>Sanford</surname> <given-names>TJ</given-names></name><name><surname>Emmott</surname> <given-names>E</given-names></name><name><surname>Graham</surname> <given-names>SC</given-names></name><name><surname>Mansur</surname> <given-names>DS</given-names></name><name><surname>Sweeney</surname> <given-names>TR</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>IFIT3 and IFIT2/3 promote IFIT1-mediated translation inhibition by enhancing binding to non-self RNA</article-title><source>Nucleic Acids Research</source><volume>46</volume><fpage>5269</fpage><lpage>5285</lpage><pub-id pub-id-type="doi">10.1093/nar/gky191</pub-id><pub-id pub-id-type="pmid">29554348</pub-id></element-citation></ref><ref id="bib54"><element-citation publication-type="preprint"><person-group person-group-type="author"><name><surname>Frank</surname> <given-names>JA</given-names></name><name><surname>Singh</surname> <given-names>M</given-names></name><name><surname>Cullen</surname> <given-names>HB</given-names></name><name><surname>Kirou</surname> <given-names>RA</given-names></name><name><surname>Coyne</surname> <given-names>CB</given-names></name><name><surname>Feschotte</surname> <given-names>C</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Antiviral activity of a human placental protein of retroviral origin. </article-title><source>bioRxiv</source><pub-id pub-id-type="doi">10.1101/2020.08.23.263665</pub-id></element-citation></ref><ref id="bib55"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fregoso</surname> <given-names>OI</given-names></name><name><surname>Ahn</surname> <given-names>J</given-names></name><name><surname>Wang</surname> <given-names>C</given-names></name><name><surname>Mehrens</surname> <given-names>J</given-names></name><name><surname>Skowronski</surname> <given-names>J</given-names></name><name><surname>Emerman</surname> <given-names>M</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Evolutionary toggling of vpx/Vpr specificity results in divergent recognition of the restriction factor SAMHD1</article-title><source>PLOS Pathogens</source><volume>9</volume><elocation-id>e1003496</elocation-id><pub-id pub-id-type="doi">10.1371/journal.ppat.1003496</pub-id><pub-id pub-id-type="pmid">23874202</pub-id></element-citation></ref><ref id="bib56"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fricke</surname> <given-names>T</given-names></name><name><surname>White</surname> <given-names>TE</given-names></name><name><surname>Schulte</surname> <given-names>B</given-names></name><name><surname>de Souza Aranha Vieira</surname> <given-names>DA</given-names></name><name><surname>Dharan</surname> <given-names>A</given-names></name><name><surname>Campbell</surname> <given-names>EM</given-names></name><name><surname>Brandariz-Nuñez</surname> <given-names>A</given-names></name><name><surname>Diaz-Griffero</surname> <given-names>F</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>MxB binds to the HIV-1 core and prevents the uncoating process of HIV-1</article-title><source>Retrovirology</source><volume>11</volume><elocation-id>68</elocation-id><pub-id pub-id-type="doi">10.1186/s12977-014-0068-x</pub-id><pub-id pub-id-type="pmid">25123063</pub-id></element-citation></ref><ref id="bib57"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Galão</surname> <given-names>RP</given-names></name><name><surname>Le Tortorec</surname> <given-names>A</given-names></name><name><surname>Pickering</surname> <given-names>S</given-names></name><name><surname>Kueck</surname> <given-names>T</given-names></name><name><surname>Neil</surname> <given-names>SJ</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Innate sensing of HIV-1 assembly by tetherin induces NFκB-dependent proinflammatory responses</article-title><source>Cell Host &amp; Microbe</source><volume>12</volume><fpage>633</fpage><lpage>644</lpage><pub-id pub-id-type="doi">10.1016/j.chom.2012.10.007</pub-id><pub-id pub-id-type="pmid">23159053</pub-id></element-citation></ref><ref id="bib58"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ganser-Pornillos</surname> <given-names>BK</given-names></name><name><surname>Chandrasekaran</surname> <given-names>V</given-names></name><name><surname>Pornillos</surname> <given-names>O</given-names></name><name><surname>Sodroski</surname> <given-names>JG</given-names></name><name><surname>Sundquist</surname> <given-names>WI</given-names></name><name><surname>Yeager</surname> <given-names>M</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Hexagonal assembly of a restricting TRIM5alpha protein</article-title><source>PNAS</source><volume>108</volume><fpage>534</fpage><lpage>539</lpage><pub-id pub-id-type="doi">10.1073/pnas.1013426108</pub-id><pub-id pub-id-type="pmid">21187419</pub-id></element-citation></ref><ref id="bib59"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gariano</surname> <given-names>GR</given-names></name><name><surname>Dell'Oste</surname> <given-names>V</given-names></name><name><surname>Bronzini</surname> <given-names>M</given-names></name><name><surname>Gatti</surname> <given-names>D</given-names></name><name><surname>Luganini</surname> <given-names>A</given-names></name><name><surname>De Andrea</surname> <given-names>M</given-names></name><name><surname>Gribaudo</surname> <given-names>G</given-names></name><name><surname>Gariglio</surname> <given-names>M</given-names></name><name><surname>Landolfo</surname> <given-names>S</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>The intracellular DNA sensor IFI16 gene acts as restriction factor for human Cytomegalovirus replication</article-title><source>PLOS Pathogens</source><volume>8</volume><elocation-id>e1002498</elocation-id><pub-id pub-id-type="doi">10.1371/journal.ppat.1002498</pub-id><pub-id pub-id-type="pmid">22291595</pub-id></element-citation></ref><ref id="bib60"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gebhardt</surname> <given-names>A</given-names></name><name><surname>Laudenbach</surname> <given-names>BT</given-names></name><name><surname>Pichlmair</surname> <given-names>A</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Discrimination of Self and Non-Self Ribonucleic Acids</article-title><source>Journal of Interferon &amp; Cytokine Research</source><volume>37</volume><fpage>184</fpage><lpage>197</lpage><pub-id pub-id-type="doi">10.1089/jir.2016.0092</pub-id></element-citation></ref><ref id="bib61"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ghimire</surname> <given-names>D</given-names></name><name><surname>Rai</surname> <given-names>M</given-names></name><name><surname>Gaur</surname> <given-names>R</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Novel host restriction factors implicated in HIV-1 replication</article-title><source>Journal of General Virology</source><volume>99</volume><fpage>435</fpage><lpage>446</lpage><pub-id pub-id-type="doi">10.1099/jgv.0.001026</pub-id></element-citation></ref><ref id="bib62"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ghosh</surname> <given-names>S</given-names></name><name><surname>Marsh</surname> <given-names>ENG</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Viperin: An ancient radical SAM enzyme finds its place in modern cellular metabolism and innate immunity</article-title><source>Journal of Biological Chemistry</source><volume>295</volume><fpage>11513</fpage><lpage>11528</lpage><pub-id pub-id-type="doi">10.1074/jbc.REV120.012784</pub-id></element-citation></ref><ref id="bib63"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gizzi</surname> <given-names>AS</given-names></name><name><surname>Grove</surname> <given-names>TL</given-names></name><name><surname>Arnold</surname> <given-names>JJ</given-names></name><name><surname>Jose</surname> <given-names>J</given-names></name><name><surname>Jangra</surname> <given-names>RK</given-names></name><name><surname>Garforth</surname> <given-names>SJ</given-names></name><name><surname>Du</surname> <given-names>Q</given-names></name><name><surname>Cahill</surname> <given-names>SM</given-names></name><name><surname>Dulyaninova</surname> <given-names>NG</given-names></name><name><surname>Love</surname> <given-names>JD</given-names></name><name><surname>Chandran</surname> <given-names>K</given-names></name><name><surname>Bresnick</surname> <given-names>AR</given-names></name><name><surname>Cameron</surname> <given-names>CE</given-names></name><name><surname>Almo</surname> <given-names>SC</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>A naturally occurring antiviral ribonucleotide encoded by the human genome</article-title><source>Nature</source><volume>558</volume><fpage>610</fpage><lpage>614</lpage><pub-id pub-id-type="doi">10.1038/s41586-018-0238-4</pub-id></element-citation></ref><ref id="bib64"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Godet</surname> <given-names>A-C</given-names></name><name><surname>David</surname> <given-names>F</given-names></name><name><surname>Hantelys</surname> <given-names>F</given-names></name><name><surname>Tatin</surname> <given-names>F</given-names></name><name><surname>Lacazette</surname> <given-names>E</given-names></name><name><surname>Garmy-Susini</surname> <given-names>B</given-names></name><name><surname>Prats</surname> <given-names>A-C</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>IRES Trans-Acting factors, key actors of the stress response</article-title><source>International Journal of Molecular Sciences</source><volume>20</volume><elocation-id>924</elocation-id><pub-id pub-id-type="doi">10.3390/ijms20040924</pub-id></element-citation></ref><ref id="bib65"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Goldstone</surname> <given-names>DC</given-names></name><name><surname>Ennis-Adeniran</surname> <given-names>V</given-names></name><name><surname>Hedden</surname> <given-names>JJ</given-names></name><name><surname>Groom</surname> <given-names>HCT</given-names></name><name><surname>Rice</surname> <given-names>GI</given-names></name><name><surname>Christodoulou</surname> <given-names>E</given-names></name><name><surname>Walker</surname> <given-names>PA</given-names></name><name><surname>Kelly</surname> <given-names>G</given-names></name><name><surname>Haire</surname> <given-names>LF</given-names></name><name><surname>Yap</surname> <given-names>MW</given-names></name><name><surname>de Carvalho</surname> <given-names>LPS</given-names></name><name><surname>Stoye</surname> <given-names>JP</given-names></name><name><surname>Crow</surname> <given-names>YJ</given-names></name><name><surname>Taylor</surname> <given-names>IA</given-names></name><name><surname>Webb</surname> <given-names>M</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>HIV-1 restriction factor SAMHD1 is a deoxynucleoside triphosphate triphosphohydrolase</article-title><source>Nature</source><volume>480</volume><fpage>379</fpage><lpage>382</lpage><pub-id pub-id-type="doi">10.1038/nature10623</pub-id></element-citation></ref><ref id="bib66"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Goodier</surname> <given-names>JL</given-names></name><name><surname>Pereira</surname> <given-names>GC</given-names></name><name><surname>Cheung</surname> <given-names>LE</given-names></name><name><surname>Rose</surname> <given-names>RJ</given-names></name><name><surname>Kazazian</surname> <given-names>HH</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>The Broad-Spectrum Antiviral Protein ZAP Restricts Human Retrotransposition</article-title><source>PLOS Genetics</source><volume>11</volume><elocation-id>e1005252</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pgen.1005252</pub-id></element-citation></ref><ref id="bib67"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Goujon</surname> <given-names>C</given-names></name><name><surname>Moncorgé</surname> <given-names>O</given-names></name><name><surname>Bauby</surname> <given-names>H</given-names></name><name><surname>Doyle</surname> <given-names>T</given-names></name><name><surname>Ward</surname> <given-names>CC</given-names></name><name><surname>Schaller</surname> <given-names>T</given-names></name><name><surname>Hué</surname> <given-names>S</given-names></name><name><surname>Barclay</surname> <given-names>WS</given-names></name><name><surname>Schulz</surname> <given-names>R</given-names></name><name><surname>Malim</surname> <given-names>MH</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Human MX2 is an interferon-induced post-entry inhibitor of HIV-1 infection</article-title><source>Nature</source><volume>502</volume><fpage>559</fpage><lpage>562</lpage><pub-id pub-id-type="doi">10.1038/nature12542</pub-id><pub-id pub-id-type="pmid">24048477</pub-id></element-citation></ref><ref id="bib68"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Guo</surname> <given-names>J</given-names></name><name><surname>Hui</surname> <given-names>DJ</given-names></name><name><surname>Merrick</surname> <given-names>WC</given-names></name><name><surname>Sen</surname> <given-names>GC</given-names></name></person-group><year iso-8601-date="2000">2000</year><article-title>A new pathway of translational regulation mediated by eukaryotic initiation factor 3</article-title><source>The EMBO Journal</source><volume>19</volume><fpage>6891</fpage><lpage>6899</lpage><pub-id pub-id-type="doi">10.1093/emboj/19.24.6891</pub-id><pub-id pub-id-type="pmid">11118224</pub-id></element-citation></ref><ref id="bib69"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Haller</surname> <given-names>O</given-names></name><name><surname>Staeheli</surname> <given-names>P</given-names></name><name><surname>Schwemmle</surname> <given-names>M</given-names></name><name><surname>Kochs</surname> <given-names>G</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Mx GTPases: dynamin-like antiviral machines of innate immunity</article-title><source>Trends in Microbiology</source><volume>23</volume><fpage>154</fpage><lpage>163</lpage><pub-id pub-id-type="doi">10.1016/j.tim.2014.12.003</pub-id><pub-id pub-id-type="pmid">25572883</pub-id></element-citation></ref><ref id="bib70"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Han</surname> <given-names>K</given-names></name><name><surname>Lou</surname> <given-names>DI</given-names></name><name><surname>Sawyer</surname> <given-names>SL</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Identification of a genomic reservoir for new TRIM genes in primate genomes</article-title><source>PLOS Genetics</source><volume>7</volume><elocation-id>e1002388</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pgen.1002388</pub-id><pub-id pub-id-type="pmid">22144910</pub-id></element-citation></ref><ref id="bib71"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Harris</surname> <given-names>RS</given-names></name><name><surname>Hultquist</surname> <given-names>JF</given-names></name><name><surname>Evans</surname> <given-names>DT</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>The restriction factors of human immunodeficiency virus</article-title><source>Journal of Biological Chemistry</source><volume>287</volume><fpage>40875</fpage><lpage>40883</lpage><pub-id pub-id-type="doi">10.1074/jbc.R112.416925</pub-id></element-citation></ref><ref id="bib72"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Harris</surname> <given-names>RS</given-names></name><name><surname>Dudley</surname> <given-names>JP</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>APOBECs and virus restriction</article-title><source>Virology</source><volume>479-480</volume><fpage>131</fpage><lpage>145</lpage><pub-id pub-id-type="doi">10.1016/j.virol.2015.03.012</pub-id><pub-id pub-id-type="pmid">25818029</pub-id></element-citation></ref><ref id="bib73"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Heigele</surname> <given-names>A</given-names></name><name><surname>Kmiec</surname> <given-names>D</given-names></name><name><surname>Regensburger</surname> <given-names>K</given-names></name><name><surname>Langer</surname> <given-names>S</given-names></name><name><surname>Peiffer</surname> <given-names>L</given-names></name><name><surname>Stürzel</surname> <given-names>CM</given-names></name><name><surname>Sauter</surname> <given-names>D</given-names></name><name><surname>Peeters</surname> <given-names>M</given-names></name><name><surname>Pizzato</surname> <given-names>M</given-names></name><name><surname>Learn</surname> <given-names>GH</given-names></name><name><surname>Hahn</surname> <given-names>BH</given-names></name><name><surname>Kirchhoff</surname> <given-names>F</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>The potency of Nef-Mediated SERINC5 antagonism correlates with the prevalence of primate lentiviruses in the wild</article-title><source>Cell Host &amp; Microbe</source><volume>20</volume><fpage>381</fpage><lpage>391</lpage><pub-id pub-id-type="doi">10.1016/j.chom.2016.08.004</pub-id><pub-id pub-id-type="pmid">27631701</pub-id></element-citation></ref><ref id="bib74"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hinson</surname> <given-names>ER</given-names></name><name><surname>Cresswell</surname> <given-names>P</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>The N-terminal amphipathic α-Helix of viperin mediates localization to the cytosolic face of the endoplasmic reticulum and inhibits protein secretion</article-title><source>Journal of Biological Chemistry</source><volume>284</volume><fpage>4705</fpage><lpage>4712</lpage><pub-id pub-id-type="doi">10.1074/jbc.M807261200</pub-id></element-citation></ref><ref id="bib75"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hotter</surname> <given-names>D</given-names></name><name><surname>Sauter</surname> <given-names>D</given-names></name><name><surname>Kirchhoff</surname> <given-names>F</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Emerging role of the host restriction factor tetherin in viral immune sensing</article-title><source>Journal of Molecular Biology</source><volume>425</volume><fpage>4956</fpage><lpage>4964</lpage><pub-id pub-id-type="doi">10.1016/j.jmb.2013.09.029</pub-id><pub-id pub-id-type="pmid">24075872</pub-id></element-citation></ref><ref id="bib76"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hotter</surname> <given-names>D</given-names></name><name><surname>Bosso</surname> <given-names>M</given-names></name><name><surname>Jønsson</surname> <given-names>KL</given-names></name><name><surname>Krapp</surname> <given-names>C</given-names></name><name><surname>Stürzel</surname> <given-names>CM</given-names></name><name><surname>Das</surname> <given-names>A</given-names></name><name><surname>Littwitz-Salomon</surname> <given-names>E</given-names></name><name><surname>Berkhout</surname> <given-names>B</given-names></name><name><surname>Russ</surname> <given-names>A</given-names></name><name><surname>Wittmann</surname> <given-names>S</given-names></name><name><surname>Gramberg</surname> <given-names>T</given-names></name><name><surname>Zheng</surname> <given-names>Y</given-names></name><name><surname>Martins</surname> <given-names>LJ</given-names></name><name><surname>Planelles</surname> <given-names>V</given-names></name><name><surname>Jakobsen</surname> <given-names>MR</given-names></name><name><surname>Hahn</surname> <given-names>BH</given-names></name><name><surname>Dittmer</surname> <given-names>U</given-names></name><name><surname>Sauter</surname> <given-names>D</given-names></name><name><surname>Kirchhoff</surname> <given-names>F</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>IFI16 targets the transcription factor Sp1 to suppress HIV-1 transcription and latency reactivation</article-title><source>Cell Host &amp; Microbe</source><volume>25</volume><fpage>858</fpage><lpage>872</lpage><pub-id pub-id-type="doi">10.1016/j.chom.2019.05.002</pub-id><pub-id pub-id-type="pmid">31175045</pub-id></element-citation></ref><ref id="bib77"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hrecka</surname> <given-names>K</given-names></name><name><surname>Hao</surname> <given-names>C</given-names></name><name><surname>Gierszewska</surname> <given-names>M</given-names></name><name><surname>Swanson</surname> <given-names>SK</given-names></name><name><surname>Kesik-Brodacka</surname> <given-names>M</given-names></name><name><surname>Srivastava</surname> <given-names>S</given-names></name><name><surname>Florens</surname> <given-names>L</given-names></name><name><surname>Washburn</surname> <given-names>MP</given-names></name><name><surname>Skowronski</surname> <given-names>J</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Vpx relieves inhibition of HIV-1 infection of macrophages mediated by the SAMHD1 protein</article-title><source>Nature</source><volume>474</volume><fpage>658</fpage><lpage>661</lpage><pub-id pub-id-type="doi">10.1038/nature10195</pub-id><pub-id pub-id-type="pmid">21720370</pub-id></element-citation></ref><ref id="bib78"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hui</surname> <given-names>DJ</given-names></name><name><surname>Bhasker</surname> <given-names>CR</given-names></name><name><surname>Merrick</surname> <given-names>WC</given-names></name><name><surname>Sen</surname> <given-names>GC</given-names></name></person-group><year iso-8601-date="2003">2003</year><article-title>Viral Stress-inducible Protein p56 Inhibits Translation by Blocking the Interaction of eIF3 with the Ternary Complex eIF2·GTP·Met-tRNA <sub>i</sub></article-title><source>Journal of Biological Chemistry</source><volume>278</volume><fpage>39477</fpage><lpage>39482</lpage><pub-id pub-id-type="doi">10.1074/jbc.M305038200</pub-id></element-citation></ref><ref id="bib79"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hwang</surname> <given-names>CY</given-names></name><name><surname>Holl</surname> <given-names>J</given-names></name><name><surname>Rajan</surname> <given-names>D</given-names></name><name><surname>Lee</surname> <given-names>Y</given-names></name><name><surname>Kim</surname> <given-names>S</given-names></name><name><surname>Um</surname> <given-names>M</given-names></name><name><surname>Kwon</surname> <given-names>K-S</given-names></name><name><surname>Song</surname> <given-names>B</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Hsp70 interacts with the retroviral restriction factor TRIM5α and assists the folding of TRIM5α</article-title><source>Journal of Biological Chemistry</source><volume>285</volume><fpage>7827</fpage><lpage>7837</lpage><pub-id pub-id-type="doi">10.1074/jbc.M109.040618</pub-id></element-citation></ref><ref id="bib80"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Inuzuka</surname> <given-names>M</given-names></name><name><surname>Hayakawa</surname> <given-names>M</given-names></name><name><surname>Ingi</surname> <given-names>T</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>Serinc, an Activity-regulated protein family, incorporates serine into membrane lipid synthesis</article-title><source>Journal of Biological Chemistry</source><volume>280</volume><fpage>35776</fpage><lpage>35783</lpage><pub-id pub-id-type="doi">10.1074/jbc.M505712200</pub-id></element-citation></ref><ref id="bib81"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ivanova</surname> <given-names>PT</given-names></name><name><surname>Myers</surname> <given-names>DS</given-names></name><name><surname>Milne</surname> <given-names>SB</given-names></name><name><surname>McClaren</surname> <given-names>JL</given-names></name><name><surname>Thomas</surname> <given-names>PG</given-names></name><name><surname>Brown</surname> <given-names>HA</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Lipid composition of the viral envelope of three strains of influenza Virus—Not All Viruses Are Created Equal</article-title><source>ACS Infectious Diseases</source><volume>1</volume><fpage>435</fpage><lpage>442</lpage><pub-id pub-id-type="doi">10.1021/acsinfecdis.5b00040</pub-id></element-citation></ref><ref id="bib82"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jakobsen</surname> <given-names>MR</given-names></name><name><surname>Bak</surname> <given-names>RO</given-names></name><name><surname>Andersen</surname> <given-names>A</given-names></name><name><surname>Berg</surname> <given-names>RK</given-names></name><name><surname>Jensen</surname> <given-names>SB</given-names></name><name><surname>Tengchuan</surname> <given-names>J</given-names></name><name><surname>Jin</surname> <given-names>T</given-names></name><name><surname>Laustsen</surname> <given-names>A</given-names></name><name><surname>Hansen</surname> <given-names>K</given-names></name><name><surname>Ostergaard</surname> <given-names>L</given-names></name><name><surname>Fitzgerald</surname> <given-names>KA</given-names></name><name><surname>Xiao</surname> <given-names>TS</given-names></name><name><surname>Mikkelsen</surname> <given-names>JG</given-names></name><name><surname>Mogensen</surname> <given-names>TH</given-names></name><name><surname>Paludan</surname> <given-names>SR</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>IFI16 senses DNA forms of the lentiviral replication cycle and controls HIV-1 replication</article-title><source>PNAS</source><volume>110</volume><fpage>E4571</fpage><lpage>E4580</lpage><pub-id pub-id-type="doi">10.1073/pnas.1311669110</pub-id><pub-id pub-id-type="pmid">24154727</pub-id></element-citation></ref><ref id="bib83"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>James</surname> <given-names>LC</given-names></name><name><surname>Jacques</surname> <given-names>DA</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>The human immunodeficiency virus capsid is more than just a genome package</article-title><source>Annual Review of Virology</source><volume>5</volume><fpage>209</fpage><lpage>225</lpage><pub-id pub-id-type="doi">10.1146/annurev-virology-092917-043430</pub-id><pub-id pub-id-type="pmid">30052493</pub-id></element-citation></ref><ref id="bib84"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Janahi</surname> <given-names>EM</given-names></name><name><surname>McGarvey</surname> <given-names>MJ</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>The inhibition of hepatitis B virus by APOBEC cytidine deaminases</article-title><source>Journal of Viral Hepatitis</source><volume>20</volume><fpage>821</fpage><lpage>828</lpage><pub-id pub-id-type="doi">10.1111/jvh.12192</pub-id><pub-id pub-id-type="pmid">24304451</pub-id></element-citation></ref><ref id="bib85"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Johnson</surname> <given-names>KE</given-names></name><name><surname>Bottero</surname> <given-names>V</given-names></name><name><surname>Flaherty</surname> <given-names>S</given-names></name><name><surname>Dutta</surname> <given-names>S</given-names></name><name><surname>Singh</surname> <given-names>VV</given-names></name><name><surname>Chandran</surname> <given-names>B</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>IFI16 restricts HSV-1 replication by accumulating on the hsv-1 genome, repressing HSV-1 gene expression, and directly or indirectly modulating histone modifications</article-title><source>PLOS Pathogens</source><volume>10</volume><elocation-id>e1004503</elocation-id><pub-id pub-id-type="doi">10.1371/journal.ppat.1004503</pub-id><pub-id pub-id-type="pmid">25375629</pub-id></element-citation></ref><ref id="bib86"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jønsson</surname> <given-names>KL</given-names></name><name><surname>Laustsen</surname> <given-names>A</given-names></name><name><surname>Krapp</surname> <given-names>C</given-names></name><name><surname>Skipper</surname> <given-names>KA</given-names></name><name><surname>Thavachelvam</surname> <given-names>K</given-names></name><name><surname>Hotter</surname> <given-names>D</given-names></name><name><surname>Egedal</surname> <given-names>JH</given-names></name><name><surname>Kjolby</surname> <given-names>M</given-names></name><name><surname>Mohammadi</surname> <given-names>P</given-names></name><name><surname>Prabakaran</surname> <given-names>T</given-names></name><name><surname>Sørensen</surname> <given-names>LK</given-names></name><name><surname>Sun</surname> <given-names>C</given-names></name><name><surname>Jensen</surname> <given-names>SB</given-names></name><name><surname>Holm</surname> <given-names>CK</given-names></name><name><surname>Lebbink</surname> <given-names>RJ</given-names></name><name><surname>Johannsen</surname> <given-names>M</given-names></name><name><surname>Nyegaard</surname> <given-names>M</given-names></name><name><surname>Mikkelsen</surname> <given-names>JG</given-names></name><name><surname>Kirchhoff</surname> <given-names>F</given-names></name><name><surname>Paludan</surname> <given-names>SR</given-names></name><name><surname>Jakobsen</surname> <given-names>MR</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>IFI16 is required for DNA sensing in human macrophages by promoting production and function of cGAMP</article-title><source>Nature Communications</source><volume>8</volume><elocation-id>14391</elocation-id><pub-id pub-id-type="doi">10.1038/ncomms14391</pub-id><pub-id pub-id-type="pmid">28186168</pub-id></element-citation></ref><ref id="bib87"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jónsson</surname> <given-names>SR</given-names></name><name><surname>Andrésdóttir</surname> <given-names>V</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Host restriction of lentiviruses and viral countermeasures: apobec3 and vif</article-title><source>Viruses</source><volume>5</volume><fpage>1934</fpage><lpage>1947</lpage><pub-id pub-id-type="doi">10.3390/v5081934</pub-id><pub-id pub-id-type="pmid">23903287</pub-id></element-citation></ref><ref id="bib88"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kaiser</surname> <given-names>SM</given-names></name><name><surname>Malik</surname> <given-names>HS</given-names></name><name><surname>Emerman</surname> <given-names>M</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Restriction of an extinct retrovirus by the human TRIM5alpha antiviral protein</article-title><source>Science</source><volume>316</volume><fpage>1756</fpage><lpage>1758</lpage><pub-id pub-id-type="doi">10.1126/science.1140579</pub-id><pub-id pub-id-type="pmid">17588933</pub-id></element-citation></ref><ref id="bib89"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kane</surname> <given-names>M</given-names></name><name><surname>Yadav</surname> <given-names>SS</given-names></name><name><surname>Bitzegeio</surname> <given-names>J</given-names></name><name><surname>Kutluay</surname> <given-names>SB</given-names></name><name><surname>Zang</surname> <given-names>T</given-names></name><name><surname>Wilson</surname> <given-names>SJ</given-names></name><name><surname>Schoggins</surname> <given-names>JW</given-names></name><name><surname>Rice</surname> <given-names>CM</given-names></name><name><surname>Yamashita</surname> <given-names>M</given-names></name><name><surname>Hatziioannou</surname> <given-names>T</given-names></name><name><surname>Bieniasz</surname> <given-names>PD</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>MX2 is an interferon-induced inhibitor of HIV-1 infection</article-title><source>Nature</source><volume>502</volume><fpage>563</fpage><lpage>566</lpage><pub-id pub-id-type="doi">10.1038/nature12653</pub-id><pub-id pub-id-type="pmid">24121441</pub-id></element-citation></ref><ref id="bib90"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kane</surname> <given-names>M</given-names></name><name><surname>Rebensburg</surname> <given-names>SV</given-names></name><name><surname>Takata</surname> <given-names>MA</given-names></name><name><surname>Zang</surname> <given-names>TM</given-names></name><name><surname>Yamashita</surname> <given-names>M</given-names></name><name><surname>Kvaratskhelia</surname> <given-names>M</given-names></name><name><surname>Bieniasz</surname> <given-names>PD</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Nuclear pore heterogeneity influences HIV-1 infection and the antiviral activity of MX2</article-title><source>eLife</source><volume>7</volume><elocation-id>e35738</elocation-id><pub-id pub-id-type="doi">10.7554/eLife.35738</pub-id><pub-id pub-id-type="pmid">30084827</pub-id></element-citation></ref><ref id="bib91"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Karlin</surname> <given-names>S</given-names></name><name><surname>Doerfler</surname> <given-names>W</given-names></name><name><surname>Cardon</surname> <given-names>LR</given-names></name></person-group><year iso-8601-date="1994">1994</year><article-title>Why is CpG suppressed in the genomes of virtually all small eukaryotic viruses but not in those of large eukaryotic viruses?</article-title><source>Journal of Virology</source><volume>68</volume><fpage>2889</fpage><lpage>2897</lpage><pub-id pub-id-type="doi">10.1128/JVI.68.5.2889-2897.1994</pub-id><pub-id pub-id-type="pmid">8151759</pub-id></element-citation></ref><ref id="bib92"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kauzlaric</surname> <given-names>A</given-names></name><name><surname>Jang</surname> <given-names>SM</given-names></name><name><surname>Morchikh</surname> <given-names>M</given-names></name><name><surname>Cassano</surname> <given-names>M</given-names></name><name><surname>Planet</surname> <given-names>E</given-names></name><name><surname>Benkirane</surname> <given-names>M</given-names></name><name><surname>Trono</surname> <given-names>D</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>KAP1 targets actively transcribed genomic loci to exert pleomorphic effects on RNA polymerase II activity</article-title><source>Philosophical Transactions of the Royal Society B: Biological Sciences</source><volume>375</volume><elocation-id>20190334</elocation-id><pub-id pub-id-type="doi">10.1098/rstb.2019.0334</pub-id></element-citation></ref><ref id="bib93"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kawaoka</surname> <given-names>Y</given-names></name><name><surname>Nestorowicz</surname> <given-names>A</given-names></name><name><surname>Alexander</surname> <given-names>DJ</given-names></name><name><surname>Webster</surname> <given-names>RG</given-names></name></person-group><year iso-8601-date="1987">1987</year><article-title>Molecular analyses of the hemagglutinin genes of H5 influenza viruses: origin of a virulent turkey strain</article-title><source>Virology</source><volume>158</volume><fpage>218</fpage><lpage>227</lpage><pub-id pub-id-type="doi">10.1016/0042-6822(87)90256-X</pub-id><pub-id pub-id-type="pmid">3576972</pub-id></element-citation></ref><ref id="bib94"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname> <given-names>MJ</given-names></name><name><surname>Hwang</surname> <given-names>SY</given-names></name><name><surname>Imaizumi</surname> <given-names>T</given-names></name><name><surname>Yoo</surname> <given-names>JY</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Negative feedback regulation of RIG-I-mediated antiviral signaling by interferon-induced ISG15 conjugation</article-title><source>Journal of Virology</source><volume>82</volume><fpage>1474</fpage><lpage>1483</lpage><pub-id pub-id-type="doi">10.1128/JVI.01650-07</pub-id><pub-id pub-id-type="pmid">18057259</pub-id></element-citation></ref><ref id="bib95"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname> <given-names>YJ</given-names></name><name><surname>Kim</surname> <given-names>ET</given-names></name><name><surname>Kim</surname> <given-names>YE</given-names></name><name><surname>Lee</surname> <given-names>MK</given-names></name><name><surname>Kwon</surname> <given-names>KM</given-names></name><name><surname>Kim</surname> <given-names>KI</given-names></name><name><surname>Stamminger</surname> <given-names>T</given-names></name><name><surname>Ahn</surname> <given-names>JH</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Consecutive inhibition of ISG15 expression and ISGylation by Cytomegalovirus regulators</article-title><source>PLOS Pathogens</source><volume>12</volume><elocation-id>e1005850</elocation-id><pub-id pub-id-type="doi">10.1371/journal.ppat.1005850</pub-id><pub-id pub-id-type="pmid">27564865</pub-id></element-citation></ref><ref id="bib96"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname> <given-names>K</given-names></name><name><surname>Dauphin</surname> <given-names>A</given-names></name><name><surname>Komurlu</surname> <given-names>S</given-names></name><name><surname>McCauley</surname> <given-names>SM</given-names></name><name><surname>Yurkovetskiy</surname> <given-names>L</given-names></name><name><surname>Carbone</surname> <given-names>C</given-names></name><name><surname>Diehl</surname> <given-names>WE</given-names></name><name><surname>Strambio-De-Castillia</surname> <given-names>C</given-names></name><name><surname>Campbell</surname> <given-names>EM</given-names></name><name><surname>Luban</surname> <given-names>J</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Cyclophilin A protects HIV-1 from restriction by human TRIM5α</article-title><source>Nature Microbiology</source><volume>4</volume><fpage>2044</fpage><lpage>2051</lpage><pub-id pub-id-type="doi">10.1038/s41564-019-0592-5</pub-id><pub-id pub-id-type="pmid">31636416</pub-id></element-citation></ref><ref id="bib97"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kluge</surname> <given-names>SF</given-names></name><name><surname>Sauter</surname> <given-names>D</given-names></name><name><surname>Kirchhoff</surname> <given-names>F</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>SnapShot: antiviral restriction factors</article-title><source>Cell</source><volume>163</volume><fpage>774</fpage><lpage>774.e1</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2015.10.019</pub-id><pub-id pub-id-type="pmid">26496613</pub-id></element-citation></ref><ref id="bib98"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kmiec</surname> <given-names>D</given-names></name><name><surname>Nchioua</surname> <given-names>R</given-names></name><name><surname>Sherrill-Mix</surname> <given-names>S</given-names></name><name><surname>Stürzel</surname> <given-names>CM</given-names></name><name><surname>Heusinger</surname> <given-names>E</given-names></name><name><surname>Braun</surname> <given-names>E</given-names></name><name><surname>Gondim</surname> <given-names>MVP</given-names></name><name><surname>Hotter</surname> <given-names>D</given-names></name><name><surname>Sparrer</surname> <given-names>KMJ</given-names></name><name><surname>Hahn</surname> <given-names>BH</given-names></name><name><surname>Sauter</surname> <given-names>D</given-names></name><name><surname>Kirchhoff</surname> <given-names>F</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>CpG frequency in the 5' Third of the <italic>env</italic> gene determines sensitivity of primary HIV-1 strains to the Zinc-Finger antiviral protein</article-title><source>mBio</source><volume>11</volume><elocation-id>e02903</elocation-id><pub-id pub-id-type="doi">10.1128/mBio.02903-19</pub-id><pub-id pub-id-type="pmid">31937644</pub-id></element-citation></ref><ref id="bib99"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Koepke</surname> <given-names>L</given-names></name><name><surname>Gack</surname> <given-names>MU</given-names></name><name><surname>Sparrer</surname> <given-names>KMJ</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>The antiviral activities of TRIM proteins</article-title><source>Current Opinion in Microbiology</source><volume>59</volume><fpage>50</fpage><lpage>57</lpage><pub-id pub-id-type="doi">10.1016/j.mib.2020.07.005</pub-id></element-citation></ref><ref id="bib100"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Krapp</surname> <given-names>C</given-names></name><name><surname>Hotter</surname> <given-names>D</given-names></name><name><surname>Gawanbacht</surname> <given-names>A</given-names></name><name><surname>McLaren</surname> <given-names>PJ</given-names></name><name><surname>Kluge</surname> <given-names>SF</given-names></name><name><surname>Stürzel</surname> <given-names>CM</given-names></name><name><surname>Mack</surname> <given-names>K</given-names></name><name><surname>Reith</surname> <given-names>E</given-names></name><name><surname>Engelhart</surname> <given-names>S</given-names></name><name><surname>Ciuffi</surname> <given-names>A</given-names></name><name><surname>Hornung</surname> <given-names>V</given-names></name><name><surname>Sauter</surname> <given-names>D</given-names></name><name><surname>Telenti</surname> <given-names>A</given-names></name><name><surname>Kirchhoff</surname> <given-names>F</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Guanylate binding protein (GBP) 5 is an Interferon-Inducible inhibitor of HIV-1 infectivity</article-title><source>Cell Host &amp; Microbe</source><volume>19</volume><fpage>504</fpage><lpage>514</lpage><pub-id pub-id-type="doi">10.1016/j.chom.2016.02.019</pub-id><pub-id pub-id-type="pmid">26996307</pub-id></element-citation></ref><ref id="bib101"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kumar</surname> <given-names>P</given-names></name><name><surname>Sweeney</surname> <given-names>TR</given-names></name><name><surname>Skabkin</surname> <given-names>MA</given-names></name><name><surname>Skabkina</surname> <given-names>OV</given-names></name><name><surname>Hellen</surname> <given-names>CU</given-names></name><name><surname>Pestova</surname> <given-names>TV</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Inhibition of translation by IFIT family members is determined by their ability to interact selectively with the 5'-terminal regions of cap0-, cap1- and 5'ppp- mRNAs</article-title><source>Nucleic Acids Research</source><volume>42</volume><fpage>3228</fpage><lpage>3245</lpage><pub-id pub-id-type="doi">10.1093/nar/gkt1321</pub-id><pub-id pub-id-type="pmid">24371270</pub-id></element-citation></ref><ref id="bib102"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Laguette</surname> <given-names>N</given-names></name><name><surname>Sobhian</surname> <given-names>B</given-names></name><name><surname>Casartelli</surname> <given-names>N</given-names></name><name><surname>Ringeard</surname> <given-names>M</given-names></name><name><surname>Chable-Bessia</surname> <given-names>C</given-names></name><name><surname>Ségéral</surname> <given-names>E</given-names></name><name><surname>Yatim</surname> <given-names>A</given-names></name><name><surname>Emiliani</surname> <given-names>S</given-names></name><name><surname>Schwartz</surname> <given-names>O</given-names></name><name><surname>Benkirane</surname> <given-names>M</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>SAMHD1 is the dendritic- and myeloid-cell-specific HIV-1 restriction factor counteracted by vpx</article-title><source>Nature</source><volume>474</volume><fpage>654</fpage><lpage>657</lpage><pub-id pub-id-type="doi">10.1038/nature10117</pub-id><pub-id pub-id-type="pmid">21613998</pub-id></element-citation></ref><ref id="bib103"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lahouassa</surname> <given-names>H</given-names></name><name><surname>Daddacha</surname> <given-names>W</given-names></name><name><surname>Hofmann</surname> <given-names>H</given-names></name><name><surname>Ayinde</surname> <given-names>D</given-names></name><name><surname>Logue</surname> <given-names>EC</given-names></name><name><surname>Dragin</surname> <given-names>L</given-names></name><name><surname>Bloch</surname> <given-names>N</given-names></name><name><surname>Maudet</surname> <given-names>C</given-names></name><name><surname>Bertrand</surname> <given-names>M</given-names></name><name><surname>Gramberg</surname> <given-names>T</given-names></name><name><surname>Pancino</surname> <given-names>G</given-names></name><name><surname>Priet</surname> <given-names>S</given-names></name><name><surname>Canard</surname> <given-names>B</given-names></name><name><surname>Laguette</surname> <given-names>N</given-names></name><name><surname>Benkirane</surname> <given-names>M</given-names></name><name><surname>Transy</surname> <given-names>C</given-names></name><name><surname>Landau</surname> <given-names>NR</given-names></name><name><surname>Kim</surname> <given-names>B</given-names></name><name><surname>Margottin-Goguet</surname> <given-names>F</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>SAMHD1 restricts the replication of human immunodeficiency virus type 1 by depleting the intracellular pool of deoxynucleoside triphosphates</article-title><source>Nature Immunology</source><volume>13</volume><fpage>223</fpage><lpage>228</lpage><pub-id pub-id-type="doi">10.1038/ni.2236</pub-id><pub-id pub-id-type="pmid">22327569</pub-id></element-citation></ref><ref id="bib104"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lamprecht</surname> <given-names>B</given-names></name><name><surname>Walter</surname> <given-names>K</given-names></name><name><surname>Kreher</surname> <given-names>S</given-names></name><name><surname>Kumar</surname> <given-names>R</given-names></name><name><surname>Hummel</surname> <given-names>M</given-names></name><name><surname>Lenze</surname> <given-names>D</given-names></name><name><surname>Köchert</surname> <given-names>K</given-names></name><name><surname>Bouhlel</surname> <given-names>MA</given-names></name><name><surname>Richter</surname> <given-names>J</given-names></name><name><surname>Soler</surname> <given-names>E</given-names></name><name><surname>Stadhouders</surname> <given-names>R</given-names></name><name><surname>Jöhrens</surname> <given-names>K</given-names></name><name><surname>Wurster</surname> <given-names>KD</given-names></name><name><surname>Callen</surname> <given-names>DF</given-names></name><name><surname>Harte</surname> <given-names>MF</given-names></name><name><surname>Giefing</surname> <given-names>M</given-names></name><name><surname>Barlow</surname> <given-names>R</given-names></name><name><surname>Stein</surname> <given-names>H</given-names></name><name><surname>Anagnostopoulos</surname> <given-names>I</given-names></name><name><surname>Janz</surname> <given-names>M</given-names></name><name><surname>Cockerill</surname> <given-names>PN</given-names></name><name><surname>Siebert</surname> <given-names>R</given-names></name><name><surname>Dörken</surname> <given-names>B</given-names></name><name><surname>Bonifer</surname> <given-names>C</given-names></name><name><surname>Mathas</surname> <given-names>S</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Derepression of an endogenous long terminal repeat activates the CSF1R proto-oncogene in human lymphoma</article-title><source>Nature Medicine</source><volume>16</volume><fpage>571</fpage><lpage>579</lpage><pub-id pub-id-type="doi">10.1038/nm.2129</pub-id></element-citation></ref><ref id="bib105"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lariccia</surname> <given-names>V</given-names></name><name><surname>Magi</surname> <given-names>S</given-names></name><name><surname>Serfilippi</surname> <given-names>T</given-names></name><name><surname>Toujani</surname> <given-names>M</given-names></name><name><surname>Gratteri</surname> <given-names>S</given-names></name><name><surname>Amoroso</surname> <given-names>S</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Challenges and opportunities from targeting inflammatory responses to SARS-CoV-2 infection: a narrative review</article-title><source>Journal of Clinical Medicine</source><volume>9</volume><elocation-id>4021</elocation-id><pub-id pub-id-type="doi">10.3390/jcm9124021</pub-id></element-citation></ref><ref id="bib106"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Le Sage</surname> <given-names>V</given-names></name><name><surname>Mouland</surname> <given-names>AJ</given-names></name><name><surname>Valiente-Echeverría</surname> <given-names>F</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Roles of HIV-1 capsid in viral replication and immune evasion</article-title><source>Virus Research</source><volume>193</volume><fpage>116</fpage><lpage>129</lpage><pub-id pub-id-type="doi">10.1016/j.virusres.2014.07.010</pub-id><pub-id pub-id-type="pmid">25036886</pub-id></element-citation></ref><ref id="bib107"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lenz</surname> <given-names>G</given-names></name><name><surname>Staudt</surname> <given-names>LM</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Aggressive lymphomas</article-title><source>New England Journal of Medicine</source><volume>362</volume><fpage>1417</fpage><lpage>1429</lpage><pub-id pub-id-type="doi">10.1056/NEJMra0807082</pub-id></element-citation></ref><ref id="bib108"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname> <given-names>M</given-names></name><name><surname>Kao</surname> <given-names>E</given-names></name><name><surname>Gao</surname> <given-names>X</given-names></name><name><surname>Sandig</surname> <given-names>H</given-names></name><name><surname>Limmer</surname> <given-names>K</given-names></name><name><surname>Pavon-Eternod</surname> <given-names>M</given-names></name><name><surname>Jones</surname> <given-names>TE</given-names></name><name><surname>Landry</surname> <given-names>S</given-names></name><name><surname>Pan</surname> <given-names>T</given-names></name><name><surname>Weitzman</surname> <given-names>MD</given-names></name><name><surname>David</surname> <given-names>M</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Codon-usage-based inhibition of HIV protein synthesis by human schlafen 11</article-title><source>Nature</source><volume>491</volume><fpage>125</fpage><lpage>128</lpage><pub-id pub-id-type="doi">10.1038/nature11433</pub-id><pub-id pub-id-type="pmid">23000900</pub-id></element-citation></ref><ref id="bib109"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname> <given-names>K</given-names></name><name><surname>Markosyan</surname> <given-names>RM</given-names></name><name><surname>Zheng</surname> <given-names>YM</given-names></name><name><surname>Golfetto</surname> <given-names>O</given-names></name><name><surname>Bungart</surname> <given-names>B</given-names></name><name><surname>Li</surname> <given-names>M</given-names></name><name><surname>Ding</surname> <given-names>S</given-names></name><name><surname>He</surname> <given-names>Y</given-names></name><name><surname>Liang</surname> <given-names>C</given-names></name><name><surname>Lee</surname> <given-names>JC</given-names></name><name><surname>Gratton</surname> <given-names>E</given-names></name><name><surname>Cohen</surname> <given-names>FS</given-names></name><name><surname>Liu</surname> <given-names>SL</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>IFITM proteins restrict viral membrane hemifusion</article-title><source>PLOS Pathogens</source><volume>9</volume><elocation-id>e1003124</elocation-id><pub-id pub-id-type="doi">10.1371/journal.ppat.1003124</pub-id><pub-id pub-id-type="pmid">23358889</pub-id></element-citation></ref><ref id="bib110"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname> <given-names>Y</given-names></name><name><surname>Banerjee</surname> <given-names>S</given-names></name><name><surname>Wang</surname> <given-names>Y</given-names></name><name><surname>Goldstein</surname> <given-names>SA</given-names></name><name><surname>Dong</surname> <given-names>B</given-names></name><name><surname>Gaughan</surname> <given-names>C</given-names></name><name><surname>Silverman</surname> <given-names>RH</given-names></name><name><surname>Weiss</surname> <given-names>SR</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Activation of RNase L is dependent on OAS3 expression during infection with diverse human viruses</article-title><source>PNAS</source><volume>113</volume><fpage>2241</fpage><lpage>2246</lpage><pub-id pub-id-type="doi">10.1073/pnas.1519657113</pub-id><pub-id pub-id-type="pmid">26858407</pub-id></element-citation></ref><ref id="bib111"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname> <given-names>MM</given-names></name><name><surname>Lau</surname> <given-names>Z</given-names></name><name><surname>Cheung</surname> <given-names>P</given-names></name><name><surname>Aguilar</surname> <given-names>EG</given-names></name><name><surname>Schneider</surname> <given-names>WM</given-names></name><name><surname>Bozzacco</surname> <given-names>L</given-names></name><name><surname>Molina</surname> <given-names>H</given-names></name><name><surname>Buehler</surname> <given-names>E</given-names></name><name><surname>Takaoka</surname> <given-names>A</given-names></name><name><surname>Rice</surname> <given-names>CM</given-names></name><name><surname>Felsenfeld</surname> <given-names>DP</given-names></name><name><surname>MacDonald</surname> <given-names>MR</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>TRIM25 enhances the antiviral action of Zinc-Finger antiviral protein (ZAP)</article-title><source>PLOS Pathogens</source><volume>13</volume><elocation-id>e1006145</elocation-id><pub-id pub-id-type="doi">10.1371/journal.ppat.1006145</pub-id><pub-id pub-id-type="pmid">28060952</pub-id></element-citation></ref><ref id="bib112"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname> <given-names>L</given-names></name><name><surname>Davie</surname> <given-names>JR</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>The role of Sp1 and Sp3 in normal and Cancer cell biology</article-title><source>Annals of Anatomy - Anatomischer Anzeiger</source><volume>192</volume><fpage>275</fpage><lpage>283</lpage><pub-id pub-id-type="doi">10.1016/j.aanat.2010.07.010</pub-id><pub-id pub-id-type="pmid">20810260</pub-id></element-citation></ref><ref id="bib113"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lilly</surname> <given-names>F</given-names></name></person-group><year iso-8601-date="1970">1970</year><article-title>Fv-2: identification and location of a second gene governing the spleen focus response to friend leukemia virus in mice</article-title><source>Journal of the National Cancer Institute</source><volume>45</volume><fpage>163</fpage><lpage>169</lpage><pub-id pub-id-type="doi">10.1093/jnci/45.1.163</pub-id><pub-id pub-id-type="pmid">5449211</pub-id></element-citation></ref><ref id="bib114"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname> <given-names>Z</given-names></name><name><surname>Pan</surname> <given-names>Q</given-names></name><name><surname>Ding</surname> <given-names>S</given-names></name><name><surname>Qian</surname> <given-names>J</given-names></name><name><surname>Xu</surname> <given-names>F</given-names></name><name><surname>Zhou</surname> <given-names>J</given-names></name><name><surname>Cen</surname> <given-names>S</given-names></name><name><surname>Guo</surname> <given-names>F</given-names></name><name><surname>Liang</surname> <given-names>C</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>The interferon-inducible MxB protein inhibits HIV-1 infection</article-title><source>Cell Host &amp; Microbe</source><volume>14</volume><fpage>398</fpage><lpage>410</lpage><pub-id pub-id-type="doi">10.1016/j.chom.2013.08.015</pub-id><pub-id pub-id-type="pmid">24055605</pub-id></element-citation></ref><ref id="bib115"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname> <given-names>Y</given-names></name><name><surname>Wang</surname> <given-names>H</given-names></name><name><surname>Zhang</surname> <given-names>J</given-names></name><name><surname>Yang</surname> <given-names>J</given-names></name><name><surname>Bai</surname> <given-names>L</given-names></name><name><surname>Zheng</surname> <given-names>B</given-names></name><name><surname>Zheng</surname> <given-names>T</given-names></name><name><surname>Wang</surname> <given-names>Y</given-names></name><name><surname>Li</surname> <given-names>J</given-names></name><name><surname>Zhang</surname> <given-names>W</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>SERINC5 inhibits the secretion of complete and Genome-Free hepatitis B virions through interfering with the glycosylation of the HBV envelope</article-title><source>Frontiers in Microbiology</source><volume>11</volume><elocation-id>697</elocation-id><pub-id pub-id-type="doi">10.3389/fmicb.2020.00697</pub-id><pub-id pub-id-type="pmid">32431673</pub-id></element-citation></ref><ref id="bib116"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lo Cigno</surname> <given-names>I</given-names></name><name><surname>De Andrea</surname> <given-names>M</given-names></name><name><surname>Borgogna</surname> <given-names>C</given-names></name><name><surname>Albertini</surname> <given-names>S</given-names></name><name><surname>Landini</surname> <given-names>MM</given-names></name><name><surname>Peretti</surname> <given-names>A</given-names></name><name><surname>Johnson</surname> <given-names>KE</given-names></name><name><surname>Chandran</surname> <given-names>B</given-names></name><name><surname>Landolfo</surname> <given-names>S</given-names></name><name><surname>Gariglio</surname> <given-names>M</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>The nuclear DNA sensor IFI16 acts as a restriction factor for human papillomavirus replication through epigenetic modifications of the viral promoters</article-title><source>Journal of Virology</source><volume>89</volume><fpage>7506</fpage><lpage>7520</lpage><pub-id pub-id-type="doi">10.1128/JVI.00013-15</pub-id><pub-id pub-id-type="pmid">25972554</pub-id></element-citation></ref><ref id="bib117"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Makins</surname> <given-names>C</given-names></name><name><surname>Ghosh</surname> <given-names>S</given-names></name><name><surname>Román-Meléndez</surname> <given-names>GD</given-names></name><name><surname>Malec</surname> <given-names>PA</given-names></name><name><surname>Kennedy</surname> <given-names>RT</given-names></name><name><surname>Marsh</surname> <given-names>ENG</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Doe<italic>s</italic> Viperin Function a<italic>s</italic> a Radical <italic>S</italic> -Adenosyl-l-methionine-dependent Enzyme in Regulating Farnesylpyrophosphate Synthase Expression and Activity?</article-title><source>Journal of Biological Chemistry</source><volume>291</volume><fpage>26806</fpage><lpage>26815</lpage><pub-id pub-id-type="doi">10.1074/jbc.M116.751040</pub-id></element-citation></ref><ref id="bib118"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Malakhova</surname> <given-names>OA</given-names></name><name><surname>Yan</surname> <given-names>M</given-names></name><name><surname>Malakhov</surname> <given-names>MP</given-names></name><name><surname>Yuan</surname> <given-names>Y</given-names></name><name><surname>Ritchie</surname> <given-names>KJ</given-names></name><name><surname>Kim</surname> <given-names>KI</given-names></name><name><surname>Peterson</surname> <given-names>LF</given-names></name><name><surname>Shuai</surname> <given-names>K</given-names></name><name><surname>Zhang</surname> <given-names>DE</given-names></name></person-group><year iso-8601-date="2003">2003</year><article-title>Protein ISGylation modulates the JAK-STAT signaling pathway</article-title><source>Genes &amp; Development</source><volume>17</volume><fpage>455</fpage><lpage>460</lpage><pub-id pub-id-type="doi">10.1101/gad.1056303</pub-id><pub-id pub-id-type="pmid">12600939</pub-id></element-citation></ref><ref id="bib119"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Malim</surname> <given-names>MH</given-names></name><name><surname>Bieniasz</surname> <given-names>PD</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>HIV restriction factors and mechanisms of evasion</article-title><source>Cold Spring Harbor Perspectives in Medicine</source><volume>2</volume><elocation-id>a006940</elocation-id><pub-id pub-id-type="doi">10.1101/cshperspect.a006940</pub-id><pub-id pub-id-type="pmid">22553496</pub-id></element-citation></ref><ref id="bib120"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Martinez-Salas</surname> <given-names>E</given-names></name><name><surname>Francisco-Velilla</surname> <given-names>R</given-names></name><name><surname>Fernandez-Chamorro</surname> <given-names>J</given-names></name><name><surname>Embarek</surname> <given-names>AM</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Insights into structural and mechanistic features of viral IRES elements</article-title><source>Frontiers in Microbiology</source><volume>8</volume><elocation-id>2629</elocation-id><pub-id pub-id-type="doi">10.3389/fmicb.2017.02629</pub-id><pub-id pub-id-type="pmid">29354113</pub-id></element-citation></ref><ref id="bib121"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McCarthy</surname> <given-names>KR</given-names></name><name><surname>Kirmaier</surname> <given-names>A</given-names></name><name><surname>Autissier</surname> <given-names>P</given-names></name><name><surname>Johnson</surname> <given-names>WE</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Evolutionary and functional analysis of old world primate TRIM5 reveals the ancient emergence of primate lentiviruses and convergent evolution targeting a conserved capsid interface</article-title><source>PLOS Pathogens</source><volume>11</volume><elocation-id>e1005085</elocation-id><pub-id pub-id-type="doi">10.1371/journal.ppat.1005085</pub-id><pub-id pub-id-type="pmid">26291613</pub-id></element-citation></ref><ref id="bib122"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McCune</surname> <given-names>JM</given-names></name><name><surname>Rabin</surname> <given-names>LB</given-names></name><name><surname>Feinberg</surname> <given-names>MB</given-names></name><name><surname>Lieberman</surname> <given-names>M</given-names></name><name><surname>Kosek</surname> <given-names>JC</given-names></name><name><surname>Reyes</surname> <given-names>GR</given-names></name><name><surname>Weissman</surname> <given-names>IL</given-names></name></person-group><year iso-8601-date="1988">1988</year><article-title>Endoproteolytic cleavage of gp160 is required for the activation of human immunodeficiency virus</article-title><source>Cell</source><volume>53</volume><fpage>55</fpage><lpage>67</lpage><pub-id pub-id-type="doi">10.1016/0092-8674(88)90487-4</pub-id><pub-id pub-id-type="pmid">2450679</pub-id></element-citation></ref><ref id="bib123"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Meagher</surname> <given-names>JL</given-names></name><name><surname>Takata</surname> <given-names>M</given-names></name><name><surname>Gonçalves-Carneiro</surname> <given-names>D</given-names></name><name><surname>Keane</surname> <given-names>SC</given-names></name><name><surname>Rebendenne</surname> <given-names>A</given-names></name><name><surname>Ong</surname> <given-names>H</given-names></name><name><surname>Orr</surname> <given-names>VK</given-names></name><name><surname>MacDonald</surname> <given-names>MR</given-names></name><name><surname>Stuckey</surname> <given-names>JA</given-names></name><name><surname>Bieniasz</surname> <given-names>PD</given-names></name><name><surname>Smith</surname> <given-names>JL</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Structure of the zinc-finger antiviral protein in complex with RNA reveals a mechanism for selective targeting of CG-rich viral sequences</article-title><source>PNAS</source><volume>116</volume><fpage>24303</fpage><lpage>24309</lpage><pub-id pub-id-type="doi">10.1073/pnas.1913232116</pub-id><pub-id pub-id-type="pmid">31719195</pub-id></element-citation></ref><ref id="bib124"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mi</surname> <given-names>S</given-names></name><name><surname>Lee</surname> <given-names>X</given-names></name><name><surname>Li</surname> <given-names>X</given-names></name><name><surname>Veldman</surname> <given-names>GM</given-names></name><name><surname>Finnerty</surname> <given-names>H</given-names></name><name><surname>Racie</surname> <given-names>L</given-names></name><name><surname>LaVallie</surname> <given-names>E</given-names></name><name><surname>Tang</surname> <given-names>XY</given-names></name><name><surname>Edouard</surname> <given-names>P</given-names></name><name><surname>Howes</surname> <given-names>S</given-names></name><name><surname>Keith</surname> <given-names>JC</given-names></name><name><surname>McCoy</surname> <given-names>JM</given-names></name></person-group><year iso-8601-date="2000">2000</year><article-title>Syncytin is a captive retroviral envelope protein involved in human placental morphogenesis</article-title><source>Nature</source><volume>403</volume><fpage>785</fpage><lpage>789</lpage><pub-id pub-id-type="doi">10.1038/35001608</pub-id><pub-id pub-id-type="pmid">10693809</pub-id></element-citation></ref><ref id="bib125"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Milewska</surname> <given-names>A</given-names></name><name><surname>Kindler</surname> <given-names>E</given-names></name><name><surname>Vkovski</surname> <given-names>P</given-names></name><name><surname>Zeglen</surname> <given-names>S</given-names></name><name><surname>Ochman</surname> <given-names>M</given-names></name><name><surname>Thiel</surname> <given-names>V</given-names></name><name><surname>Rajfur</surname> <given-names>Z</given-names></name><name><surname>Pyrc</surname> <given-names>K</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>APOBEC3-mediated restriction of RNA virus replication</article-title><source>Scientific Reports</source><volume>8</volume><elocation-id>5960</elocation-id><pub-id pub-id-type="doi">10.1038/s41598-018-24448-2</pub-id><pub-id pub-id-type="pmid">29654310</pub-id></element-citation></ref><ref id="bib126"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Morrone</surname> <given-names>SR</given-names></name><name><surname>Wang</surname> <given-names>T</given-names></name><name><surname>Constantoulakis</surname> <given-names>LM</given-names></name><name><surname>Hooy</surname> <given-names>RM</given-names></name><name><surname>Delannoy</surname> <given-names>MJ</given-names></name><name><surname>Sohn</surname> <given-names>J</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Cooperative assembly of IFI16 filaments on dsDNA provides insights into host defense strategy</article-title><source>PNAS</source><volume>111</volume><fpage>E62</fpage><lpage>E71</lpage><pub-id pub-id-type="doi">10.1073/pnas.1313577111</pub-id><pub-id pub-id-type="pmid">24367117</pub-id></element-citation></ref><ref id="bib127"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nakaya</surname> <given-names>Y</given-names></name><name><surname>Stavrou</surname> <given-names>S</given-names></name><name><surname>Blouch</surname> <given-names>K</given-names></name><name><surname>Tattersall</surname> <given-names>P</given-names></name><name><surname>Ross</surname> <given-names>SR</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title><italic>In vivo</italic> Examination of Mouse APOBEC3- and Human APOBEC3A- and APOBEC3G-Mediated Restriction of Parvovirus and Herpesvirus Infection in Mouse Models</article-title><source>Journal of Virology</source><volume>90</volume><fpage>8005</fpage><lpage>8012</lpage><pub-id pub-id-type="doi">10.1128/JVI.00973-16</pub-id><pub-id pub-id-type="pmid">27356895</pub-id></element-citation></ref><ref id="bib128"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nchioua</surname> <given-names>R</given-names></name><name><surname>Bosso</surname> <given-names>M</given-names></name><name><surname>Kmiec</surname> <given-names>D</given-names></name><name><surname>Kirchhoff</surname> <given-names>F</given-names></name></person-group><year iso-8601-date="2020">2020a</year><article-title>Cellular factors targeting HIV-1 transcription and viral RNA transcripts</article-title><source>Viruses</source><volume>12</volume><elocation-id>495</elocation-id><pub-id pub-id-type="doi">10.3390/v12050495</pub-id></element-citation></ref><ref id="bib129"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nchioua</surname> <given-names>R</given-names></name><name><surname>Kmiec</surname> <given-names>D</given-names></name><name><surname>Müller</surname> <given-names>JA</given-names></name><name><surname>Conzelmann</surname> <given-names>C</given-names></name><name><surname>Groß</surname> <given-names>R</given-names></name><name><surname>Swanson</surname> <given-names>CM</given-names></name><name><surname>Neil</surname> <given-names>SJD</given-names></name><name><surname>Stenger</surname> <given-names>S</given-names></name><name><surname>Sauter</surname> <given-names>D</given-names></name><name><surname>Münch</surname> <given-names>J</given-names></name><name><surname>Sparrer</surname> <given-names>KMJ</given-names></name><name><surname>Kirchhoff</surname> <given-names>F</given-names></name></person-group><year iso-8601-date="2020">2020b</year><article-title>SARS-CoV-2 is restricted by zinc finger antiviral protein despite preadaptation to the Low-CpG environment in humans</article-title><source>mBio</source><volume>11</volume><elocation-id>16</elocation-id><pub-id pub-id-type="doi">10.1128/mBio.01930-20</pub-id></element-citation></ref><ref id="bib130"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Neil</surname> <given-names>SJ</given-names></name><name><surname>Zang</surname> <given-names>T</given-names></name><name><surname>Bieniasz</surname> <given-names>PD</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Tetherin inhibits retrovirus release and is antagonized by HIV-1 vpu</article-title><source>Nature</source><volume>451</volume><fpage>425</fpage><lpage>430</lpage><pub-id pub-id-type="doi">10.1038/nature06553</pub-id><pub-id pub-id-type="pmid">18200009</pub-id></element-citation></ref><ref id="bib131"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Neil</surname> <given-names>SJ</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>The antiviral activities of tetherin</article-title><source>Current Topics in Microbiology and Immunology</source><volume>371</volume><fpage>67</fpage><lpage>104</lpage><pub-id pub-id-type="doi">10.1007/978-3-642-37765-5_3</pub-id><pub-id pub-id-type="pmid">23686232</pub-id></element-citation></ref><ref id="bib132"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nieman</surname> <given-names>DC</given-names></name><name><surname>Wentz</surname> <given-names>LM</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>The compelling link between physical activity and the body's defense system</article-title><source>Journal of Sport and Health Science</source><volume>8</volume><fpage>201</fpage><lpage>217</lpage><pub-id pub-id-type="doi">10.1016/j.jshs.2018.09.009</pub-id><pub-id pub-id-type="pmid">31193280</pub-id></element-citation></ref><ref id="bib133"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nogales</surname> <given-names>V</given-names></name><name><surname>Reinhold</surname> <given-names>WC</given-names></name><name><surname>Varma</surname> <given-names>S</given-names></name><name><surname>Martinez-Cardus</surname> <given-names>A</given-names></name><name><surname>Moutinho</surname> <given-names>C</given-names></name><name><surname>Moran</surname> <given-names>S</given-names></name><name><surname>Heyn</surname> <given-names>H</given-names></name><name><surname>Sebio</surname> <given-names>A</given-names></name><name><surname>Barnadas</surname> <given-names>A</given-names></name><name><surname>Pommier</surname> <given-names>Y</given-names></name><name><surname>Esteller</surname> <given-names>M</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Epigenetic inactivation of the putative DNA/RNA helicase SLFN11 in human Cancer confers resistance to platinum drugs</article-title><source>Oncotarget</source><volume>7</volume><fpage>3084</fpage><lpage>3097</lpage><pub-id pub-id-type="doi">10.18632/oncotarget.6413</pub-id><pub-id pub-id-type="pmid">26625211</pub-id></element-citation></ref><ref id="bib134"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Novikova</surname> <given-names>M</given-names></name><name><surname>Zhang</surname> <given-names>Y</given-names></name><name><surname>Freed</surname> <given-names>EO</given-names></name><name><surname>Peng</surname> <given-names>K</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Multiple Roles of HIV-1 Capsid during the Virus Replication Cycle</article-title><source>Virologica Sinica</source><volume>34</volume><fpage>119</fpage><lpage>134</lpage><pub-id pub-id-type="doi">10.1007/s12250-019-00095-3</pub-id></element-citation></ref><ref id="bib135"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>O'Connor</surname> <given-names>L</given-names></name><name><surname>Gilmour</surname> <given-names>J</given-names></name><name><surname>Bonifer</surname> <given-names>C</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>The role of the ubiquitously expressed transcription factor Sp1 in Tissue-specific transcriptional regulation and in disease</article-title><source>The Yale Journal of Biology and Medicine</source><volume>89</volume><fpage>513</fpage><lpage>525</lpage><pub-id pub-id-type="pmid">28018142</pub-id></element-citation></ref><ref id="bib136"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Odon</surname> <given-names>V</given-names></name><name><surname>Fros</surname> <given-names>JJ</given-names></name><name><surname>Goonawardane</surname> <given-names>N</given-names></name><name><surname>Dietrich</surname> <given-names>I</given-names></name><name><surname>Ibrahim</surname> <given-names>A</given-names></name><name><surname>Alshaikhahmed</surname> <given-names>K</given-names></name><name><surname>Nguyen</surname> <given-names>D</given-names></name><name><surname>Simmonds</surname> <given-names>P</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>The role of ZAP and OAS3/RNAseL pathways in the attenuation of an RNA virus with elevated frequencies of CpG and UpA dinucleotides</article-title><source>Nucleic Acids Research</source><volume>47</volume><fpage>8061</fpage><lpage>8083</lpage><pub-id pub-id-type="doi">10.1093/nar/gkz581</pub-id><pub-id pub-id-type="pmid">31276592</pub-id></element-citation></ref><ref id="bib137"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Okumura</surname> <given-names>F</given-names></name><name><surname>Okumura</surname> <given-names>AJ</given-names></name><name><surname>Uematsu</surname> <given-names>K</given-names></name><name><surname>Hatakeyama</surname> <given-names>S</given-names></name><name><surname>Zhang</surname> <given-names>D-E</given-names></name><name><surname>Kamura</surname> <given-names>T</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Activation of Double-stranded RNA-activated protein kinase (PKR) by Interferon-stimulated gene 15 (ISG15) Modification Down-regulates protein translation</article-title><source>Journal of Biological Chemistry</source><volume>288</volume><fpage>2839</fpage><lpage>2847</lpage><pub-id pub-id-type="doi">10.1074/jbc.M112.401851</pub-id></element-citation></ref><ref id="bib138"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Olson</surname> <given-names>ME</given-names></name><name><surname>Harris</surname> <given-names>RS</given-names></name><name><surname>Harki</surname> <given-names>DA</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>APOBEC enzymes as targets for virus and Cancer therapy</article-title><source>Cell Chemical Biology</source><volume>25</volume><fpage>36</fpage><lpage>49</lpage><pub-id pub-id-type="doi">10.1016/j.chembiol.2017.10.007</pub-id><pub-id pub-id-type="pmid">29153851</pub-id></element-citation></ref><ref id="bib139"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pakos-Zebrucka</surname> <given-names>K</given-names></name><name><surname>Koryga</surname> <given-names>I</given-names></name><name><surname>Mnich</surname> <given-names>K</given-names></name><name><surname>Ljujic</surname> <given-names>M</given-names></name><name><surname>Samali</surname> <given-names>A</given-names></name><name><surname>Gorman</surname> <given-names>AM</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>The integrated stress response</article-title><source>EMBO Reports</source><volume>17</volume><fpage>1374</fpage><lpage>1395</lpage><pub-id pub-id-type="doi">10.15252/embr.201642195</pub-id><pub-id pub-id-type="pmid">27629041</pub-id></element-citation></ref><ref id="bib140"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Perez-Caballero</surname> <given-names>D</given-names></name><name><surname>Zang</surname> <given-names>T</given-names></name><name><surname>Ebrahimi</surname> <given-names>A</given-names></name><name><surname>McNatt</surname> <given-names>MW</given-names></name><name><surname>Gregory</surname> <given-names>DA</given-names></name><name><surname>Johnson</surname> <given-names>MC</given-names></name><name><surname>Bieniasz</surname> <given-names>PD</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Tetherin inhibits HIV-1 release by directly tethering virions to cells</article-title><source>Cell</source><volume>139</volume><fpage>499</fpage><lpage>511</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2009.08.039</pub-id><pub-id pub-id-type="pmid">19879838</pub-id></element-citation></ref><ref id="bib141"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Perng</surname> <given-names>YC</given-names></name><name><surname>Lenschow</surname> <given-names>DJ</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>ISG15 in antiviral immunity and beyond</article-title><source>Nature Reviews Microbiology</source><volume>16</volume><fpage>423</fpage><lpage>439</lpage><pub-id pub-id-type="doi">10.1038/s41579-018-0020-5</pub-id><pub-id pub-id-type="pmid">29769653</pub-id></element-citation></ref><ref id="bib142"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Petersen-Mahrt</surname> <given-names>SK</given-names></name><name><surname>Harris</surname> <given-names>RS</given-names></name><name><surname>Neuberger</surname> <given-names>MS</given-names></name></person-group><year iso-8601-date="2002">2002</year><article-title>AID mutates <italic>E. coli</italic> suggesting a DNA deamination mechanism for antibody diversification</article-title><source>Nature</source><volume>418</volume><fpage>99</fpage><lpage>104</lpage><pub-id pub-id-type="doi">10.1038/nature00862</pub-id><pub-id pub-id-type="pmid">12097915</pub-id></element-citation></ref><ref id="bib143"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Petljak</surname> <given-names>M</given-names></name><name><surname>Alexandrov</surname> <given-names>LB</given-names></name><name><surname>Brammeld</surname> <given-names>JS</given-names></name><name><surname>Price</surname> <given-names>S</given-names></name><name><surname>Wedge</surname> <given-names>DC</given-names></name><name><surname>Grossmann</surname> <given-names>S</given-names></name><name><surname>Dawson</surname> <given-names>KJ</given-names></name><name><surname>Ju</surname> <given-names>YS</given-names></name><name><surname>Iorio</surname> <given-names>F</given-names></name><name><surname>Tubio</surname> <given-names>JMC</given-names></name><name><surname>Koh</surname> <given-names>CC</given-names></name><name><surname>Georgakopoulos-Soares</surname> <given-names>I</given-names></name><name><surname>Rodríguez-Martín</surname> <given-names>B</given-names></name><name><surname>Otlu</surname> <given-names>B</given-names></name><name><surname>O'Meara</surname> <given-names>S</given-names></name><name><surname>Butler</surname> <given-names>AP</given-names></name><name><surname>Menzies</surname> <given-names>A</given-names></name><name><surname>Bhosle</surname> <given-names>SG</given-names></name><name><surname>Raine</surname> <given-names>K</given-names></name><name><surname>Jones</surname> <given-names>DR</given-names></name><name><surname>Teague</surname> <given-names>JW</given-names></name><name><surname>Beal</surname> <given-names>K</given-names></name><name><surname>Latimer</surname> <given-names>C</given-names></name><name><surname>O'Neill</surname> <given-names>L</given-names></name><name><surname>Zamora</surname> <given-names>J</given-names></name><name><surname>Anderson</surname> <given-names>E</given-names></name><name><surname>Patel</surname> <given-names>N</given-names></name><name><surname>Maddison</surname> <given-names>M</given-names></name><name><surname>Ng</surname> <given-names>BL</given-names></name><name><surname>Graham</surname> <given-names>J</given-names></name><name><surname>Garnett</surname> <given-names>MJ</given-names></name><name><surname>McDermott</surname> <given-names>U</given-names></name><name><surname>Nik-Zainal</surname> <given-names>S</given-names></name><name><surname>Campbell</surname> <given-names>PJ</given-names></name><name><surname>Stratton</surname> <given-names>MR</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Characterizing mutational signatures in human Cancer cell lines reveals episodic APOBEC mutagenesis</article-title><source>Cell</source><volume>176</volume><fpage>1282</fpage><lpage>1294</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2019.02.012</pub-id><pub-id pub-id-type="pmid">30849372</pub-id></element-citation></ref><ref id="bib144"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pichlmair</surname> <given-names>A</given-names></name><name><surname>Lassnig</surname> <given-names>C</given-names></name><name><surname>Eberle</surname> <given-names>CA</given-names></name><name><surname>Górna</surname> <given-names>MW</given-names></name><name><surname>Baumann</surname> <given-names>CL</given-names></name><name><surname>Burkard</surname> <given-names>TR</given-names></name><name><surname>Bürckstümmer</surname> <given-names>T</given-names></name><name><surname>Stefanovic</surname> <given-names>A</given-names></name><name><surname>Krieger</surname> <given-names>S</given-names></name><name><surname>Bennett</surname> <given-names>KL</given-names></name><name><surname>Rülicke</surname> <given-names>T</given-names></name><name><surname>Weber</surname> <given-names>F</given-names></name><name><surname>Colinge</surname> <given-names>J</given-names></name><name><surname>Müller</surname> <given-names>M</given-names></name><name><surname>Superti-Furga</surname> <given-names>G</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>IFIT1 is an antiviral protein that recognizes 5'-triphosphate RNA</article-title><source>Nature Immunology</source><volume>12</volume><fpage>624</fpage><lpage>630</lpage><pub-id pub-id-type="doi">10.1038/ni.2048</pub-id><pub-id pub-id-type="pmid">21642987</pub-id></element-citation></ref><ref id="bib145"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pinto</surname> <given-names>Y</given-names></name><name><surname>Gabay</surname> <given-names>O</given-names></name><name><surname>Arbiza</surname> <given-names>L</given-names></name><name><surname>Sams</surname> <given-names>AJ</given-names></name><name><surname>Keinan</surname> <given-names>A</given-names></name><name><surname>Levanon</surname> <given-names>EY</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Clustered mutations in hominid genome evolution are consistent with APOBEC3G enzymatic activity</article-title><source>Genome Research</source><volume>26</volume><fpage>579</fpage><lpage>587</lpage><pub-id pub-id-type="doi">10.1101/gr.199240.115</pub-id><pub-id pub-id-type="pmid">27056836</pub-id></element-citation></ref><ref id="bib146"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Powell</surname> <given-names>LM</given-names></name><name><surname>Wallis</surname> <given-names>SC</given-names></name><name><surname>Pease</surname> <given-names>RJ</given-names></name><name><surname>Edwards</surname> <given-names>YH</given-names></name><name><surname>Knott</surname> <given-names>TJ</given-names></name><name><surname>Scott</surname> <given-names>J</given-names></name></person-group><year iso-8601-date="1987">1987</year><article-title>A novel form of tissue-specific RNA processing produces apolipoprotein-B48 in intestine</article-title><source>Cell</source><volume>50</volume><fpage>831</fpage><lpage>840</lpage><pub-id pub-id-type="doi">10.1016/0092-8674(87)90510-1</pub-id><pub-id pub-id-type="pmid">3621347</pub-id></element-citation></ref><ref id="bib147"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Powell</surname> <given-names>RD</given-names></name><name><surname>Holland</surname> <given-names>PJ</given-names></name><name><surname>Hollis</surname> <given-names>T</given-names></name><name><surname>Perrino</surname> <given-names>FW</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Aicardi-Goutières syndrome gene and HIV-1 restriction factor SAMHD1 is a dGTP-regulated deoxynucleotide triphosphohydrolase</article-title><source>Journal of Biological Chemistry</source><volume>286</volume><fpage>43596</fpage><lpage>43600</lpage><pub-id pub-id-type="doi">10.1074/jbc.C111.317628</pub-id></element-citation></ref><ref id="bib148"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pyndiah</surname> <given-names>N</given-names></name><name><surname>Telenti</surname> <given-names>A</given-names></name><name><surname>Rausell</surname> <given-names>A</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Evolutionary genomics and HIV restriction factors</article-title><source>Current Opinion in HIV and AIDS</source><volume>10</volume><fpage>79</fpage><lpage>83</lpage><pub-id pub-id-type="doi">10.1097/COH.0000000000000138</pub-id><pub-id pub-id-type="pmid">25594315</pub-id></element-citation></ref><ref id="bib149"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Qiao</surname> <given-names>H</given-names></name><name><surname>Jiang</surname> <given-names>T</given-names></name><name><surname>Mu</surname> <given-names>P</given-names></name><name><surname>Chen</surname> <given-names>X</given-names></name><name><surname>Wen</surname> <given-names>X</given-names></name><name><surname>Hu</surname> <given-names>Z</given-names></name><name><surname>Tang</surname> <given-names>S</given-names></name><name><surname>Wen</surname> <given-names>J</given-names></name><name><surname>Deng</surname> <given-names>Y</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Cell fate determined by the activation balance between PKR and SPHK1</article-title><source>Cell Death &amp; Differentiation</source><volume>28</volume><fpage>401</fpage><lpage>418</lpage><pub-id pub-id-type="doi">10.1038/s41418-020-00608-8</pub-id></element-citation></ref><ref id="bib150"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Quirch</surname> <given-names>M</given-names></name><name><surname>Lee</surname> <given-names>J</given-names></name><name><surname>Rehman</surname> <given-names>S</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Hazards of the cytokine storm and Cytokine-Targeted therapy in patients with COVID-19: review</article-title><source>Journal of Medical Internet Research</source><volume>22</volume><elocation-id>e20193</elocation-id><pub-id pub-id-type="doi">10.2196/20193</pub-id><pub-id pub-id-type="pmid">32707537</pub-id></element-citation></ref><ref id="bib151"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ramanathan</surname> <given-names>A</given-names></name><name><surname>Robb</surname> <given-names>GB</given-names></name><name><surname>Chan</surname> <given-names>SH</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>mRNA capping: biological functions and applications</article-title><source>Nucleic Acids Research</source><volume>44</volume><fpage>7511</fpage><lpage>7526</lpage><pub-id pub-id-type="doi">10.1093/nar/gkw551</pub-id><pub-id pub-id-type="pmid">27317694</pub-id></element-citation></ref><ref id="bib152"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Raychoudhuri</surname> <given-names>A</given-names></name><name><surname>Shrivastava</surname> <given-names>S</given-names></name><name><surname>Steele</surname> <given-names>R</given-names></name><name><surname>Kim</surname> <given-names>H</given-names></name><name><surname>Ray</surname> <given-names>R</given-names></name><name><surname>Ray</surname> <given-names>RB</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>ISG56 and IFITM1 proteins inhibit hepatitis C virus replication</article-title><source>Journal of Virology</source><volume>85</volume><fpage>12881</fpage><lpage>12889</lpage><pub-id pub-id-type="doi">10.1128/JVI.05633-11</pub-id><pub-id pub-id-type="pmid">21976647</pub-id></element-citation></ref><ref id="bib153"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rice</surname> <given-names>CM</given-names></name><name><surname>Lenches</surname> <given-names>EM</given-names></name><name><surname>Eddy</surname> <given-names>SR</given-names></name><name><surname>Shin</surname> <given-names>SJ</given-names></name><name><surname>Sheets</surname> <given-names>RL</given-names></name><name><surname>Strauss</surname> <given-names>JH</given-names></name></person-group><year iso-8601-date="1985">1985</year><article-title>Nucleotide sequence of yellow fever virus: implications for Flavivirus gene expression and evolution</article-title><source>Science</source><volume>229</volume><fpage>726</fpage><lpage>733</lpage><pub-id pub-id-type="doi">10.1126/science.4023707</pub-id><pub-id pub-id-type="pmid">4023707</pub-id></element-citation></ref><ref id="bib154"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Richardson</surname> <given-names>C</given-names></name><name><surname>Hull</surname> <given-names>D</given-names></name><name><surname>Greer</surname> <given-names>P</given-names></name><name><surname>Hasel</surname> <given-names>K</given-names></name><name><surname>Berkovich</surname> <given-names>A</given-names></name><name><surname>Englund</surname> <given-names>G</given-names></name><name><surname>Bellini</surname> <given-names>W</given-names></name><name><surname>Rima</surname> <given-names>B</given-names></name><name><surname>Lazzarini</surname> <given-names>R</given-names></name></person-group><year iso-8601-date="1986">1986</year><article-title>The nucleotide sequence of the mRNA encoding the fusion protein of measles virus (Edmonston strain): a comparison of fusion proteins from several different paramyxoviruses</article-title><source>Virology</source><volume>155</volume><fpage>508</fpage><lpage>523</lpage><pub-id pub-id-type="doi">10.1016/0042-6822(86)90212-6</pub-id><pub-id pub-id-type="pmid">3788062</pub-id></element-citation></ref><ref id="bib155"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Roberts</surname> <given-names>SA</given-names></name><name><surname>Lawrence</surname> <given-names>MS</given-names></name><name><surname>Klimczak</surname> <given-names>LJ</given-names></name><name><surname>Grimm</surname> <given-names>SA</given-names></name><name><surname>Fargo</surname> <given-names>D</given-names></name><name><surname>Stojanov</surname> <given-names>P</given-names></name><name><surname>Kiezun</surname> <given-names>A</given-names></name><name><surname>Kryukov</surname> <given-names>GV</given-names></name><name><surname>Carter</surname> <given-names>SL</given-names></name><name><surname>Saksena</surname> <given-names>G</given-names></name><name><surname>Harris</surname> <given-names>S</given-names></name><name><surname>Shah</surname> <given-names>RR</given-names></name><name><surname>Resnick</surname> <given-names>MA</given-names></name><name><surname>Getz</surname> <given-names>G</given-names></name><name><surname>Gordenin</surname> <given-names>DA</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>An APOBEC cytidine deaminase mutagenesis pattern is widespread in human cancers</article-title><source>Nature Genetics</source><volume>45</volume><fpage>970</fpage><lpage>976</lpage><pub-id pub-id-type="doi">10.1038/ng.2702</pub-id><pub-id pub-id-type="pmid">23852170</pub-id></element-citation></ref><ref id="bib156"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Roberts</surname> <given-names>L</given-names></name><name><surname>Wieden</surname> <given-names>HJ</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Viruses, IRESs, and a universal translation initiation mechanism</article-title><source>Biotechnology and Genetic Engineering Reviews</source><volume>34</volume><fpage>60</fpage><lpage>75</lpage><pub-id pub-id-type="doi">10.1080/02648725.2018.1471567</pub-id><pub-id pub-id-type="pmid">29804514</pub-id></element-citation></ref><ref id="bib157"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Roper</surname> <given-names>N</given-names></name><name><surname>Gao</surname> <given-names>S</given-names></name><name><surname>Maity</surname> <given-names>TK</given-names></name><name><surname>Banday</surname> <given-names>AR</given-names></name><name><surname>Zhang</surname> <given-names>X</given-names></name><name><surname>Venugopalan</surname> <given-names>A</given-names></name><name><surname>Cultraro</surname> <given-names>CM</given-names></name><name><surname>Patidar</surname> <given-names>R</given-names></name><name><surname>Sindiri</surname> <given-names>S</given-names></name><name><surname>Brown</surname> <given-names>AL</given-names></name><name><surname>Goncearenco</surname> <given-names>A</given-names></name><name><surname>Panchenko</surname> <given-names>AR</given-names></name><name><surname>Biswas</surname> <given-names>R</given-names></name><name><surname>Thomas</surname> <given-names>A</given-names></name><name><surname>Rajan</surname> <given-names>A</given-names></name><name><surname>Carter</surname> <given-names>CA</given-names></name><name><surname>Kleiner</surname> <given-names>DE</given-names></name><name><surname>Hewitt</surname> <given-names>SM</given-names></name><name><surname>Khan</surname> <given-names>J</given-names></name><name><surname>Prokunina-Olsson</surname> <given-names>L</given-names></name><name><surname>Guha</surname> <given-names>U</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>APOBEC mutagenesis and Copy-Number alterations are drivers of proteogenomic tumor evolution and heterogeneity in metastatic thoracic tumors</article-title><source>Cell Reports</source><volume>26</volume><fpage>2651</fpage><lpage>2666</lpage><pub-id pub-id-type="doi">10.1016/j.celrep.2019.02.028</pub-id><pub-id pub-id-type="pmid">30840888</pub-id></element-citation></ref><ref id="bib158"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rosa</surname> <given-names>A</given-names></name><name><surname>Chande</surname> <given-names>A</given-names></name><name><surname>Ziglio</surname> <given-names>S</given-names></name><name><surname>De Sanctis</surname> <given-names>V</given-names></name><name><surname>Bertorelli</surname> <given-names>R</given-names></name><name><surname>Goh</surname> <given-names>SL</given-names></name><name><surname>McCauley</surname> <given-names>SM</given-names></name><name><surname>Nowosielska</surname> <given-names>A</given-names></name><name><surname>Antonarakis</surname> <given-names>SE</given-names></name><name><surname>Luban</surname> <given-names>J</given-names></name><name><surname>Santoni</surname> <given-names>FA</given-names></name><name><surname>Pizzato</surname> <given-names>M</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>HIV-1 nef promotes infection by excluding SERINC5 from virion incorporation</article-title><source>Nature</source><volume>526</volume><fpage>212</fpage><lpage>217</lpage><pub-id pub-id-type="doi">10.1038/nature15399</pub-id><pub-id pub-id-type="pmid">26416734</pub-id></element-citation></ref><ref id="bib159"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ryoo</surname> <given-names>J</given-names></name><name><surname>Choi</surname> <given-names>J</given-names></name><name><surname>Oh</surname> <given-names>C</given-names></name><name><surname>Kim</surname> <given-names>S</given-names></name><name><surname>Seo</surname> <given-names>M</given-names></name><name><surname>Kim</surname> <given-names>SY</given-names></name><name><surname>Seo</surname> <given-names>D</given-names></name><name><surname>Kim</surname> <given-names>J</given-names></name><name><surname>White</surname> <given-names>TE</given-names></name><name><surname>Brandariz-Nuñez</surname> <given-names>A</given-names></name><name><surname>Diaz-Griffero</surname> <given-names>F</given-names></name><name><surname>Yun</surname> <given-names>CH</given-names></name><name><surname>Hollenbaugh</surname> <given-names>JA</given-names></name><name><surname>Kim</surname> <given-names>B</given-names></name><name><surname>Baek</surname> <given-names>D</given-names></name><name><surname>Ahn</surname> <given-names>K</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>The ribonuclease activity of SAMHD1 is required for HIV-1 restriction</article-title><source>Nature Medicine</source><volume>20</volume><fpage>936</fpage><lpage>941</lpage><pub-id pub-id-type="doi">10.1038/nm.3626</pub-id><pub-id pub-id-type="pmid">25038827</pub-id></element-citation></ref><ref id="bib160"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sachan</surname> <given-names>V</given-names></name><name><surname>Lodge</surname> <given-names>R</given-names></name><name><surname>Mihara</surname> <given-names>K</given-names></name><name><surname>Hamelin</surname> <given-names>J</given-names></name><name><surname>Power</surname> <given-names>C</given-names></name><name><surname>Gelman</surname> <given-names>BB</given-names></name><name><surname>Hollenberg</surname> <given-names>MD</given-names></name><name><surname>Cohen</surname> <given-names>ÉA</given-names></name><name><surname>Seidah</surname> <given-names>NG</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>HIV-induced neuroinflammation: impact of PAR1 and PAR2 processing by furin</article-title><source>Cell Death &amp; Differentiation</source><volume>26</volume><fpage>1942</fpage><lpage>1954</lpage><pub-id pub-id-type="doi">10.1038/s41418-018-0264-7</pub-id><pub-id pub-id-type="pmid">30683917</pub-id></element-citation></ref><ref id="bib161"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Safe</surname> <given-names>S</given-names></name><name><surname>Imanirad</surname> <given-names>P</given-names></name><name><surname>Sreevalsan</surname> <given-names>S</given-names></name><name><surname>Nair</surname> <given-names>V</given-names></name><name><surname>Jutooru</surname> <given-names>I</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Transcription factor Sp1, also known as specificity protein 1 as a therapeutic target</article-title><source>Expert Opinion on Therapeutic Targets</source><volume>18</volume><fpage>759</fpage><lpage>769</lpage><pub-id pub-id-type="doi">10.1517/14728222.2014.914173</pub-id><pub-id pub-id-type="pmid">24793594</pub-id></element-citation></ref><ref id="bib162"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Salter</surname> <given-names>JD</given-names></name><name><surname>Bennett</surname> <given-names>RP</given-names></name><name><surname>Smith</surname> <given-names>HC</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>The APOBEC protein family: united by structure, divergent in function</article-title><source>Trends in Biochemical Sciences</source><volume>41</volume><fpage>578</fpage><lpage>594</lpage><pub-id pub-id-type="doi">10.1016/j.tibs.2016.05.001</pub-id><pub-id pub-id-type="pmid">27283515</pub-id></element-citation></ref><ref id="bib163"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sauter</surname> <given-names>D</given-names></name><name><surname>Kirchhoff</surname> <given-names>F</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Multilayered and versatile inhibition of cellular antiviral factors by HIV and SIV accessory proteins</article-title><source>Cytokine &amp; Growth Factor Reviews</source><volume>40</volume><fpage>3</fpage><lpage>12</lpage><pub-id pub-id-type="doi">10.1016/j.cytogfr.2018.02.005</pub-id><pub-id pub-id-type="pmid">29526437</pub-id></element-citation></ref><ref id="bib164"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sawyer</surname> <given-names>SL</given-names></name><name><surname>Wu</surname> <given-names>LI</given-names></name><name><surname>Emerman</surname> <given-names>M</given-names></name><name><surname>Malik</surname> <given-names>HS</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>Positive selection of primate TRIM5alpha identifies a critical species-specific retroviral restriction domain</article-title><source>PNAS</source><volume>102</volume><fpage>2832</fpage><lpage>2837</lpage><pub-id pub-id-type="doi">10.1073/pnas.0409853102</pub-id><pub-id pub-id-type="pmid">15689398</pub-id></element-citation></ref><ref id="bib165"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Seplyarskiy</surname> <given-names>VB</given-names></name><name><surname>Soldatov</surname> <given-names>RA</given-names></name><name><surname>Popadin</surname> <given-names>KY</given-names></name><name><surname>Antonarakis</surname> <given-names>SE</given-names></name><name><surname>Bazykin</surname> <given-names>GA</given-names></name><name><surname>Nikolaev</surname> <given-names>SI</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>APOBEC-induced mutations in human cancers are strongly enriched on the lagging DNA strand during replication</article-title><source>Genome Research</source><volume>26</volume><fpage>174</fpage><lpage>182</lpage><pub-id pub-id-type="doi">10.1101/gr.197046.115</pub-id><pub-id pub-id-type="pmid">26755635</pub-id></element-citation></ref><ref id="bib166"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Serra</surname> <given-names>RW</given-names></name><name><surname>Fang</surname> <given-names>M</given-names></name><name><surname>Park</surname> <given-names>SM</given-names></name><name><surname>Hutchinson</surname> <given-names>L</given-names></name><name><surname>Green</surname> <given-names>MR</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>A KRAS-directed transcriptional silencing pathway that mediates the CpG island methylator phenotype</article-title><source>eLife</source><volume>3</volume><elocation-id>e02313</elocation-id><pub-id pub-id-type="doi">10.7554/eLife.02313</pub-id><pub-id pub-id-type="pmid">24623306</pub-id></element-citation></ref><ref id="bib167"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shi</surname> <given-names>HX</given-names></name><name><surname>Yang</surname> <given-names>K</given-names></name><name><surname>Liu</surname> <given-names>X</given-names></name><name><surname>Liu</surname> <given-names>XY</given-names></name><name><surname>Wei</surname> <given-names>B</given-names></name><name><surname>Shan</surname> <given-names>YF</given-names></name><name><surname>Zhu</surname> <given-names>LH</given-names></name><name><surname>Wang</surname> <given-names>C</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Positive regulation of interferon regulatory factor 3 activation by Herc5 via ISG15 modification</article-title><source>Molecular and Cellular Biology</source><volume>30</volume><fpage>2424</fpage><lpage>2436</lpage><pub-id pub-id-type="doi">10.1128/MCB.01466-09</pub-id><pub-id pub-id-type="pmid">20308324</pub-id></element-citation></ref><ref id="bib168"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shi</surname> <given-names>G</given-names></name><name><surname>Schwartz</surname> <given-names>O</given-names></name><name><surname>Compton</surname> <given-names>AA</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>More than meets the I: the diverse antiviral and cellular functions of interferon-induced transmembrane proteins</article-title><source>Retrovirology</source><volume>14</volume><elocation-id>53</elocation-id><pub-id pub-id-type="doi">10.1186/s12977-017-0377-y</pub-id><pub-id pub-id-type="pmid">29162141</pub-id></element-citation></ref><ref id="bib169"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Smith</surname> <given-names>S</given-names></name><name><surname>Weston</surname> <given-names>S</given-names></name><name><surname>Kellam</surname> <given-names>P</given-names></name><name><surname>Marsh</surname> <given-names>M</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>IFITM proteins-cellular inhibitors of viral entry</article-title><source>Current Opinion in Virology</source><volume>4</volume><fpage>71</fpage><lpage>77</lpage><pub-id pub-id-type="doi">10.1016/j.coviro.2013.11.004</pub-id><pub-id pub-id-type="pmid">24480526</pub-id></element-citation></ref><ref id="bib170"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sood</surname> <given-names>C</given-names></name><name><surname>Marin</surname> <given-names>M</given-names></name><name><surname>Chande</surname> <given-names>A</given-names></name><name><surname>Pizzato</surname> <given-names>M</given-names></name><name><surname>Melikyan</surname> <given-names>GB</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>SERINC5 protein inhibits HIV-1 fusion pore formation by promoting functional inactivation of envelope glycoproteins</article-title><source>Journal of Biological Chemistry</source><volume>292</volume><fpage>6014</fpage><lpage>6026</lpage><pub-id pub-id-type="doi">10.1074/jbc.M117.777714</pub-id></element-citation></ref><ref id="bib171"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Srinivasachar Badarinarayan</surname> <given-names>S</given-names></name><name><surname>Shcherbakova</surname> <given-names>I</given-names></name><name><surname>Langer</surname> <given-names>S</given-names></name><name><surname>Koepke</surname> <given-names>L</given-names></name><name><surname>Preising</surname> <given-names>A</given-names></name><name><surname>Hotter</surname> <given-names>D</given-names></name><name><surname>Kirchhoff</surname> <given-names>F</given-names></name><name><surname>Sparrer</surname> <given-names>KMJ</given-names></name><name><surname>Schotta</surname> <given-names>G</given-names></name><name><surname>Sauter</surname> <given-names>D</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>HIV-1 infection activates endogenous retroviral promoters regulating antiviral gene expression</article-title><source>Nucleic Acids Research</source><volume>48</volume><fpage>10890</fpage><lpage>10908</lpage><pub-id pub-id-type="doi">10.1093/nar/gkaa832</pub-id><pub-id pub-id-type="pmid">33021676</pub-id></element-citation></ref><ref id="bib172"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stadler</surname> <given-names>K</given-names></name><name><surname>Allison</surname> <given-names>SL</given-names></name><name><surname>Schalich</surname> <given-names>J</given-names></name><name><surname>Heinz</surname> <given-names>FX</given-names></name></person-group><year iso-8601-date="1997">1997</year><article-title>Proteolytic activation of tick-borne encephalitis virus by furin</article-title><source>Journal of Virology</source><volume>71</volume><fpage>8475</fpage><lpage>8481</lpage><pub-id pub-id-type="doi">10.1128/JVI.71.11.8475-8481.1997</pub-id><pub-id pub-id-type="pmid">9343204</pub-id></element-citation></ref><ref id="bib173"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Staeheli</surname> <given-names>P</given-names></name><name><surname>Haller</surname> <given-names>O</given-names></name><name><surname>Boll</surname> <given-names>W</given-names></name><name><surname>Lindenmann</surname> <given-names>J</given-names></name><name><surname>Weissmann</surname> <given-names>C</given-names></name></person-group><year iso-8601-date="1986">1986</year><article-title>Mx protein: constitutive expression in 3t3 cells transformed with cloned mx cDNA confers selective resistance to influenza virus</article-title><source>Cell</source><volume>44</volume><fpage>147</fpage><lpage>158</lpage><pub-id pub-id-type="doi">10.1016/0092-8674(86)90493-9</pub-id><pub-id pub-id-type="pmid">3000619</pub-id></element-citation></ref><ref id="bib174"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stavrou</surname> <given-names>S</given-names></name><name><surname>Ross</surname> <given-names>SR</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>APOBEC3 proteins in viral immunity</article-title><source>The Journal of Immunology</source><volume>195</volume><fpage>4565</fpage><lpage>4570</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.1501504</pub-id><pub-id pub-id-type="pmid">26546688</pub-id></element-citation></ref><ref id="bib175"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stiasny</surname> <given-names>K</given-names></name><name><surname>Heinz</surname> <given-names>FX</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>Effect of membrane Curvature-Modifying lipids on membrane fusion by Tick-Borne encephalitis virus</article-title><source>Journal of Virology</source><volume>78</volume><fpage>8536</fpage><lpage>8542</lpage><pub-id pub-id-type="doi">10.1128/JVI.78.16.8536-8542.2004</pub-id></element-citation></ref><ref id="bib176"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stratmann</surname> <given-names>SA</given-names></name><name><surname>Morrone</surname> <given-names>SR</given-names></name><name><surname>van Oijen</surname> <given-names>AM</given-names></name><name><surname>Sohn</surname> <given-names>J</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>The innate immune sensor IFI16 recognizes foreign DNA in the nucleus by scanning along the duplex</article-title><source>eLife</source><volume>4</volume><elocation-id>e11721</elocation-id><pub-id pub-id-type="doi">10.7554/eLife.11721</pub-id><pub-id pub-id-type="pmid">26673078</pub-id></element-citation></ref><ref id="bib177"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stremlau</surname> <given-names>M</given-names></name><name><surname>Owens</surname> <given-names>CM</given-names></name><name><surname>Perron</surname> <given-names>MJ</given-names></name><name><surname>Kiessling</surname> <given-names>M</given-names></name><name><surname>Autissier</surname> <given-names>P</given-names></name><name><surname>Sodroski</surname> <given-names>J</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>The cytoplasmic body component TRIM5alpha restricts HIV-1 infection in old world monkeys</article-title><source>Nature</source><volume>427</volume><fpage>848</fpage><lpage>853</lpage><pub-id pub-id-type="doi">10.1038/nature02343</pub-id><pub-id pub-id-type="pmid">14985764</pub-id></element-citation></ref><ref id="bib178"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sugimoto</surname> <given-names>J</given-names></name><name><surname>Sugimoto</surname> <given-names>M</given-names></name><name><surname>Bernstein</surname> <given-names>H</given-names></name><name><surname>Jinno</surname> <given-names>Y</given-names></name><name><surname>Schust</surname> <given-names>D</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>A novel human endogenous retroviral protein inhibits cell-cell fusion</article-title><source>Scientific Reports</source><volume>3</volume><elocation-id>1462</elocation-id><pub-id pub-id-type="doi">10.1038/srep01462</pub-id><pub-id pub-id-type="pmid">23492904</pub-id></element-citation></ref><ref id="bib179"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Suzuki</surname> <given-names>T</given-names></name><name><surname>Suzuki</surname> <given-names>Y</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>Virus infection and lipid rafts</article-title><source>Biological &amp; Pharmaceutical Bulletin</source><volume>29</volume><fpage>1538</fpage><lpage>1541</lpage><pub-id pub-id-type="doi">10.1248/bpb.29.1538</pub-id><pub-id pub-id-type="pmid">16880600</pub-id></element-citation></ref><ref id="bib180"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Takata</surname> <given-names>MA</given-names></name><name><surname>Gonçalves-Carneiro</surname> <given-names>D</given-names></name><name><surname>Zang</surname> <given-names>TM</given-names></name><name><surname>Soll</surname> <given-names>SJ</given-names></name><name><surname>York</surname> <given-names>A</given-names></name><name><surname>Blanco-Melo</surname> <given-names>D</given-names></name><name><surname>Bieniasz</surname> <given-names>PD</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>CG dinucleotide suppression enables antiviral defence targeting non-self RNA</article-title><source>Nature</source><volume>550</volume><fpage>124</fpage><lpage>127</lpage><pub-id pub-id-type="doi">10.1038/nature24039</pub-id><pub-id pub-id-type="pmid">28953888</pub-id></element-citation></ref><ref id="bib181"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tang</surname> <given-names>Y</given-names></name><name><surname>Zhong</surname> <given-names>G</given-names></name><name><surname>Zhu</surname> <given-names>L</given-names></name><name><surname>Liu</surname> <given-names>X</given-names></name><name><surname>Shan</surname> <given-names>Y</given-names></name><name><surname>Feng</surname> <given-names>H</given-names></name><name><surname>Bu</surname> <given-names>Z</given-names></name><name><surname>Chen</surname> <given-names>H</given-names></name><name><surname>Wang</surname> <given-names>C</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Herc5 attenuates influenza A virus by catalyzing ISGylation of viral NS1 protein</article-title><source>The Journal of Immunology</source><volume>184</volume><fpage>5777</fpage><lpage>5790</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.0903588</pub-id><pub-id pub-id-type="pmid">20385878</pub-id></element-citation></ref><ref id="bib182"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Teng</surname> <given-names>B</given-names></name><name><surname>Burant</surname> <given-names>CF</given-names></name><name><surname>Davidson</surname> <given-names>NO</given-names></name></person-group><year iso-8601-date="1993">1993</year><article-title>Molecular cloning of an apolipoprotein B messenger RNA editing protein</article-title><source>Science</source><volume>260</volume><fpage>1816</fpage><lpage>1819</lpage><pub-id pub-id-type="doi">10.1126/science.8511591</pub-id><pub-id pub-id-type="pmid">8511591</pub-id></element-citation></ref><ref id="bib183"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tian</surname> <given-names>S</given-names></name><name><surname>Huang</surname> <given-names>Q</given-names></name><name><surname>Fang</surname> <given-names>Y</given-names></name><name><surname>Wu</surname> <given-names>J</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>FurinDB: a database of 20-residue furin cleavage site motifs, substrates and their associated drugs</article-title><source>International Journal of Molecular Sciences</source><volume>12</volume><fpage>1060</fpage><lpage>1065</lpage><pub-id pub-id-type="doi">10.3390/ijms12021060</pub-id><pub-id pub-id-type="pmid">21541042</pub-id></element-citation></ref><ref id="bib184"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tie</surname> <given-names>CH</given-names></name><name><surname>Fernandes</surname> <given-names>L</given-names></name><name><surname>Conde</surname> <given-names>L</given-names></name><name><surname>Robbez-Masson</surname> <given-names>L</given-names></name><name><surname>Sumner</surname> <given-names>RP</given-names></name><name><surname>Peacock</surname> <given-names>T</given-names></name><name><surname>Rodriguez-Plata</surname> <given-names>MT</given-names></name><name><surname>Mickute</surname> <given-names>G</given-names></name><name><surname>Gifford</surname> <given-names>R</given-names></name><name><surname>Towers</surname> <given-names>GJ</given-names></name><name><surname>Herrero</surname> <given-names>J</given-names></name><name><surname>Rowe</surname> <given-names>HM</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>KAP 1 regulates endogenous retroviruses in adult human cells and contributes to innate immune control</article-title><source>EMBO Reports</source><volume>19</volume><elocation-id>e45000</elocation-id><pub-id pub-id-type="doi">10.15252/embr.201745000</pub-id><pub-id pub-id-type="pmid">30061100</pub-id></element-citation></ref><ref id="bib185"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Timilsina</surname> <given-names>U</given-names></name><name><surname>Umthong</surname> <given-names>S</given-names></name><name><surname>Lynch</surname> <given-names>B</given-names></name><name><surname>Stablewski</surname> <given-names>A</given-names></name><name><surname>Stavrou</surname> <given-names>S</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>SERINC5 potently restricts retrovirus infection <italic>In Vivo</italic></article-title><source>mBio</source><volume>11</volume><elocation-id>e00588-20</elocation-id><pub-id pub-id-type="doi">10.1128/mBio.00588-20</pub-id><pub-id pub-id-type="pmid">32665269</pub-id></element-citation></ref><ref id="bib186"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Todorova</surname> <given-names>T</given-names></name><name><surname>Bock</surname> <given-names>FJ</given-names></name><name><surname>Chang</surname> <given-names>P</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>PARP13 regulates cellular mRNA post-transcriptionally and functions as a pro-apoptotic factor by destabilizing TRAILR4 transcript</article-title><source>Nature Communications</source><volume>5</volume><elocation-id>5362</elocation-id><pub-id pub-id-type="doi">10.1038/ncomms6362</pub-id><pub-id pub-id-type="pmid">25382312</pub-id></element-citation></ref><ref id="bib187"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Trautz</surname> <given-names>B</given-names></name><name><surname>Wiedemann</surname> <given-names>H</given-names></name><name><surname>Lüchtenborg</surname> <given-names>C</given-names></name><name><surname>Pierini</surname> <given-names>V</given-names></name><name><surname>Kranich</surname> <given-names>J</given-names></name><name><surname>Glass</surname> <given-names>B</given-names></name><name><surname>Kräusslich</surname> <given-names>H-G</given-names></name><name><surname>Brocker</surname> <given-names>T</given-names></name><name><surname>Pizzato</surname> <given-names>M</given-names></name><name><surname>Ruggieri</surname> <given-names>A</given-names></name><name><surname>Brügger</surname> <given-names>B</given-names></name><name><surname>Fackler</surname> <given-names>OT</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>The host-cell restriction factor SERINC5 restricts HIV-1 infectivity without altering the lipid composition and organization of viral particles</article-title><source>Journal of Biological Chemistry</source><volume>292</volume><fpage>13702</fpage><lpage>13713</lpage><pub-id pub-id-type="doi">10.1074/jbc.M117.797332</pub-id></element-citation></ref><ref id="bib188"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Turrini</surname> <given-names>F</given-names></name><name><surname>Marelli</surname> <given-names>S</given-names></name><name><surname>Kajaste-Rudnitski</surname> <given-names>A</given-names></name><name><surname>Lusic</surname> <given-names>M</given-names></name><name><surname>Van Lint</surname> <given-names>C</given-names></name><name><surname>Das</surname> <given-names>AT</given-names></name><name><surname>Harwig</surname> <given-names>A</given-names></name><name><surname>Berkhout</surname> <given-names>B</given-names></name><name><surname>Vicenzi</surname> <given-names>E</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>HIV-1 transcriptional silencing caused by TRIM22 inhibition of Sp1 binding to the viral promoter</article-title><source>Retrovirology</source><volume>12</volume><elocation-id>104</elocation-id><pub-id pub-id-type="doi">10.1186/s12977-015-0230-0</pub-id><pub-id pub-id-type="pmid">26683615</pub-id></element-citation></ref><ref id="bib189"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Turrini</surname> <given-names>F</given-names></name><name><surname>Saliu</surname> <given-names>F</given-names></name><name><surname>Forlani</surname> <given-names>G</given-names></name><name><surname>Das</surname> <given-names>AT</given-names></name><name><surname>Van Lint</surname> <given-names>C</given-names></name><name><surname>Accolla</surname> <given-names>RS</given-names></name><name><surname>Berkhout</surname> <given-names>B</given-names></name><name><surname>Poli</surname> <given-names>G</given-names></name><name><surname>Vicenzi</surname> <given-names>E</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Interferon-inducible TRIM22 contributes to maintenance of HIV-1 proviral latency in T cell lines</article-title><source>Virus Research</source><volume>269</volume><elocation-id>197631</elocation-id><pub-id pub-id-type="doi">10.1016/j.virusres.2019.05.009</pub-id><pub-id pub-id-type="pmid">31136823</pub-id></element-citation></ref><ref id="bib190"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Usami</surname> <given-names>Y</given-names></name><name><surname>Wu</surname> <given-names>Y</given-names></name><name><surname>Göttlinger</surname> <given-names>HG</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>SERINC3 and SERINC5 restrict HIV-1 infectivity and are counteracted by nef</article-title><source>Nature</source><volume>526</volume><fpage>218</fpage><lpage>223</lpage><pub-id pub-id-type="doi">10.1038/nature15400</pub-id><pub-id pub-id-type="pmid">26416733</pub-id></element-citation></ref><ref id="bib191"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Van Damme</surname> <given-names>N</given-names></name><name><surname>Goff</surname> <given-names>D</given-names></name><name><surname>Katsura</surname> <given-names>C</given-names></name><name><surname>Jorgenson</surname> <given-names>RL</given-names></name><name><surname>Mitchell</surname> <given-names>R</given-names></name><name><surname>Johnson</surname> <given-names>MC</given-names></name><name><surname>Stephens</surname> <given-names>EB</given-names></name><name><surname>Guatelli</surname> <given-names>J</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>The interferon-induced protein BST-2 restricts HIV-1 release and is downregulated from the cell surface by the viral vpu protein</article-title><source>Cell Host &amp; Microbe</source><volume>3</volume><fpage>245</fpage><lpage>252</lpage><pub-id pub-id-type="doi">10.1016/j.chom.2008.03.001</pub-id><pub-id pub-id-type="pmid">18342597</pub-id></element-citation></ref><ref id="bib192"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname> <given-names>X</given-names></name><name><surname>Hinson</surname> <given-names>ER</given-names></name><name><surname>Cresswell</surname> <given-names>P</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>The interferon-inducible protein viperin inhibits influenza virus release by perturbing lipid rafts</article-title><source>Cell Host &amp; Microbe</source><volume>2</volume><fpage>96</fpage><lpage>105</lpage><pub-id pub-id-type="doi">10.1016/j.chom.2007.06.009</pub-id><pub-id pub-id-type="pmid">18005724</pub-id></element-citation></ref><ref id="bib193"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Woo</surname> <given-names>PC</given-names></name><name><surname>Wong</surname> <given-names>BH</given-names></name><name><surname>Huang</surname> <given-names>Y</given-names></name><name><surname>Lau</surname> <given-names>SK</given-names></name><name><surname>Yuen</surname> <given-names>KY</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Cytosine deamination and selection of CpG suppressed clones are the two major independent biological forces that shape Codon usage Bias in coronaviruses</article-title><source>Virology</source><volume>369</volume><fpage>431</fpage><lpage>442</lpage><pub-id pub-id-type="doi">10.1016/j.virol.2007.08.010</pub-id><pub-id pub-id-type="pmid">17881030</pub-id></element-citation></ref><ref id="bib194"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Woods</surname> <given-names>MW</given-names></name><name><surname>Kelly</surname> <given-names>JN</given-names></name><name><surname>Hattlmann</surname> <given-names>CJ</given-names></name><name><surname>Tong</surname> <given-names>JG</given-names></name><name><surname>Xu</surname> <given-names>LS</given-names></name><name><surname>Coleman</surname> <given-names>MD</given-names></name><name><surname>Quest</surname> <given-names>GR</given-names></name><name><surname>Smiley</surname> <given-names>JR</given-names></name><name><surname>Barr</surname> <given-names>SD</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Human HERC5 restricts an early stage of HIV-1 assembly by a mechanism correlating with the ISGylation of gag</article-title><source>Retrovirology</source><volume>8</volume><elocation-id>95</elocation-id><pub-id pub-id-type="doi">10.1186/1742-4690-8-95</pub-id><pub-id pub-id-type="pmid">22093708</pub-id></element-citation></ref><ref id="bib195"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yockey</surname> <given-names>LJ</given-names></name><name><surname>Iwasaki</surname> <given-names>A</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Interferons and proinflammatory cytokines in pregnancy and fetal development</article-title><source>Immunity</source><volume>49</volume><fpage>397</fpage><lpage>412</lpage><pub-id pub-id-type="doi">10.1016/j.immuni.2018.07.017</pub-id><pub-id pub-id-type="pmid">30231982</pub-id></element-citation></ref><ref id="bib196"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhao</surname> <given-names>C</given-names></name><name><surname>Sridharan</surname> <given-names>H</given-names></name><name><surname>Chen</surname> <given-names>R</given-names></name><name><surname>Baker</surname> <given-names>DP</given-names></name><name><surname>Wang</surname> <given-names>S</given-names></name><name><surname>Krug</surname> <given-names>RM</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Influenza B virus non-structural protein 1 counteracts ISG15 antiviral activity by sequestering ISGylated viral proteins</article-title><source>Nature Communications</source><volume>7</volume><elocation-id>12754</elocation-id><pub-id pub-id-type="doi">10.1038/ncomms12754</pub-id><pub-id pub-id-type="pmid">27587337</pub-id></element-citation></ref><ref id="bib197"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhao</surname> <given-names>J</given-names></name><name><surname>Chen</surname> <given-names>J</given-names></name><name><surname>Li</surname> <given-names>M</given-names></name><name><surname>Chen</surname> <given-names>M</given-names></name><name><surname>Sun</surname> <given-names>C</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Multifaceted functions of CH25H and 25hc to modulate the lipid metabolism, immune responses, and broadly antiviral activities</article-title><source>Viruses</source><volume>12</volume><elocation-id>727</elocation-id><pub-id pub-id-type="doi">10.3390/v12070727</pub-id></element-citation></ref><ref id="bib198"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zheng</surname> <given-names>X</given-names></name><name><surname>Wang</surname> <given-names>X</given-names></name><name><surname>Tu</surname> <given-names>F</given-names></name><name><surname>Wang</surname> <given-names>Q</given-names></name><name><surname>Fan</surname> <given-names>Z</given-names></name><name><surname>Gao</surname> <given-names>G</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>TRIM25 is required for the antiviral activity of zinc finger antiviral protein</article-title><source>Journal of Virology</source><volume>91</volume><elocation-id>e00088</elocation-id><pub-id pub-id-type="doi">10.1128/JVI.00088-17</pub-id><pub-id pub-id-type="pmid">28202764</pub-id></element-citation></ref><ref id="bib199"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zou</surname> <given-names>J</given-names></name><name><surname>Wang</surname> <given-names>C</given-names></name><name><surname>Ma</surname> <given-names>X</given-names></name><name><surname>Wang</surname> <given-names>E</given-names></name><name><surname>Peng</surname> <given-names>G</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>APOBEC3B, a molecular driver of mutagenesis in human cancers</article-title><source>Cell &amp; Bioscience</source><volume>7</volume><elocation-id>29</elocation-id><pub-id pub-id-type="doi">10.1186/s13578-017-0156-4</pub-id><pub-id pub-id-type="pmid">28572915</pub-id></element-citation></ref></ref-list></back></article>